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1. Introduction 
1.1. mRNA localization, a conserved process essential for somatic 
cell polarity and embryonic development. 
 
Cytoplasmic mRNA localization is a powerful mechanism for generating spatially restricted 
protein function in a variety of organisms and cell types. Virtually every cell that 
demonstrates some form of asymmetry will almost certainly contain some unevenly 
distributed RNAs. Such localized mRNAs are not instantly subjected to translation but first 
are targeted to specific destinations for local translation. Thereby gene expression can be 
locally regulated on a post-transcriptional level. After description of the signal peptide and 
other protein resident sorting signals (von Heijne, 1990) it was thought for some time that 
protein targeting to specific subcellular locations was solely performed following translation. 
However it soon became clear that localization of mRNAs can serve as an important tool to 
create the basis for local protein expression prior to translation (Bassell et al., 1999; Jansen, 
2001; Shav-Tal et al., 2005).  
One major advantage of localizing an mRNA rather than the encoded protein is that on a 
single transported message several rounds of translation can occur at a specific subcellular 
location. From an energetic point of view this is therefore more favourable since it helps 
cutting the cell’s energy cost for transport. Secondly, the local distribution of a transcript 
helps to prevent the unwanted and perhaps even deleterious expression of a protein in other 
regions of the cell. Finally, mRNA targeting and the resulting local translational control 
enables a fast and independent regulation of protein expression in different parts of the cell. 
In the nervous system, for instance, this allows for a quick response to synaptic stimuli in 
peripheral regions of neurons far from translational events in the cell body. 
Until recently, estimations had envisaged that in Drosophila only 1-10% of all transcripts are 
distributed to specific sites prior to translation (Palacios et al., 2001). However, last year a 
milestone publication in Cell (Lecuyer et al., 2007) made clear that the importance of mRNA 
localization seems to be far higher than expected until then. Lecuyer and co-workers 
reported that the majority - that is to say 71% - of the embryonically expressed mRNAs in 
Drosophila are targeted to specific sites and the authors propose that the process of mRNA 
localization is involved in the majority of cellular processes.  
In general, mRNA localization is an important contributor to cell polarity in both somatic cells 
and oocytes. Within somatic cells this process is crucial for the establishment and 
maintenance of cell morphology and motility. In the case of oocytes and embryos, mRNA 
trafficking is the basis for patterning during embryonic development. 
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1.1.1. mRNA localization in polarized somatic cells 
1.1.1.1. Migrating fibroblasts 
 
As mentioned above, mRNA sorting is also crucial in somatic cells. In asymmetric cells like 
migrating fibroblasts this process is important for establishment and maintenance of cell 
polarity. One of the best characterized examples is ß-actin mRNA. In several motile cell 
types, -actin mRNA is targeted to the leading edge of lamellipodia (Condeelis & Singer, 
2005). These flattened cytoplasmic extensions are actin rich and polymerizing actin filaments 
provide the protrusive force for the extension of lamellipodia during cell motility. In case of 
the ß-actin transcript, mRNA targeting is thought to facilitate the compartmentalized 
assembly of a multifactor complex, i.e. ß-actin filaments. RNA localization apparently creates 
a microenvironment in which the newly synthesized actin monomers are available at much 
higher concentration. As ß-actin translation occurs in a restricted cell compartment like the 
thin lamellipodium (Rodriguez et al., 2006), elevated local levels of ß-actin monomers can 
considerably enhance the dynamics of actin polymerization. Additionally, mRNA localization 
easily allows for sorting of specific actin isoforms. Since only ß-actin, but not - or -actin 
mRNA, is targeted to the cell periphery in moving cells (Kislauskis et al., 1993), its local 
translation probably prevents formation of unwanted isoform heteromers. The importance of 
mRNA localization in migrating cells becomes clear upon their failure to correctly target ß-
actin mRNA which leads to an impaired cell morphology and motility (Kislauskis et al., 1997). 
Even more severe, the loss of cell polarization due to mistargeting of ß-actin mRNA can have 
deleterious effects such as the gain of metastatic potential in tumour cells (CondeelisSinger 
et al., 2005; Shestakova et al., 1999). 
 
1.1.1.2. Neurons 
 
Another somatic cell structure in which cellular asymmetry is especially critical is the nervous 
system. Neurons transmit electrical and chemical signals and they use their intrinsic polarity 
to split signal input and output domains. For this purpose, they develop two types of 
processes, axons and dendrites, and to make it even more challenging, these have further 
specialized functional areas such as growth cones and synapses. To establish and maintain 
this polarity the different domains must vary in their protein composition. One way to achieve 
this is by selected mRNA targeting and localized translation within dendrites and axons (Job 
et al., 2001). Therefore, RNA localization is a widespread phenomenon in neurons.  
To list only a few examples: messages coding for microtubule-associated protein MAP2 
(Garner et al., 1988), Arc (activity-related cytoskeletal protein) (Steward et al., 1998), the -
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subunit of Calcium/Calmodulin dependent Kinase II (CaMKII) (Mayford et al., 1996), ß-actin 
mRNA (Tiruchinapalli et al., 2003) localize to dendrites whereas tau mRNA (Aronov et al., 
2002) and again ß-actin mRNA (Bassell et al., 1998) are known to travel along axons. 
For many candidates detailed knowledge about the functional significance of their 
localization has not yet been derived. Nevertheless, there are more and more indications that 
mRNA localization is essential for the establishment and maintenance of neuronal and 
synaptic morphology. mRNA targeting obviously contributes to the growth of developing 
axons and enhances growth cone dynamics and consequently axon guidance (Steward, 
2002). In addition, there is growing evidence that mRNA targeting and local translation are 
crucial for the formation of synaptic plasticity which is involved in higher brain functions as 
learning and memory (Martin, 2004; Sutton et al., 2006). 
 
Figure 1: mRNA localization in higher eukaryotes (pictures taken from (Dahm et al., 2005; St 
Johnston, 1995, 2005))  
(A) In cultured hippocampal neurons, -actin mRNA granules (red) localize to developing axons. An 
axonal marker is shown in green, arrows indicate -actin mRNA particles.  
(B) ß-actin mRNA is targeted to the leading edge of migrating fibroblasts.  
(C and D) Localization of Vg1 and Xcat2 mRNA, respectively, to the vegetal pole of Xenopus 
occytes.  
(E, F and G) Drosophila embryos with specifically sorted mRNAs: oskar, bicoid and gurken. 
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1.1.2. mRNA localization in oocytes and developing embryos 
1.1.2.1. Drosophila melanogaster 
 
From what is known so far, mRNA localization in non somatic cells is primarily involved in 
developmental processes. For instance in the Drosophila embryo, proper development is 
dependent on regionalization of both proteins and RNAs (Palacios et al., 2001). The large 
number of localized mRNAs in Drosophila mentioned earlier (Lecuyer et al., 2007) indicates 
that mRNA sorting is important for a vast number of cellular processes. However, the best 
characterized mRNAs that are localized asymmetrically within the developing egg or 
syncytial embryo are the ones involved in determination of the oocyte, specification of 
embryonic axes, and establishment of germ cells in Drosophila. Amongst them are for 
example maternal mRNAs encoding anterior and posterior determinants like oskar (osk), 
bicoid (bcd) or nanos (nos) (Lasko, 1999). 
One of the first RNAs to localize during oogenesis is osk mRNA. The targeting of osk 
message to the posterior pole initiates assembly of the germ plasm (Lasko, 1999). Two other 
transcripts, nos and bcd are localized to opposite poles of the oocyte. nos accumulates at the 
posterior pole at the end of oogenesis. Its mRNA localization requires Oskar protein and thus 
depends on the prior posterior targeting of osk mRNA (Johnstone et al., 2001). bcd mRNA 
becomes localized to the anterior pole during late stages of oogenesis. The encoded protein, 
a transcription factor, then forms a morphogenic gradient along the embryo by diffusion from 
the anterior pole (Ephrussi et al., 2004).  
Another localized transcript, gurken (grk) mRNA, encodes the Drosophila homolog of TGF. 
Its localization to the antero-dorsal region of the oocyte is not only crucial for establishment 
of the antero-posterior axis but also for outlining the dorso-ventral axis (Johnstone et al., 
2001). 
The aforementioned mRNAs represent only a minute fraction of all localized transcripts but 
they illustrate that mRNA sorting in Drosophila is crucial for normal establishment of the 
embryonic body plan. 
 
1.1.2.2. Xenopus laevis 
 
Also in another organism, Xenopus laevis, localization of numerous mRNAs to either the 
animal or the vegetal hemisphere of the oocyte coincides with polarity along the 
animal/vegetal axis (Kloc et al., 2005). Oogenesis in Xenopus is divided into six stages and 
during this time period the animal/vegetal axis is developed. This axis then determines the 
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fate map of the three primary germ layers in the future embryo: endo-, meso- and ectoderm. 
The animal hemisphere of the oocyte later on gives rise to ectodermal components like the 
skin and the nervous system. The progeny of the vegetal pole follow endodermal fates 
primarily forming the gut. Finally, cells in the equatorial or marginal zone will build the 
mesoderm and thus elements like muscles, blood and bones. Amongst the transcripts 
localized to the animal hemisphere are for instance An1 (a ubiquitin like fusion protein), An2 
(a mitochondrial ATPase subunit) and An3 (a DEAD box RNA helicase). Examples for 
vegetally sorted messages are Xcat2 (Zn finger protein), Xdazl (RNA binding protein), VegT 
(T-box transcription factor) and Vg1 (a TGF-ß family member) (King et al., 2005). 
One interesting feature about mRNA localization to the vegetal cortex in Xenopus oocytes is 
that vegetally localized RNAs follow two distinct sorting pathways and arrive at the cortex 
during different phases of oogenesis. These two chronologically different mechanisms are 
termed “early” and “late” pathway (Figure 2) (Kloc et al., 1995). 
 
Figure 2: Early and late mRNA localization pathway in Xenopus 
Early stage I: The Vg1 mRNA (red dots) is homogenously distributed throughout the cytoplasm while 
the early mRNAs are located within the METRO (messenger transport organizer) of the MC 
(Mitochondrial cloud) (blue). Late stage I: A cap of ER forms at the nuclear side of the MC and the 
METRO including the early mRNAs migrates towards the vegetal pole. Stage II: Formation of a 
wedge shaped ER structure (green) when the early mRNAs are located as an apical disk at the 
vegetal pole (blue). Vg1 mRNA co-localizes with this ER subdomain. Stage III: Translocation of Vg1 
mRNA to the vegetal cortex, a process probably mediated by the ER. 
 
The early pathway or METRO pathway localizes mRNAs such as Xcat2 and Xdazl in stage I 
and II oocytes using a specialized structure referred to as the METRO (messenger transport 
organizer). In a first step, early mRNAs localize to a macroscopic structure called the 
mitochondrial cloud (MC) in late stage I. The MC is an accumulation of mitochondria 
enclosed by electron-dense material that lies on the presumed vegetal side of the oocyte 
nucleus. The fraction of the MC that contains early localizing transcripts is the METRO. Via 
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this structure, the messages are then translocated to a dense, disk shaped region at the 
apex of the vegetal pole in stage II (Mowry et al., 1999). 
The late or Vg1 pathway localizes mRNAs such as VegT and Vg1. During stage I and early 
stage II, when METRO RNAs are localized, late mRNAs like Vg1 are uniformly distributed 
throughout the cytoplasm and excluded from the MC. Vg1 starts to localize only when the 
MC arrives at the vegetal cortex, breaks down and the early RNAs become associated with 
the vegetal cortex. Concomitantly to this events a unique ER structure forms in a wedge 
shaped zone between the oocyte nucleus and the vegetal pole. Vg1 then accumulates and 
co-localizes with this specialized ER subdomain. During stages III and IV, Vg1 translocates 
to the vegetal cortex where, in contrast to the early transcripts, it becomes broadly 
distributed. By stages V to VI, Vg1 mRNA inhabits a thin cortical layer reaching from the 
vegetal pole up to equatorial zone (King et al., 2005).  
Although occurring during different stages of oogenesis, both pathways are indispensable for 
normal development and differentiation of the Xenopus embryo. 
 
1.2. Mechanisms of mRNA localization 
 
There are a few mechanistic options on how asymmetric sorting of newly synthesized 
transcripts can occur.  
First, the probably easiest way to achieve regionalization of mRNAs is their local synthesis. 
This is the case for example in mammalian myofibres, large multinucleated, syncytial cells. 
The mRNAs for - and -subunits of the acetylcholine receptor are exclusively transcribed in 
the nuclei which are directly adjacent to the neuromuscular junctions. This local transcription 
process generates the mRNAs for the receptor subunits right at the synapse, their future site 
of function (St Johnston, 2005). 
Secondly, non-uniform distribution of messages can be driven by a vectorial nucleo-
cytoplasmic export from one side of a nucleus only. In the biflagellated single cell algae 
Chlamydomonas reinhardtii for instance, ß2-tubulin mRNA is enriched at the posterior region 
of the cell which contains a high concentration of ribosomes. The basis for this phenomenon 
is probably the preferred positioning of nuclear pore complexes (NPCs) at the posterior side 
of the nucleus. Apparently this targets the messages to the translation “hot spots” in order to 
achieve high levels of protein expression (Palacios, 2007).  
Thirdly, mRNA shuttling to specific sub-cellular regions can be achieved by passive diffusion 
and entrapment at their final destination via a previously localized anchor. Cytoplasmic 
streaming events probably facilitate movement by diffusion. nanos mRNA in Drosophila is 
segregated to the posterior pole of the embryo by such a mechanism (Forrest et al., 2003) 
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and in Xenopus, the same is true for the early pathway transcripts Xcat2 and Xdazl 
(Palacios, 2007). 
An additional way to achieve compartmentalization of transcripts within a cell or embryo is 
the spatial control of mRNA stability. In case of hsp83 mRNA in Drosophila, generalized 
degradation combined with local protection creates its asymmetric distribution. In the 
beginning, hsp38 transcript is dispersed uniformly throughout the entire embryo. Its levels 
are then strongly reduced with exception of the pole plasm where a protection factor 
mediates its posterior stabilization (Lipshitz et al., 2000). For hunchback mRNA on the other 
hand its localized degradation not its localized protection confers asymmetry. The anterior-
posterior gradient for hunchback transcript is created by posterior Nanos protein which 
inhibits hunchback translation and thereby causes its instability at the posterior pole (St 
Johnston, 1995). 
Finally, the probably most studied mechanism to establish asymmetric mRNA patterning is 
directed cytoplasmic transport (St Johnston, 2005). This active translocation process occurs 
along cytoskeletal elements such as microtubules or actin filaments and is mediated by 
members of all three motor protein groups i.e. myosin, kinesin or dynein families (Bullock, 
2007). In general, such localized mRNAs contain cis-acting localization elements or 
“zipcodes”. These specific sequence elements are mainly found in the untranslated regions 
(UTRs) of the transcripts and form secondary or tertiary structures as recognition sites for 
RNA-binding proteins (RBPs). RBPs and additional trans-acting factors then couple the 
corresponding transcripts to the locomotion machinery (ChabanonMickleburgh et al., 2004; 
Hamilton et al., 2007; Jambhekar et al., 2007). In a last step, the mRNAs need to be retained 
at their final destination by anchoring (Czaplinski et al., 2006). CaMKII mRNA in neurons 
(Mayford et al., 1996), bcd, osk and grk mRNA in Drosophila (Johnstone et al., 2001): 
examples for actively transported messages exist throughout all kinds of organisms and cell 
types and amongst them also in the yeast Saccharomyces cerevisiae. 
 
1.3. mRNA localization in S. cerevisiae 
 
The unicellular yeast Saccharomyces cerevisiae is a model system for establishment of cell 
polarity. Yeast cells proliferate by budding, a process involving the development and 
asymmetric enlargement of the bud which finally pinches off to form a new daughter cell. 
This asymmetric cell division proceeds in a stem cell like fashion meaning that the division 
gives rise to two sister cells with different fates. This is achieved by segregation of 
determinants such as localized proteins and mRNAs which then establish distinct cell fates 
for the mother and the daughter cell (Horvitz et al., 1992). 
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In yeast mRNA localization serves as an important mechanism for the polarized inheritance 
of cell fate determinants during asymmetric cell division and probably the best characterized 
example so far is the localization of ASH1 mRNA to the bud tip of the daughter cell.  
 
1.3.1. ASH1 mRNA - the most prominent localized mRNA in yeast regulates 
mating type switching 
 
The asymmetric localization of ASH1 mRNA in yeast serves to control the process of mating 
type switching. S. cerevisiae has the capability to swap between a diploid and a haploid 
growth form. Upon nutrient deprivation, diploids can partition themselves to four haploid 
spores by meiosis and in return, the way back to a diploid state is achieved by the fusion of 
two haploid cells with opposite mating type (a or ). During the vegetative growth phase of 
haploid cells, mothers and daughters have distinct fates in terms of interconversion between 
a and  mating types. Only mother cells can undergo mating type switching and never 
daughter cells. This assures that an isolated haploid spore can again form a diploid cell by 
fusion with its progeny.  
On the molecular level this is achieved by exclusively expressing the HO endonuclease in 
mother not daughter cells. HO endonuclease initiates mating type switching by genomic 
rearrangement of the MAT locus which then leads to the alteration of a cell from a to  or 
vice versa (Cosma, 2004). In a daughter cell, expression of the HO endonuclease is 
specifically repressed due to the uneven accumulation of the transcriptional inhibitor Ash1p 
in daughter but not mother cell nuclei (Bobola et al., 1996b; Jansen et al., 1996; Sil et al., 
1996). This non-uniform Ash1p expression pattern results solely from the asymmetric 
targeting of its mRNA to the bud tip of the daughter cell (Chartrand et al., 2002; Long et al., 
1997; Takizawa et al., 1997) (Figure 3).  
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Figure 3: Localization of ASH1 mRNA regulates mating type switching in Saccharomyces 
cerevisiae: ASH1 mRNA is targeted to the bud tip during late anaphase. This results in the exclusive 
expression of the Ash1p transcription repressor in the nucleus of the daughter cell. Therefore only in 
the daughter cell expression of the HO endonuclease and hence mating type interconversion is 
suppressed. 
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Within the ASH1 transcript, four cis-acting localization signals, also termed “zipcodes”, are 
responsible for its targeting to the yeast bud tip (Chartrand et al., 2002; Chartrand et al., 
1999; Gonzalez et al., 1999). Three of these localization elements (LEs) lie within the coding 
sequence of the mRNA: E1 (115 bp), E2A (118 bp) and E2B (250 bp). The fourth zipcode, 
E3 (118 bp), extends into the 3’UTR and it consists of the last 15 bp of the coding sequence, 
the stop codon and 100 bp of the 3’UTR (Chartrand et al., 1999). The four LEs are 
functionally redundant since each of them is sufficient to mediate targeting of a reporter 
mRNA to the bud tip (Chartrand et al., 2002). Each LE can be bound by the RNA binding 
protein She2p (Bohl et al., 2000; Long et al., 2000). All four LEs in concert have a synergistic 
effect and together they increase the frequency and efficiency of the mRNA translocation 
process (Bertrand et al., 1998; Long et al., 1997; Takizawa et al., 1997). 
The comparison of all four ASH1 LE sequences did not show any obvious sequence 
homologies implying that rather structure not primary sequence serves as the sorting signal. 
In addition, the zipcodes were predicted to form RNA secondary structures containing stem-
loops (Chartrand et al., 2002; Chartrand et al., 1999; Gonzalez et al., 1999). Recently a 
conserved RNA motif was identified which is necessary for bud localization of ASH1 and two 
other localized yeast mRNAs (IST2 and EAR1). This motif consists of a CGA triplet in a loop 
combined with a single-stranded cytosine six bases from and on the opposite side of the 
triplet (Olivier et al., 2005). Another study identified a motif which is applicable to a larger 
group of localized yeast mRNAs and consists of a conserved, single-stranded, seven base 
motif containing a CG dinucleotide though the structural context of this motif also seems to 
be of great relevance (Jambhekar et al., 2005). These data indicate that She2p recognizes 
very precise, three dimensional structures in the zipcodes of its mRNA targets (Jambhekar et 
al., 2007). 
The ASH1 zipcodes seem to have an additional role besides mediating the mere transport of 
mRNAs. Apparently they keep the localizing messages in a translationally-quiescent state 
while those are on their way to the bud tip. This translational silencing suppresses 
unintended Ash1p expression in the mother cell (Chartrand et al., 2002). However, as we will 
see later in this section, translational repression also depends on some cooperating trans-
acting factors (Section 1.3.2.2.) 
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1.3.2. Trans-acting factors: the mRNA localization machinery 
1.3.2.1. The core locasome 
 
In the original genetic screen selecting for mutants defective in asymmetric expression of HO 
endonuclease, five genes SHE1-5 were identified (Jansen et al., 1996). Three of them 
namely SHE1, SHE2 and SHE3 code for proteins which together form the so called core 
locasome (Figure 4). This heterotrimeric complex essential for mRNA transport consists of 
the motor protein Myo4p/She1p, the RNA binding protein She2p, and She3p, the adaptor 
protein bridging the other two components. All three factors of the core locasome co-localize 
in vivo with each other and with the transported ASH1 mRNA (Bohl et al., 2000; Gonsalvez 
et al., 2004; Long et al., 2000; Takizawa & Vale, 2000).  
 
 
Figure 4: Components 
of the core locasome 
The central machinery of 
mRNA localization in 
yeast consists of three 
components: the mRNA 
binding protein She2p, 
the adaptor protein She3p 
and a motor protein of the 
type V family of myosins, 
Myo4p. 
 
 
1.3.2.1.1. Myo4 (She1p), a motor protein of the myosin V family 
 
mRNA localization in yeast is dependent on the actin cytoskeleton as latrunculin-A, an actin 
filament disrupting drug or the use of mutants leading to the depolymerization of actin cables 
both result in the loss of ASH1 mRNA targeting (Long et al., 1997; Takizawa et al., 1997). 
The actin based motor essential for mRNA localization in yeast is She1p, also named 
Myo4p, a nonessential motor protein of the class V myosin family (Jansen et al., 1996). 
Studies in living yeast demonstrated that Myo4p is the factor which actively transports the 
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ASH1 cargo along polarized actin cables (Beach et al., 1999; Bertrand et al., 1998; Munchow 
et al., 1999).  
Besides Myo4p there is a second type V myosin in yeast, Myo2p. In contrast to Myo4p, 
Myo2p is essential in yeast and it is responsible for the transport of the vacuole, post-Golgi 
vesicles, the trans-Golgi-network, peroxisomes and mitochondria and for the proper 
orientation of the mitotic spindle (Altmann et al., 2008; Pruyne et al., 2004). However, Myo4p 
is the only motor protein in yeast which mediates mRNA localization, but like Myo2p, Myo4p 
is a motor with very low processivity (Reck-Peterson et al., 2001). Therefore the presence of 
several zipcodes in a localized mRNA like ASH1 presumably helps to assure continuous 
movement of the cargo (Darzacq et al., 2003). In the absence of She3p, Myo4p does not 
translocate to the bud tip. This suggests that Myo4p must associate with its transport cargo 
or as a minimum with its adaptor She3p in order to localize to the bud tip (Jansen et al., 
1996). 
 
1.3.2.1.2. She3p, the adaptor protein 
 
The adaptor protein She3p is necessary for Myo4p’s association with the She2p-mRNA 
complex. She3p displays the characteristics of a bona fide adaptor: it interacts with the RNA 
binding protein She2p via its C-terminus while it can bind to the coiled-coil region and the C-
terminal tail of Myo4p via its N-terminus thereby linking the motor to its cargo complex (Bohl 
et al., 2000; Heuck et al., 2007; Long et al., 2000; Takizawa & Vale, 2000). 
Interestingly the requirement of She2p for RNA localization can be circumvented by directly 
tethering the mRNA to She3p. If the MS2 coat protein (MS2-CP) is fused to She3p and a 
reporter mRNA contains the MS2 loops which are bound by the MS2-CP, this mRNA 
becomes correctly targeted even in absence of She2p (Long et al., 2000). This confirms that 
the Myo4 protein is recruited to the mRNA via the adaptor protein She3p which in turn binds 
to the RNA binding protein She2p. 
 
1.3.2.1.3. She2p, an unconventional RNA-binding protein 
 
Amongst the group of SHE genes, only the 28 kDa protein She2p associates specifically with 
all four LEs, albeit with weak affinity in the nano-molar range (Chartrand et al., 1999; 
Niessing et al., 2004). It is the key player for mRNA localization as it binds to the zipcodes 
even if the other SHE genes are deleted (Bohl et al., 2000; Takizawa & Vale, 2000). 
However, She2p-mRNA binding seems to be enhanced in the presence of She3p (Bohl et 
al., 2000). 
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By sequence analysis, She2p is an non-canonical RNA-binding protein lacking so far 
described RNA-binding domains such as RRMs (RNA-recognition motif) or KH-domains 
(heterogeneous nuclear (hn)RNP K-homology domain) (Lunde et al., 2007).  
 
 
 
Figure 5: X-ray structure of She2p homodimer (Figure adapted from Niessing et al., 2004). 
(A) Stereoview of the She2p homodimer with each monomer in blue or green (PyMOL, DeLano 
Scientific, CA). Vertical line labeled with “2-fold” indicates the axis of 2-fold non-crystallographic 
symmetry relating the halves of the homodimer. Arrows on the green subunit denote the two -
helices of the basic helical hairpin, containing residues required for RNA binding. (B) GRASP surface 
representation of the chemical properties of the solvent-accessible surface of She2p. The surface 
electrostatic potential is colour coded red and blue, representing electrostatic potentials between 
< 14 to > +14 kBT, where kB is the Boltzmann constant and T is the temperature. Orientation is 
identical to (A). (C) Stereoview of (A) rotated 90° around the vertical axis. Dotted lines represent an 
eight amino acid gap in the final refinement model.(D) GRASP surface representation of (B) rotated 
90° around the vertical axis. 
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From X-ray structural analysis (Figure 5) it is known that the She2 polypeptide folds into a 
single globular domain consisting of a bundle of five antiparallel -helices with a small 
additional helix protruding at right angles form the middle of the globular domain. 
Furthermore, there is an unstructured loop which projects at the bottom of the She2p 
molecule (Niessing et al., 2004). Two globular She2p monomers form a symmetric 
homodimer and this pairing is essential for She2p function. If dimerization is disrupted like in 
the case of the S120Y or C68Y mutant protein, She2p does neither efficiently bind mRNA in 
vitro nor does it correctly localize ASH1 mRNA in yeast cells (Niessing et al., 2004). The 
comparison of the She2p structure to other structures available in databases, lead to the 
conclusion that She2p displays a novel protein fold and is a completely unconventional RNA-
binding protein. Apparently one of these She2p homodimers binds to one mRNA zipcode 
element (Niessing et al., 2004). 
 
From previous studies it is known that She2p’s RNA-binding activity lies within the first 70 
amino acids since the deletion of this domain disrupts its ability to co-precipitate ASH1 
mRNA (Kruse et al., 2002). Consistent with this, another study identified five amino acid 
residues involved in mRNA binding within these first 70 amino acids (Asn36, Arg43, Arg44, 
Arg52 and Arg63). If these specific residues e.g. Asn36 or Arg63 were converted to Ser or 
Leu respectively (N36S, R63K), these She2p mutants lost the ability to bind mRNA in vivo 
and in vitro (Gonsalvez et al., 2003). From the She2p X-ray structure it became clear that 
these five residues lie within a surface area with positive electrostatic potential. This basic 
surface patch (Figure 5) is exceptional compared to the remaining exterior of She2p which in 
large parts is negatively charged. This positively charged surface area consisting of two 
antiparallel -helices separated by a loop is now defined as the “basic helical hairpin” RNA 
binding motif of She2p (Niessing et al., 2004).  
In addition to the basic helical hairpin as the primary mRNA binding site, a conserved, 
uncharged surface patch at the top of the She2p dimer is also important for its function. 
Mutation of Leu130 to Tyr (L130Y) also leads to a reduced in vitro RNA binding activity of 
She2p (Niessing et al., 2004) which is consistent with data showing that the L130S mutant is 
impaired in ASH1 mRNA localization (Gonsalvez et al., 2003). 
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1.3.2.2. Other trans-acting and accessory factors for mRNA localization 
 
Besides the three components of the core locasome, two additional genes, SHE4 and SHE5, 
were identified in the original genetic screen to have a defect in ASH1 mRNA localization 
(Jansen, 2001). She4p is a member of the UCS class of proteins that are involved in the 
proper folding of myosin motor domains (Yu et al., 2003). She4p was reported to associate 
with the motor domains of the yeast class V myosin Myo4p and the class I myosin Myo5p 
through its UCS domain (Toi et al., 2003; Wesche et al., 2003). This indicates that She4p 
might act as a myosin “chaperone” for Myo4p, assuring its proper folding and function and 
thus also to guarantee the integrity of the mRNA targeting motor. In she5 mutants, ASH1 
mRNA mislocalizes to the bud neck (Takizawa et al., 1997). She5p/Bni1p is a formin that 
acts in the nucleation of actin filament assembly (Evangelista et al., 2003) and mRNA 
mistargeting probably results from defects in the actin cytoskeleton (Gonsalvez et al., 2004). 
 
In addition to the She proteins, three other trans-acting factors essential for ASH1 mRNA 
localization have been identified: Khd1p, Puf6p and Loc1p. 
Two of them, Khd1p and Puf6p act as translational repressors while the mRNA cargo is en 
route to its final destination (Gu et al., 2004; Irie et al., 2002). Both of them are regulated by 
yeast kinases at the plasma membrane and their phosphorylation causes their dissociation 
from the ASH1 mRNA and finally leads to the release of the message from translational 
silencing (Deng et al., 2008; Paquin et al., 2007). Khd1p is a protein containing three KH-
domains, it binds the E1 element of ASH1 mRNA (Irie et al., 2002) and the kinase regulating 
its function is the casein kinase I (Yck1p) (Paquin et al., 2007). Puf6p is a member of the 
PUF family of highly conserved RNA-binding proteins and it binds to the conserved PUF 
binding element UUGU in the E3 LE of ASH1 mRNA (Gu et al., 2004). In analogy to Khd1p, 
the translational repression by Puf6p is terminated by the casein kinase II (Ykc2p) (Deng et 
al., 2008).  
An exclusively nuclear protein with a role in mRNA localization is Loc1p. Loc1p binds to the 
ASH1 E3 element and the transcript is delocalized in loc1 mutants (Long et al., 2001). 
However, Loc1p so far was mainly described as a factor involved in ribosome biogenesis 
(Harnpicharnchai et al., 2001; Urbinati et al., 2006). Recently it was found that Loc1p also 
influences translational regulation of ASH1 mRNA as Ash1p levels are increased in loc1 
cells (Komili et al., 2007) and (T. G. Du et al., 2008).  
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1.3.3. Additional localized mRNAs in S. cerevisiae 
 
ASH1 was the first localized mRNA discovered in S. cerevisiae but meanwhile 23 additional 
transcripts were identified to be actively transported to the bud tip. For this, 
immunoprecipitation experiments with tagged versions of the core locasome proteins 
(Myo4p, She3p and She2p) were combined with DNA microarray technology from the 
associated RNAs (Shepard et al., 2003; TakizawaDeRisi et al., 2000). The potential mRNA 
candidates were then validated by FISH (TakizawaDeRisi et al., 2000) or in a living cell GFP-
RNA assay (Shepard et al., 2003). All newly identified 23 mRNAs are localized to the tip of 
growing buds in a SHE dependent manner. However, only 8 of them display asymmetric 
distribution of the encoded protein, the others are located symmetrically in mother and 
daughter cells.  
One such targeted message is IST2 mRNA, which encodes an integral plasma membrane 
protein (Takizawa & Vale, 2000). Ist2p is symmetrically distributed between mother and 
daughter cells if expressed from its endogenous promoter. In this case, mRNA localization is 
the prerequisite for Ist2p to be synthesized in the bud. Upon deletion of the She-machinery, 
Ist2p is mostly excluded from the plasma membrane of daughter cells (Juschke et al., 2004). 
However, some Ist2p also reaches the daughter cells even in absence of mRNA transport 
and this is due to a recently identified peptide-sorting signal (Franz et al., 2007).  
Unlike Ash1p or Ist2p, the localization of the other proteins encoded by targeted mRNAs is 
unaltered in she2deletion mutants, even if the protein distribution is asymmetric (Shepard 
et al., 2003). This indicates that in these cases mRNA localization is not the key determinant 
and might serve as a redundant mechanism in addition to protein resident sorting signals. 
Eleven out of the 24 localized mRNAs are expressed only at specific stages of the cell cycle. 
Though the encoded proteins have diverse functions some of them are involved in common 
processes belonging to yeast stress signalling and response pathways and the synthesis and 
remodelling of the plasma membrane and the cell wall (Shepard et al., 2003). 
Finally one of the most remarkable features of all targeted mRNAs is that the majority and to 
be precise 16 out of 24 transcripts encode membrane or membrane associated proteins 
(Table 1).  
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 Shepard et al., 2003 SGD (http://www.yeastgenome.org) 
mRNA Cell cycle regulation Protein Localization 
Cellular 
compartment of the 
encoded protein 
signal 
peptide 
predicted 
TMDs 
ASH1 M bud nucleus nucleus - - 
BRO1 None punctae on vacuole 
cytoplasm, 
endosomes, 
membranes 
- - 
CLB2 M nuclei, spindle pole nucleus - - 
CPS1 None cytoplasmic punctae vacuole Yes 1 TMD 
DNM1 S mitochondrial periphery outer mitochondrial membrane - - 
EGT2 M membranes,  large-bud enriched cell wall Yes GPI anchor 
ERG2 M ER ER Yes 1 TMD 
IST2 None bud plasma membrane plasma membrane, cell periphery - 8 TMDs 
MID2 None cell periphery,  mother-bud junction 
plasma membrane, 
cell periphery Yes 1 TMD 
MMR1 M bud sites & tips,  mother-bud junction 
outer mitochondrial 
membrane - - 
SRL1 G1 periphery of small buds cell wall Yes - 
TPO1 M bud plasma membrane ER, cell periphery, bud - 12 TMD 
WSC2 S membranes,  bud enriched cell periphery Yes 1 TMD 
TAM41 None mitochondria mitochondria - - 
IRC8 M membranes,  bud enriched no localization data Yes 4 TMD 
YLR434C None mitochondria no localization data - - 
TCB3 G2 membranes,  bud enriched cell periphery - 1 TMD 
EAR1 None ER endosomes Yes 1 TMD 
TCB2 None membranes, bud enriched cell periphery - 1 TMD 
KSS1 None not defined cytoplasm, nucleus - - 
LCB1 None ER ER - - 
MET4 None nuclei nucleus - - 
MTL1 None not defined no localization data Yes 1 TMD 
YPL066
W None not defined bud neck   
 
Table 1: Localized mRNAs in S. cerevisiae: table 1 gives an overview of yeast localized mRNAs 
and their important characteristics. Grey cells mark mRNAs encoding membrane or secreted 
proteins. The acronym “TMD” in the last column stands for transmembrane domain. 
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1.4. Inheritance of cortical endoplasmic reticulum in S. cerevisiae 
 
Interestingly, two components of the yeast mRNA localization machinery, namely the adaptor 
protein She3p and the motor protein Myo4p, have been identified as crucial players in a 
second bud directed transport procedure: the segregation of cortical endoplasmic reticulum 
(ER). 
 
1.4.1. Structure and function of the ER 
 
One hallmark of eukaryotic cells in general is the separation of their cytoplasm into several 
membrane-bound compartments, i.e. organelles. This functional compartmentalization is 
beneficial but simultaneously confronts the cell with the task of maintaining its organelle 
population during each round of cell division (Fagarasanu et al., 2007). The ER is probably 
one of the more complex of these organelles since it is the key component to a variety of 
processes vital for the smooth functioning of eukaryotic cells. Morphologically and 
functionally it is divided into distinct subdomains: rough ER (rER), smooth ER (sER) and 
transitional ER (tER), which together accomplish a variety of functions (Estrada de Martin et 
al., 2005; Voeltz et al., 2007). 
The rER is characterized by membrane-bound ribosomes and is responsible for all 
processes linked to the biogenesis of secretory and membrane proteins. Proteins destined 
for secretion or membrane insertion mostly contain an N-terminal signal peptide and are 
recruited to the ER via the signal recognition particle (SRP)-pathway at the end of which they 
become co-translationally transferred through the translocon channel into the lumen or 
membrane of the ER (Figure 6) (Halic et al., 2005; Rapoport, 2007). Different luminal 
proteins then operate to assure the proper folding and core glycosylation of these secretory 
proteins (Kleizen et al., 2004; Ruddock et al., 2006). The sER, defined by the absence of 
membrane-associated ribosomes, functions in cellular processes like biosynthesis of 
phospholipids, cholesterol and steroids and detoxification reactions. In addition it can serve 
as a sequestering and storage site for Ca2+ which can then be released for signal 
transduction purposes. The tER is a particular type of sER where cargo packaging and 
vesicle budding and fusion take place – a reason why it is also termed ER exit site (Baumann 
et al., 2001).  
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Figure 6: The SRP-pathway: ribosome-mRNA-nascent polypeptide complexes displaying a signal 
peptide in the nascent chain are bound by the SRP (signal recognition particle) and recruited to the 
ER membrane via the SRP-receptor. At the ER membrane the proteins are co-translationally 
translocated across (for secreted proteins) or into (for transmembrane proteins) the ER membrane 
through the Sec61p translocon channel. 
 
 
In all cell types the ER builds a system of interconnected membranes with a common intra-
luminal space and is composed of sheet like cisternae and arrays of tubules. Frequently 
these ER structures even reach the outmost extensions of the cell (Voeltz et al., 2007). The 
ER can be further categorized into two classes: the perinuclear and the peripheral ER. The 
perinuclear ER consists of membrane sheets surrounding the nucleus and is contiguous with 
the nuclear envelope (NE). Except for minor differences in structural organization the 
peripheral ER in yeast resembles the one in higher eukaryotic cells. In those it takes up 
almost the complete cytoplasmic compartment. In budding yeast, the peripheral ER forms a 
highly dynamic network of interconnected tubules – similar to that of higher eukaryotes – but 
is positioned right underneath the cell cortex (Prinz et al., 2000). Therefore the peripheral ER 
is also termed “cortical ER” in S. cerevisiae. Only a few individual large tubules span the 
cytoplasm in order to connect the cortical ER and its perinuclear counterpart (Voeltz et al., 
2002).  
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1.4.2. Inheritance of the ER 
 
The ER is an organelle that cannot be simply synthesized de novo upon cell division but has 
to be passed on from the mother to the daughter cell (Y. Du et al., 2004). The fates of cortical 
and perinuclear ER during cell division however are quite different.  
Budding yeast undergoes closed mitosis meaning that the nuclear envelope and the 
surrounding ER remain intact. During M-phase, the perinuclear ER is therefore partitioned to 
the daughter cell along with the nucleus and the microtubule cytoskeleton is necessary for 
this transport process (Fagarasanu et al., 2007; Lowe et al., 2007).  
The inheritance of cortical ER precedes the segregation of perinuclear ER and it is 
dependent on actin cables as demonstrated by latrunculin A treatment, an actin filament 
disrupting drug (Estrada et al., 2003). From a mechanistic point of view, cortical ER 
inheritance is a multi-step procedure and is performed in a strictly ordered, cell cycle 
dependent manner (Figure 7).  
 
Figure 7: Inheritance of cortical ER in S. cerevisiae proceeds in several steps. (A) ER 
segregation structures i.e. ER tubules emanating from the perinuclear region of the mother cell move 
into the daughter cell along the mother-bud axis. (B) The tubules become anchored at the cortex of 
the bud tip. (C) These anchored, first cortical ER elements expand and finally fill in the whole cortex 
of the daughter cell building a reticular network like in the mother cell. 
 
The first step happens during early S-phase when a small bud has just emerged. 
Cytoplasmic ER tubules derived from the perinuclear region of the mother cell align along the 
mother-bud axis and migrate over this distance into the daughter cell (Estrada et al., 2003). 
These tubules, also termed “ER segregation structures” are the first ER elements appearing 
in the newly forming daughter cell (Estrada de Martin et al., 2005). This occurs shortly after 
the first secretory vesicles have reached the bud, but long before the nucleus starts to divide 
(Y. Du et al., 2001; Preuss et al., 1991). Secondly, the tubular elements become anchored to 
the plasma membrane at the bud tip and form the first building block of cortical ER. In a last 
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step, this first cortical domain extends into the whole bud forming a polygonal ER network 
like the one in the mother cell (Y. Du et al., 2004; Fehrenbacher et al., 2002).  
 
In order to identify components of the cortical ER inheritance machinery, several genetic 
screens have been performed in yeast.  
Some factors have been found whose exact role in ER segregation has not been unravelled 
so far. Amongst them is Ice2p, an integral membrane protein which is supposed to span the 
ER membrane multiple times. In cells lacking Ice2p, not only the transport of cortical ER into 
the daughter cell is impaired but also the structure of cortical ER network in the mother cell is 
strongly affected. Though the exact role of Ice2p still has to be determined, it seems to be 
important for morphology and segregation of cortical ER (Estrada de Martin et al., 2004). 
This contrasts the phenotype of other mutants in which only ER inheritance itself is impaired. 
Such a mutant is the aux1 deletion mutant. Aux1p (also called Swa2p) was previously 
described as a J-Domain-containing co-chaperone involved in the uncoating of clathrin-
coated vesicles. However it was shown recently that, independently from this function, it 
fulfils a second task in the process of cortical ER inheritance. Cells with a disruption of the 
AUX1 gene are defective in ER inheritance whereas the overall integrity of ER in the mother 
cell is maintained. Obviously Aux1p localizes to ER membranes but its role in ER inheritance 
remains elusive (Y. Du et al., 2001). 
In addition it has been reported that factors of the exocyst such as Sec3p, Sec5p and Sec8p 
are also involved in ER inheritance (Reinke et al., 2004; Wiederkehr et al., 2004; Wiederkehr 
et al., 2003). The exocyst is an octameric complex which is necessary for tethering secretory 
vesicles to the plasma membrane prior to their docking and fusion (TerBush et al., 1996). 
Sec3p is a non essential component since without it cells can still grow and undergo 
secretion. It is supposed to act as a spatial landmark for polarized secretion and in sec3 
cells vesicles are not targeted to the appropriate fusion sites. Additionally, cells lacking 
Sec3p have a defect in ER inheritance most likely because they fail to retain migrating ER 
tubules at the bud tip during the anchoring step (Wiederkehr et al., 2003). For the tubule 
anchoring process Sec3p might indirectly collaborate with members of the reticulon family 
(Rtn1p and Rtn2p) and Yop1 which are all conserved transmembrane proteins involved in 
generation and maintenance of ER tubules (De Craene et al., 2006; Hu et al., 2008; Voeltz et 
al., 2006). The three proteins are exclusively distributed to tubular ER structures and if they 
are all simultaneously deleted peripheral tubular ER is disrupted (Voeltz et al., 2006). 
Interestingly Rtn1p interacts with Sec6p, another exocyst component and this interaction 
might facilitate the attachment of ER tubules at the tip of the growing bud (De Craene et al., 
2006). In cells with a deficiency in anchoring, the process of cortical ER inheritance is 
considerably disturbed (De Craene et al., 2006; Wiederkehr et al., 2003). 
 Introduction  
 
 
  22   
 
Furthermore, another screen searching for cortical ER inheritance mutants identified genes 
involved in ER-to-Golgi transport like SEC21 and SEC23 and genes acting in the SRP-
dependent ER translocation pathway (Prinz et al., 2000). Amongst the second group are 
genes coding for the - and - subunit of the SRP receptor, SRP101 and SRP102. This 
receptor, a heterodimeric complex located in the ER membrane, acts together with its SRP 
(signal recognition particle) ligand to target ribosome-nascent polypeptide complexes to the 
ER membrane and to mediate co-translational protein translocation (Figure 6) (Halic et al., 
2005; Keenan et al., 2001). At restrictive temperature, srp101-47 and srp102-510 
temperature-sensitive (ts) strains, display abnormalities in the cortical ER structure of the 
mother cell and a defect in cortical ER inheritance (Prinz et al., 2000). The mechanistic 
details of this deficiency however are still unclear.  
Finally, as shortly mentioned at the beginning of section 1.4., the nonessential myosin V 
family motor protein Myo4 and the adaptor protein She3p were recently identified to be 
essential factors for segregation of cortial ER into daughter cells (Estrada et al., 2003). 
Previously, both proteins were described to be involved in the asymmetric localization of 
mRNA to the bud (Section 1.3.). However, in either a MYO4 or a SHE3 deletion strain also 
the process of ER inheritance is impaired (Estrada et al., 2003) and this is the only case so 
far where there is a clear explanation for this phenotype. A mutation in the ATP-binding 
region of the motor domain of Myo4 (myo4-1) had the same effect than the disruption of the 
whole MYO4 gene implying that the inheritance of peripheral ER in yeast is dependent on 
the motor activity of Myo4p. In contrast to the adaptor protein She3p, the mRNA binding 
protein She2p is not necessary for this process. Additionally, She3p and Myo4p both co-
fractionate with ER marker proteins in subcellular fractionation experiments indicating that 
the She3p/Myo4p motor complex is associated with ER. The ER is the only organelle whose 
partitioning is dependent on Myo4p (Estrada et al., 2003). Other organelles, like the vacuole, 
post-Golgi vesicles, the trans-Golgi-network, peroxisomes and mitochondria are transported 
by another type V myosin, Myo2p (Altmann et al., 2008; Pruyne et al., 2004). Thus, Myo4p 
and She3p seem to have a direct role in the inheritance of the cortical ER in yeast. Myo4p 
probably represents the motor driving the whole process and She3p might act as an adaptor 
which tethers Myo4p to the ER (Estrada et al., 2003). 
 
Even though it was claimed that the two processes of mRNA localization and ER inheritance 
are uncoupled from each other, the use of a common machinery still raises the question 
whether the two transport routes are coordinated.  
 
In previous chapters (1.1.1 and 1.1.2) we have seen that in higher eukaryotes, mRNA 
localization is a widespread mechanism to spatially control protein function. On the other 
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hand, as mentioned above, they also possess peripheral ER suggesting that this is not a 
yeast specific phenomenon. The major difference to yeast is, that those cells undergo an 
open mitosis in which the NE breaks down and according to the current model is 
concomitantly absorbed by the peripheral ER network (Estrada de Martin et al., 2005). 
Moreover, microtubular tracks and associated motors are most likely responsible for its 
segregation to daughter cells (Estrada de Martin et al., 2005; Lowe et al., 2007). Even in 
somatic cells forming cellular protrusions one can observe that – in analogy to yeast – the 
first elements moving into regions of asymmetric cellular growth are single ER tubules. 
These tubules then form the interconnected network of the peripheral ER in distant areas 
such as neuronal growth cones or fibroblast leading edges (Y. Du et al., 2004). 
As ER inheritance proceeds in a highly organized predictable manner in yeast, S. cerevisiae 
serves as a perfect model organism to study ER segregation and its relationship to other 
processes important for polarized growth like asymmetric mRNA localization. 
 
1.5. First indications for a link between mRNA localization and ER 
inheritance in S. cerevisiae 
 
The aforementioned discovery that two major players of the mRNA localization pathway, 
She3p and Myo4p are also involved in the process of ER inheritance raised the question, 
whether the two transport pathways could be linked.  
In a first attempt to analyze whether transport of tubular ER segregation structures and 
cytoplasmic mRNPs occur independently or in a coordinated way, mRNP and ER trafficking 
was followed simultaneously in vivo by Andreas Jaedicke in (Schmid et al., 2006). ER 
tubules were visualized by means of a constitutively expressed fusion of GFP with Hmg1p 
(hydroxymethylglutaryl-coenzyme A reductase), an ER-resident enzyme that catalyzes the 
production of mevalonate, a precursor to ergosterol and nonsterol isoprenoid compounds. 
The fusion protein is present in perinuclear and cortical ER as well as in motile ER tubules 
(Estrada et al., 2003).  
ASH1 mRNA containing six MS2 binding sites in its 3’UTR was expressed from a GAL1 
promoter. Visualization occurs via the MS2 coat protein (MS2-CP) which binds to the MS2 
loops and is fused to RedStar fluorescence protein (Figure 8). A nuclear localization signal in 
this fusion protein allows export only if mRNA is bound as a substrate. 
Although ASH1 mRNA is usually transcribed only during mitosis when buds have reached 
their mature size, we chose this mRNA as model RNA because it can be effectively localized 
to the bud at any stage of the cell cycle (Long et al., 1997).  
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Figure 8: In vivo co-
imaging of migrating ER 
tubules and mRNPs.  
Movement of ER tubules 
and mRNAs can be 
simultaneously visualized 
by GFP-tagging of an ER 
marker protein and use of 
the MS-system for the 
mRNA of choice. Six MS2 
loops are fused to the 
3’UTR of the ASH1 
mRNA. These loops are 
bound by the MS-coat 
protein (MS2-CP) which in 
turn is fused to RFP. 
 
For the analysis, larger buds (with a volume between 10% and 25% of the mother cell were 
not included as they already contain tubular and cortical ER structures. In small- to medium- 
sized buds however, the tubular ER segregation structures which are just about to move 
from the mother to the daughter cells can be detected. 
In these cells a co-localization of ASH1-MS2 RNP particles with tubular ER structures in the 
bud and in the mother cell was observed. Particles were visible decorating ER tubules along 
the entire length, but frequently a particle was found at the tip of a moving ER tubule (Figures 
9 A and B). Co-localization of mRNP particles and ER tubules was detectable over time 
spans up to 5 min (Figure 9 C and also movie S1 and S2 in (Schmid et al., 2006)). This 
suggests that ER tubules and ASH1-MS2 mRNPs move in a coordinated manner.  
In order to test whether the Myo4p/She3p motor protein complex is needed for the 
association of mRNPs and ER tubules, the co-localization in cells lacking Myo4p was 
examined. In more than 80% of myo4 cells observed, ER tubules and mRNPs do not move 
into small-sized buds. In the remaining cells (<20%), ER tubules can be detected in the bud 
which are not associated with ASH1-MS2 mRNPs (Figure 9 D). This indicates that a fraction 
of ER tubules is able to move into the bud independently of Myo4p and is consistent with a 
study that suggested that Myo4p-dependent transport might not be the sole mechanism for 
movement of ER tubules into the bud (Reinke et al., 2004).  
Strikingly, tubules remaining in the mother cell were still associated with mRNP particles, and 
both tubules and mRNP particles showed coordinated yet random movement (Figure 1D and 
movie S3 in (Schmid et al., 2006)), suggesting that co-localization of ASH1-MS2 mRNPs and 
ER tubules is independent of the Myo4/She3p complex. 
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Figure 9: Legend see next page 
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Figure 9: Co-localization of ASH1-MS2 mRNP particles with tubular ER in the bud. (adapted 
from Schmid et al., 2006) (A and B) Representative examples of cells from strain RJY2339 with 
ASH1-MS2 mRNP particles (arrows) labelled by MS2-RedStar fusion protein and ER tubules 
(arrowheads) labelled by Hmg1p-GFP fusion protein. ASH1-MS2 particles (red) co-localize with the 
tip of ER tubules (green) in the bud. Individual frames from a time-lapse series of the cell shown in 
(A). The ASH1-MS2 mRNP (red, depicted by an arrow) stays associated with an ER tubule (green) 
for more than 3 min. Arrowhead marks the tip of the ER tubule. Time point of each image is 
indicated. (D) Co-localization of ASH1-MS2 mRNP with ER tubules in the absence of Myo4p. 
Individual images from a time-lapse series (Movie S3) of strain RJY2372 showing MS2-Red- Star-
labelled ASH1-MS2 RNP particle (red, arrow) associated with tubular ER structures (green, 
arrowhead) in the mother cell. Note that in contrast to wild-type cells (C), the marked tubule does not 
show directional movement to the bud and that no ASH1-MS2 particles are visible in the bud (at the 
bottom of the cell). 
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1.6. Aim of this work 
 
Cortical ER inheritance and mRNA localization are both highly coordinated transport routes 
and are important for the regular course of proliferation in S. cerevisiae. First, two major 
players of the mRNA localization machinery, the myosin motor Myo4p and its adaptor protein 
She3p were discovered to be additionally crucial for cortical ER inheritance (Estrada et al., 
2003). Thus the two transport pathways use a common machinery as driving force, indicating 
for the first time that there might be a connection between the two processes. Furthermore in 
vivo co-imaging data revealed that ER tubules and ASH1 mRNPs co-localize and even 
migrate together to the yeast bud (Section 1.5.), an observation which strongly supports the 
notion that the transport of ER and mRNA might occur in a coordinated manner. From a 
logistic point of view this would make sense. As it was already mentioned earlier, the majority 
of localized mRNAs in S. cerevisiae encode secreted or membrane proteins (Section 1.3.3.). 
Therefore it would be even more efficient if they were preassembled and transported 
together with the structure where they are translated and further processed in the end. 
Indications for a linkage between mRNA and ER co-transport do not only exist in yeast. In 
Xenopus, Vg1 mRNA is bound by the Vera protein (VgLE binding and endoplasmic reticulum 
association), an RNA protein also associated with ER membranes and the ER was proposed 
to have a role in the localization of Vg1 mRNA (Deshler et al., 1997). As another example, 
HrPEM and macho 1 mRNAs bind to and move with rough ER at the cell cortex of ascidien 
eggs (Sardet et al., 2003). 
One aim of this work was therefore to investigate whether there is a functional link between 
mRNA localization and ER inheritance in S. cerevisiae. Another aspect was the attempt to 
unravel - via a biochemical approach - the molecular basis of the mRNP and ER tubule co-
localization observed in double live imaging. This included various subcellular fractionation 
methods to narrow down the group of potential mRNA-ER linkers to a specific candidate and 
finally, the attempt to investigate the molecular mechanism for its membrane association. 
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2. Results 
2.1. Loss of ASH1-MS2 RNP localization in cells defective for ER 
inheritance 
 
The co-localization data from live microscopy using the MS2 system described in section 1.5. 
suggest that segregation of ER and RNA localization in yeast are coupled.  
In order to recapitulate these experiments I determined the distribution of both ER tubules 
and ASH1-MS2 RNPs in aux1, myo4, srp101-47ts and wild type cells with small to 
medium sized buds. Aux1p, previously implicated in clathrin-mediated membrane trafficking, 
was recently identified as an essential factor for cortical ER inheritance. AUX1 deletion 
specifically causes a delay in the transport of cortical ER elements into the daughter cell, 
whereas the inheritance of perinuclear ER and the general morphology of the ER are 
unaffected (Y. Du et al., 2001). SRP101 encodes a subunit of the signal recognition particle 
receptor, a heterodimeric protein in the ER membrane. At restrictive temperature, strains 
carrying a srp101-47ts mutation show similar ER segregation defects like aux1 cells (Prinz 
et al., 2000). 
ER tubules were visualized with a GFP-tagged ER marker Hmg1p-GFP. ASH1-MS2 mRNPs 
were labelled by co-expression of the MS2 coat protein (MS2-CP) fused to the RedStar 
fluorescence protein. 
In wild-type cells, the majority of buds contain ER tubules (72%) and ASH1-MS2 mRNPs 
(92%) (Figure 10 A). In contrast, only 40% of srp101-47ts cells, 27% of aux1 cells, and 14% 
of myo4 cells show bud-specific cortical ER staining or ER tubules that have moved into 
small- to medium-sized buds (Figure 10 B, black bars). In accordance with the observed 
defects in ER segregation, all three mutants also affect ASH1-MS2 mRNP particle 
localization to small- or medium-sized buds. This effect is more pronounced in myo4 cells 
(0% buds with a RNP particle) than in aux1 (RNP particle in 24% of buds) or srp101-47ts 
(43% buds with RNP particles) cells (Figure 10 B, white bars). In addition, I observed that 
ASH1-MS2 RNP signals in aux1 mother cells are generally weaker than in wild-type or 
myo4 cells, possibly due to a defect in RNP assembly or particle composition. 
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Figure 10: Localization of ASH1-MS2 RNP particles to the bud is impaired in mutants affecting 
ER segregation 
(A) Top: Representative images of wild-type cells (RJY2339) with small- or medium-sized buds 
containing ASH1-MS2 mRNPs (left) or cortical ER and ER tubules (middle) in the bud. Bottom: 
Representative images of aux1 mutant (RJY2794) cells showing absence of ASH1-MS2 RNPs or 
cortical ER from the bud. (B) Quantitative analysis of ASH1-MS2 RNPs (white bars) and cortical ER 
(Hmg1p-GFP; black bars) localization to small- or medium-sized buds of wild-type, aux1, myo4 
(RYJ2372), and srp101-4 ts (RYJ2858/2859) cells. 164 cells (wild-type), 243 cells (aux1), 340 cells 
(srp101-47), or 101 cells (myo4) were scored in three independent experiments. Error bars indicate 
the standard error of the mean (SEM). 
 
The observations of a parallel loss of RNP particle and cortical ER localization in aux1, 
myo4 and srp101-47ts mutants support the notion that transport of ER tubules and of RNP 
particles are coordinated and not independent events. 
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2.2. IST2-MS2 does not localize as efficiently as ASH1-MS2 mRNA 
 
Besides ASH1 there are at least 23 additionally localized mRNAs in S. cerevisiae (Shepard 
et al., 2003). Consequently I wanted to asses whether the aforementioned functional link 
between mRNA localization and transport of ER tubules was also true for another localized 
mRNA. In analogy to the ASH1-MS2 system the IST2 ORF was cloned under control of the 
GAL1 promoter (pRJ1399) and the localization of MS2 RNPs was analyzed in wild type and 
myo4 cells. 
 
Figure 11: IST2-MS2 is not suited for live cell imaging 
The plasmid encoding IST2-6xMS2 (pRJ1399) was co-transformed with (pRJ741) into wt (RJY2049) 
and myo4(RJY2299) cells and analyzed for localization of mRNPs to the yeast bud. 413 cells (wild-
type) and 338 cells (myo4) were scored in four and three independent experiments respectively. 
Error bars indicate the standard error of the mean (SEM). 
 
Consistent with the results obtained for ASH1 as model mRNA, the vast majority of IST2 
particles (95 %) did not localize to daughter cells in a myo4 mutant (Figure 11, right panel). 
Unexpectedly though, the localization in wild type cells amounted to about 54 % only (Figure 
11, left columns). Due to this already low degree of localized particles in wild type cells, the 
MS2 system using IST2 as a localized mRNA was not suited to further analyse ER 
segregation mutants for defects in transport of IST2-MS2 particles. 
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2.3. WSC2 mRNA can be used as a model mRNA which is 
expressed earlier in cell cycle than ASH1 mRNA 
 
So far, the mRNA which was primarily used to investigate mRNA localization in yeast was 
ASH1 mRNA. However, the latter is endogenously expressed only for a very short time-span 
during late anaphase at the end of the yeast cell cycle (Bobola et al., 1996a). To circumvent 
the problem of this short time window, ASH1 was expressed from an inducible GAL promoter 
in the in vivo microscopy experiments described earlier. For future in vivo microscopy 
experiments, ASH1 mRNA should be expressed from its own promoter. It would then be 
interesting to assess whether a functional correlation between ER and mRNA transport could 
also be seen with ASH1 expressed from its endogenous promoter and with a localized 
mRNA which is per se expressed much earlier in cell cycle.  
In the long term it is therefore advisable to have another localized model mRNA which is 
expressed far earlier during cell cycle than ASH1 mRNA. Different groups conducted 
genome-wide transcriptional analysis in the yeast S. cerevisiae (R. J. Cho et al., 1998; 
Spellman et al., 1998). According to these studies, WSC2 is expressed early in cell cycle 
during S-phase. This localized mRNA (Shepard et al., 2003) encodes a predicted plasma 
membrane protein involved in maintenance of S. cerevisiae cell wall integrity and stress 
response (Ng, 2001; Verna et al., 1997). To verify the transcriptional analysis data I 
performed fluorescent in situ hybridization with Cy3-labelled oligonucleotides to probe for 
ASH1 mRNA and DIG-labelled oligonucleotides followed by anti-DIG and Alexa	488-
labelled antibodies to probe for WSC2 mRNA.  
As already described (Long et al., 1997), endogenous ASH1 mRNA was detected in the 
daughter cells of binucleate, large budded cells. Characteristically, the nucleus is just about 
to divide or has already divided and been separated to the daughter and mother cell (Figure 
12, upper panel). In sharp contrast to this, WSC2 mRNA was only detected in newly 
emerging and small buds of dividing cells (Figure 12, lower panel). 
Hence WSC2 mRNA would be well suited as a localized mRNA expressed early in cell cycle. 
However, it will be more appropriate to establish a live cell imaging system in order to 
evaluate temporal differences in mechanisms of mRNA localization at different cell cycle 
stages. Due to time limitations at the end of this study, these experiments unfortunately could 
not be performed within the scope of my thesis. 
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Figure 12: WSC2 can serve as an additional localized model mRNA expressed earlier in cell 
cycle than ASH1. (A) Cy3 labelled DNA oligonucleotides were used to detect endogenous ASH1 
mRNA expressed from its own promoter in FISH experiments. (B) WSC2 mRNA was visualized by 
FISH with DIG-labelled probes. 
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2.4. Biochemical analysis: co-migration of ER and the ASH1 mRNA 
binding protein She2p during subcellular fractionation 
 
Both, co-localization of RNP particles and ER structures in live cell microscopy and defects in 
RNA localization observed in ER segregation mutants described in sections 1.5. and 2.1. 
strongly hint to an association of ER structures and RNP particles. Due to limitations in 
spatial resolution, however, non-associated structures moving close to each other with 
identical vectors cannot easily be distinguished from associated structures moving as one 
unit. In order to test for an association of ER and RNPs that contain localized mRNAs, I 
investigated if the RNA-binding protein She2p co-fractionates with ER in different subcellular 
fractionation experiments. She2p is part of the ASH1-MS2 RNP (Bertrand et al., 1998) and it 
binds to all described mRNAs that localize to the bud tip, including ASH1 mRNA (Bohl et al., 
2000; Long et al., 2000; Shepard et al., 2003).  
For all subcellular fractionation methods described, gentle cell rupture methods like 
spheroplasting combined with douncing were applied to maintain the integrity of 
membranous structures. 
 
2.4.1. She2p co-migrates with ER markers in a discontinuous velocity sucrose 
gradient 
 
In a first approach, cell extracts were prepared and separated on an 18 – 60% velocity 
sucrose gradient. 12 fractions were collected and the distribution of She2p relative to ER 
marker proteins was determined by Western blot analysis (Figure 13). Hmg1p-GFP, the 
marker for ER, migrates close to the bottom of the gradient in the high density fractions. 
Similar migration behaviour is seen for two other ER marker proteins, Dpm1p (dolichol 
phosphate mannose synthase, figure 24) and Sec61p (an essential subunit of the yeast 
translocon, figure 20). As previously shown (Estrada et al., 2003), an HA-tagged version of 
Myo4p co-fractionates with the ER marker protein (Figure 13). Interestingly, like Myo4p, the 
RNA-binding protein She2p also fractionates with the ER marker (Figure 13) to the bottom of 
the gradient thus providing first evidence for a physical association between She2p and ER. 
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Figure 13: She2p co-migrates with ER marker proteins during velocity sucrose gradient 
centrifugation. 
Cell extract from strain RJY2479 (MYO4-HA3, URA3::HMG1-GFP) was separated on a linear 18%–
60% sucrose gradient as described in the methods section 5.5.2.. Aliquots of 12 fractions and the 
pellet were analyzed by Western blotting against HA, GFP, or She2p. She2p and Myo4p co-migrate 
with the ER marker protein Hmg1p-GFP to the dense fractions of the gradient (fractions 2-4). 
 
 
2.4.2. She2p is present in the fraction of purified ER microsomes 
 
Since She2p can shuttle between nuclei und cytoplasm (Kruse et al., 2002) and the ER 
membrane is continuous with the outer leaflet of the nucleus, I wanted to make sure that the 
heavy fractions containing an ER marker and She2p observed in the section above are not 
nuclei. Therefore, a crude membrane fraction was prepared from lysed yeast spheroplasts 
and the resuspended membranes were separated on a two-step sucrose gradient. The 
method used was originally developed for isolating functional ER membranes from yeast 
(Wuestehube et al., 1992).  
 
 
 
 
 
 
 
 
 Results  
 
 
  35   
 
 
Figure 14: She2p can be detected in a fraction of purified ER microsomes 
Yeast ER membranes were purified from a crude membrane pellet by centrifugation through a 
sucrose cushion. Numbers correspond to fractions from top to bottom. F4, the interphase between 
1.2 M and 1.5 M sucrose cushions, contains ER. She2p is also enriched in F4, but the nuclear marker 
protein Rpa49p is mainly found in F1 (broken nuclei) and F7 (nuclei). 
 
Whereas ER membranes accumulate at the interphase of the two sucrose cushions (Figure 
14, fraction 4), a marker for soluble nuclear proteins (Rpa49p, a subunit of RNA 
polymerase I) is found at the bottom of the gradient (fraction 7) or at the top (fraction 1). 
Rpa49p in the ”light” fraction 1 appears to correspond to protein released from broken nuclei 
whereas the Rpa49p signal in the pellet represents nuclear protein in intact nuclei. Only little 
Rpa49p is detected in fraction 4. In contrast, a significant amount of She2p is present in this 
fraction, suggesting a co-fractionation of She2p and ER.  
 
2.4.3. Flotation of ER membranes by equilibrium density centrifugation: She2p 
floats along 
 
In order to rule out the possibility that the heavy She2p fractions correspond to very large 
RNPs that might accidentally co-migrate with ER in sucrose gradients, I performed flotation 
experiments as described for neuronal RNP complexes (Kanai et al., 2004). Neuronal RNP 
marker proteins did not float together with membrane marker proteins to a sucrose cushion 
with lower density (interphase between 0 and 40% sucrose) but stayed in the 50% sucrose 
cushion (Kanai et al., 2004).  
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Figure 15: She2p floats to the top of the gradient together with ER membranes 
Crude yeast extract equilibrated in 50% sucrose was overlaid with two sucrose cushions containing 
0% or 40% sucrose. After equilibrium centrifugation, fractions were taken and analyzed by Western 
blotting. Numbers on top indicate sucrose concentrations of the corresponding sucrose cushions or 
interphases between cushions. She2p and Hmg1p-GFP but not Rpa49p float to the 0%/40% sucrose 
interphase, which indicates a membrane association. 
 
In striking contrast to this, a significant fraction of She2p co-migrates with the ER membrane 
marker Hmg1p (Figure 15). The floated portion of She2p is apparently smaller than that of 
Hmg1p. This result is expected since a strong association of an integral membrane protein 
like Hmg1p with ER membranes is generally not seen for a protein that is peripheral or 
loosely associated with ER. More important, the nuclear marker Rpa49p does not show 
flotation suggesting a specific behaviour of She2p. 
 
In summary, the biochemical fractionation experiments demonstrate that a substantial 
fraction of the RNA-binding protein She2p is co-fractionating with ER markers in several 
different gradients. These observations strongly substantiate that there is indeed a physical 
interaction between the RNA binding protein and ER membranes. 
 
2.5. Intact polysomes are not required for She2p-ER association  
 
In light of the data obtained above, the question arose what could constitute the molecular 
basis of She2p’s interaction with ER membranes. 
Amongst the group of localized mRNAs in S. cerevisiae, many encode membrane or 
secreted proteins (Table 1). In addition to this we know from other studies (Lange et al., 
2008) that different kinds of localized mRNAs are co-assembled and transported together in 
the same particle. Consequently it seemed possible that localizing mRNPs containing 
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mRNAs for both soluble and membrane proteins are tethered to the ER via the signal 
recognition particle (SRP) pathway. This ribonucleoprotein recognizes signal peptides from 
emerging, newly synthesized membrane or secreted proteins and delivers them to the 
translocon of ER membranes (Keenan et al., 2001). 
In order to test whether association of She2p with ER is mediated by ongoing translation and 
nascent chain - translocon interaction, I used a common method to disrupt polysomes. By 
addition of 10mM EDTA to cell extracts ribosomes are split into their 40S and 60S subunits 
(Frey et al., 2001).  
 
Figure 16: She2p association with ER does not require polysomes 
Extracts treated with 10 mM EDTA to disassemble polysomes or mock-treated extracts were 
separated as described above. A shift of ribosomal protein Rpl13p toward less dense fractions (8–11) 
of the gradient verifies successful EDTA-mediated polysome disruption. She2p and Hmg1-GFP co-
fractionate in both gradients with the peaks of Hmg1p-GFP and She2p shifting from fractions 1–3 to 
fractions 3–5, indicating a loss of polysomes from the ER. 
 
The EDTA treatment was successful in disrupting polysomes as verified by the 
disappearance of the ribosomal protein Rpl13p from higher density fractions (Figure 16). 
Intriguingly, the addition of EDTA had no effect on She2p-ER co-migration into the gradient. 
ER marker and She2p shifted by two to three fractions towards the top of the gradient, 
indicating that the now less-dense ER had lost attached ribosomes (Rieder et al., 2000) but 
in contrast had kept She2p (Figure 16, lower panel). 
From this observation we infer that ongoing translation of mRNAs for secreted or membrane 
proteins is not a prerequisite for interaction of She2p with ER membranes. 
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2.6. The She2p-ER interaction is not dependent on mRNA 
 
Even if She2p-ER association is not dependent on ongoing translation, it might still be 
possible that the interaction is mediated indirectly via the mRNAs bound to She2p. Those 
might act as molecular linkers to yet unknown ER components. Moreover it was recently 
described that even certain RNAs themselves can bind to phospholipid membranes (Janas 
et al., 2006).  
 
2.6.1. RNase treatment of whole cell extracts does not disrupt She2-ER 
association 
 
In a first attempt to test for the mRNA dependence of the She2p-ER co-migration, I treated 
cell extracts with a combination of Micrococcal Nuclease and RNase A to destroy cellular 
mRNA before performing velocity gradient centrifugation (Figure 17 A). The efficiency of the 
treatment was checked by RT-PCR detecting ASH1 and IST2 mRNAs (Figure 17 B).  
Interestingly, She2p can still be detected in high-density fractions of sucrose gradients after 
RNase treatment although a substantial amount has moved to less dense fractions (Figure 
17 A, lane 11). Even more notably, the She2p portion in the high-density part of the gradient 
shifts along with ER from the very bottom of the gradient (fractions 1 and 2) to less dense 
fractions (fractions 3 and 4). This is most likely due to loss of polysomes from the rough ER, 
in the same way as it was already observed after EDTA treatment. Upon release of 
macromolecular complexes like polysomes, the mass and also density of a membranous 
organelle is diminished (Rieder et al., 2000). The issue whether polysomes were indeed 
disrupted after the RNAse treatment was verified by the complete destruction of the 
ribosomal RNA RDN18 which was no longer detectable by RT-PCR (Figure 17 B).  
This observation indicates that She2p does not depend on the presence of mRNAs for its 
interaction with ER. 
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Figure 17: RNase treatment of whole cell extracts  
(A) Velocity gradient centrifugation: Extracts treated with a combination of Micrococcal Nuclease and 
RNase A to completely remove endogenous mRNAs or mock-treated were separated on 18-60% 
sucrose gradients as described above.  
(B) RT-PCR to assess completeness of the RNA-digest: Total RNA was isolated from aliquots of 
mock and RNase treated cell extracts. After DNase treatment pure RNA was used to generate cDNA 
and PCR was performed to verify complete RNA digest in RNase treated extracts. Oligonucleotides 
used were: ASH1: RJO 73+74; IST2: RJO 2428+2429; ribosomal rRNA RDN18: RJO 3158+3159. 
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2.6.2. The mRNA binding mutant She2p-N36S,R63K accumulates in the nucleus 
 
To directly assess a possible role of She2p’s RNA binding activity in ER association, the 
most appropriate way is to use a She2p mutant unable to bind ASH1 and other localized 
mRNAs. I generated such a mutant by introducing two point mutations into She2p, N36S and 
R63K, each of them known to disrupt RNA binding (Gonsalvez et al., 2003). Point mutations 
in the RNA binding site of She2p were reported to not alter the nuclear/cytoplasmic 
distribution equilibrium of She2p and not to result in nuclear accumulation of She2p 
(Gonsalvez et al., 2003). 
However, when purifying microsomes by 2-step density gradient centrifugation (Section 
2.4.2.), the mutant protein is only present in the nuclear pellet but absent from fractions 
containing ER marker (Figure 18 A, fraction 4). 
In order to verify that the She2p-N36S,R63K mutant protein indeed accumulates in nuclei, 
indirect immunofluorescence against She2p was performed. By microscopy I observed that, 
in contrast to wild type She2p, the mutant protein is enriched in nuclei (Figure 18 B). 
Thus, a She2p mutant deficient in RNA binding cannot be used in vivo to directly assess the 
RNA dependence of a She2p-ER association. 
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Figure 18: The She2p RNA binding mutant N36S,R63K accumulates in the nucleus 
(A) Purification of ER membranes by centrifugation through a two step sucrose gradient: After 
purification fractions were analyzed by Western Blot and probed for ER (Hmg1-GFP) and nuclear 
markers (Rpa49p). She2p-N36S,R63K is present only in the nuclear pellet, not in the ER microsomal 
fraction. (B) Analysis of subcellular localization by indirect immunofluorescence: Indirect 
immunofluorescence using an a-She2p antibody showed that She2p-N36S,R63K accumulates in the 
nucleus of yeast cells in contrast to wild type She2p which in turn is enriched at bud tips. 
 
2.7. In vitro assay: recombinant She2p co-migrates with ER on a 
velocity sucrose gradient 
 
As we have seen above, the RNA binding mutant She2p-N36S,R63K cannot be used for 
subcellular fractionation studies if expressed endogenously in yeast. However, the problem 
of its nuclear accumulation can be circumvented by adding the protein exogenously. 
Consequently I set up an in vitro system with recombinantly expressed She2p.  
 
2.7.1. Purification of recombinant She2p 
 
As a first premise for the in vitro assay it was necessary to generate pure recombinant 
protein from E. coli. For this a GST-She2p fusion protein containing an internal TEV protease 
cleavage site (Figure 19 A) was expressed in a BL21(DE3) pRIL strain. The fusion protein 
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was purified via a Glutathione-affinity column and She2 protein was eluted by a TEV 
cleavage step. Removal of His6-tagged TEV protease via Ni-NTA beads yielded highly pure 
recombinant She2 protein (Figure 19 B).  
 
 
Figure 19: Expression and purification of recombinant She2p from E. coli.  
(A) Expression vector pRJ20 (pGEX-TEV-SHE2) encodes a GST-She2p fusion protein containing an 
internal cleavage site for TEV-protease.  
(B) Expression of GST-She2p (53 kDa) was induced in the BL21(DE3) pRIL strain RJB441 with 1 mM 
IPTG. The pre-cleared cell lysate was applied to glutathione (GT) beads. She2p was eluted by TEV 
cleavage (TEV-protease is marked by an asterisk). Pure She2p (28 kDa) was obtained after removal 
of His6-tagged TEV with Ni-NTA resin. 
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2.7.2. Recombinant She2p behaves like endogenous She2p 
 
Assuming that She2p binds to ER membranes it should equally do so in an in vitro situation, 
i.e. if it is exogenously added to a crude yeast extract. Consequently I first tested whether 
recombinant She2p pre-incubated with a she2 cell extract behaves like endogenous She2p 
in wild type extract (Section 2.4.1.) if separated on an 18% to 60% velocity sucrose gradient. 
Figure 20 A depicts a schematic overview of the in vitro gradient system. Similar to the 
situation with wild type cell extract, recombinant She2p can be detected in the high density 
fractions at the bottom of the gradients, in other words, it co-migrates with the ER marker just 
as well as endogenous She2p (Figure 20 B). This behaviour is not due to aggregation of 
recombinant protein since I did not observe She2p in high density fractions upon pre-
incubation with buffer instead of cell extract (data not shown).  
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Figure 20: She2p co-migrates with ER in vitro just as well as in vivo. 
(A) Schematic overview of the in vitro assay: Recombinant She2p is incubated for 25 min with WCE 
from a she2 (RJY2370) strain. Subsequent to pre-incubation the mix is spread on an 18-60% 
velocity sucrose gradient. After centrifugation the gradient is processed for Western Blotting as 
described earlier. (B) Comparison of endogenous versus recombinant She2p. Two velocity gradients 
were performed in parallel. One with wild type cell extract containing endogenous She2p, the other 
with a pre-incubation mix of recombinant She2p and she2 cell extract. She2p behaves the same in 
both situations. 
 
Furthermore I performed the same in vitro assay with cell extract and recombinant GST 
instead of She2p. In strong contrast to She2p, GST remained exclusively in the light fractions 
on top of the gradient (Figure 21). GST represents an appropriate control for She2p since it 
not only has about the same molecular weight as She2p (GST: 26 kDa; She2p: 28 kDa) but 
also is known to form dimers (Ji et al., 1992) as described for She2p (Niessing et al., 2004).  
 
 
Figure 21: Recombinant GST does not co-migrate with ER in the in vitro assay 
The in vitro assay on 18-60% linear sucrose gradients was performed with recombinant GST instead 
of recombinant She2p added to a she2 (RJY2370) cell extract.  
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Taken together, these observations demonstrate that the in vitro assay is an appropriate tool 
to study the effects of mutations in She2p. In addition, since even the recombinant protein 
behaves in the same way as endogenous She2p, these in vitro data reinforce the whole 
concept of an association between She2p and ER membranes.  
 
2.8. The RNA binding mutant She2p-N36S,R63K is not impaired in 
ER association 
 
With the in vitro system in hands I then intended to re-examine the issue of She2p’s RNA 
binding activity in ER association. As mentioned earlier it is not possible to investigate this in 
vivo because the mutant She2p-N36S,R63K accumulates in the nucleus. Recombinant 
She2p-N36S,R63K was purified via GST affinity and TEV-cleavage steps as described 
above (Section 2.7.1.). Pure recombinant wild type- and N36S,R63K- She2 protein (Figure 
22, left panel) was incubated in the same amounts with she2 cell extracts and their 
distribution compared to ER markers was analysed on 18 – 60 % velocity gradients. 
 
Figure 22: The RNA binding mutant She2p-N36S,R63K co-fractionates with ER like WT-She2p. 
Both She2p-WT (in RJB441) and She2p-N36S,R63K (in RJB448) were expressed and purified from 
E. coli as described earlier. Both proteins were added separately to she2 (RJY2370) cell extracts 
and in vitro assays were performed as described above.  
 
In accordance with the results obtained from RNase treated samples (Section 2.6.1.) the 
RNA binding mutant co-migrates with the ER marker Sec61p to the same extent than wild 
type She2p (Figure 22, right panel). Altogether this strongly supports the notion that She2p – 
ER interaction is independent of RNA. 
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2.9. None of the best characterized mutations in She2p shows an 
effect on ER-association 
 
As we have seen above, disruption of She2p’s RNA-binding feature has no impact on its ER-
binding capacity. As a consequence I wanted to explore whether this association is impaired 
in other She2p mutants already known to have a defect in mRNA localization.  
The first amongst the group of She2p mutants tested was She2p-S120Y. This mutant was 
described to have a defect in its dimerization capability (Niessing et al., 2004). Moreover it 
displays a loss of binding activity to the ASH1 E3 element in filter binding assays and exhibits 
a failure to correctly localize ASH1 mRNA in vivo (Niessing et al., 2004) indicating that dimer 
formation is necessary for She2p’s ability to bind RNA. 
The second mutation investigated was She2p-L130S. This amino acid exchange was 
identified by a genetic screen as a mutant defective for ASH1 mRNA localization and it does 
not bind to the ASH1 E3 element as demonstrated by UV crosslinking experiments 
(Gonsalvez et al., 2003). In addition to this, it seems to be affected in its capability to bind the 
adaptor protein She3p (Gonsalvez et al., 2003). 
Finally, I tested another mutant identified by Marisa Mueller (Niessing Lab). This She2p 
mutant bears a deletion of the small -helix protruding at right angles from both sides at the 
middle of the She2 dimer (She2p- amino acids 174-183). In the following, the latter will be 
called She2p-Helix. Using filter binding assays M. Mueller had demonstrated that this 
mutant is significantly impaired in ASH1 E3 element binding (M. Mueller, personal 
communication). In addition, upon investigating She2p-Helix by fluorescent in situ 
hybridization I found, that apparently the deletion of the protruding helices also suppresses 
She2p’s ability to correctly localize ASH1 mRNA (data not shown).  
 
Subsequently, in cooperation with a bachelor student, Milijana Mirkovich-Hoesle, all three 
She2p mutants were tested for their ability to co-migrate with ER markers, as described 
earlier, in an 18-60% velocity sucrose gradient. The assay was either performed in vivo with 
cell extracts obtained from a she2 strain transformed with a plasmid encoding the 
corresponding She2p mutant or it was carried out as an in vitro assay with recombinant 
She2p added exogenously to a she2 cell extract (Section 2.4.1. and 2.7.2.). After 
centrifugation, gradient fractions were processed and analyzed by Western Blotting as 
mentioned above.  
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Figure 23: Already characterized surface residues of She2p are not responsible for its co-
migration with ER membranes. 
She2p mutants were either expressed and purified from E. coli and used in the in vitro gradient 
system as described earlier (A). For She2p-120Y plasmid pRJ1386 was transformed into BL21-pRIL. 
Alternatively the mutants were expressed in vivo from a plasmid transformed in a she2 yeast strain 
and in vivo gradients were performed as described in section 4.1. (B, C). For this, She2p-L130S 
(pRJ1605) and She2p-Helix (pRJ1482) were both transformed into the she2 strain RJY2370. 
 
Intriguingly, neither the She2p-L120S, nor She2p-L130Y nor She2p-Helix mutant tested 
was affected to any extent in co-segregation with the ER marker (Figure 23 A, B, C 
respectively). This indicates that a yet unknown feature of She2p must be responsible for its 
interaction with ER membranes. 
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2.10.Search for a protein factor acting as mediator for the She2p – 
ER interaction 
 
As we have seen in previous sections, She2p’s RNA binding activity is not a prerequisite for 
its presence on ER membranes. As a consequence one of the most plausible explanations 
could be that She2p is tethered to ER membranes via a so far unidentified protein factor. 
The most obvious and thus first candidates to test are the two other components of the core 
locasome: She3p and Myo4p. Both of them are known to be essential for inheritance of 
cortical ER and in addition they were found to co-localize with ER markers in subcellular 
fractionation assays (Estrada et al., 2003). I therefore tested whether co-segregation of 
She2p and ER is dependent on the motor protein Myo4p or its adaptor She3p.  
 
Figure 24: Myo4p and She3p are not necessary for She2p’s binding to ER 
(A) She2p co-segregates with ER to the dense fractions of the gradient not only in a myo4 
(RJY2323) but also in a she3 (RJY2475) mutant. (B) Also in the double deletion strain myo4she3 
(RJY3307) She2p co-fractionates with the ER marker Sec61p to the bottom of the gradient.  
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Deletion of MYO4 (RJY2323) or SHE3 (RJY2475) however did not affect migration of She2p 
into the gradient (Figure 24 A). In myo4, she3, or wild-type extracts, She2p co-migrates 
with three ER marker proteins (Hmg1p-GFP, Sec61, and Dpm1p) into high-density fractions 
(lanes 2–5).  
This indicates that She2p in its association to ER is not reliant on an intact Myo4/She3p 
motor complex. 
However if only one of the two proteins – either Myo4p or She3p – is absent, one could still 
imagine a scenario in which She2p is tethered to the ER by the remaining protein. To rule out 
this possibility, I created a MYO4, SHE3 double deletion strain (RJY3307) and investigated 
whether She2p distribution is altered under these circumstances. Interestingly, the RNA 
binding protein, along with the ER marker protein, could be still detected in the heavy 
fractions of the gradient (Figure 24 B). 
These data strongly suggest that She2p-ER interaction is independent of Myo4p and She3p. 
 
As deletion of the two core-locasome components mentioned above did not show any effect, 
additional putative linker candidates of the She2p-ER association were tested. 
Firstly, I wanted to investigate whether one of the identified yeast two hybrid (Y2H) 
interaction candidates of She2p (Ito et al., 2001; Uetz et al., 2000) could be the “missing 
link”. For this purpose I created deletion strains of YBR027C, YOL073C, YJL048C and 
YML088W. YBR027C, and YOL073C are still uncharacterized ORFs but the interesting 
feature about them is that both hypothetical proteins are predicted to contain transmembrane 
domains (TMDs): 2 TMDs for YBR027C and 4 TM-domains for YOL073C (SGD database 
http://www.yeastgenome.org). YML088W encodes the protein Ufo1p, a subunit of the SCF 
E3 ubiquitin ligase complex responsible for ubiquitylation and hence subsequent degradation 
of phosphorylated HO endonuclease (Kaplun et al., 2003). At the time when I performed the 
database search, it was also predicted to contain a transmembrane domain and was 
therefore chosen as a candidate to test. YJL048C encodes Ubx6p, a UBX domain containing 
protein known to be localized at the nuclear periphery (GFP database: yeastgfp.ucsf.edu) 
(Huh et al., 2003). Since the outer nuclear envelope is continuous with the endoplasmic 
reticulum (Preuss et al., 1991), it seemed possible that this Y2H candidate could be 
responsible for the She2p-ER association. 
Secondly, besides the She2p Y2H interactors, I wanted to investigate the effect of two other 
proteins, Scp160 and Asc1p. Scp160 is a 14 KH-domain containing RNA binding and 
polysome-associated protein. Interestingly, it was shown to be involved in ASH1 mRNA 
localization (Darzacq et al., 2003; Irie et al., 2002; Trautwein et al., 2004) and in addition to 
be localized to the ER (Frey et al., 2001; Wintersberger et al., 1995). Asc1p, a component of 
the ribosomal 40 S subunit (Gerbasi et al., 2004), was recently published to be necessary for 
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Scp160-polysome association and thus could possibly act as a binding platform for Scp160 
(Baum et al., 2004). In the light of this, I considered Scp160 and Asc1p as promising 
candidates for mediators of the She2p-ER interaction. 
Finally I assessed the possible linker role of another factor, namely Sec3p. This protein 
represents a component of the exocyst, an octameric protein complex that mediates 
targeting of post-Golgi vesicles to sites of active exocytosis (TerBush et al., 1996). 
Furthermore it has not only been demonstrated that Sec3p is necessary for the correct 
inheritance of cortical ER into the bud (Wiederkehr et al., 2003) but also that ASH1 mRNA 
localization is disturbed in sec3 mutants (Aronov et al., 2007). Considering these data, 
Sec3p seemed to be a likely candidate acting as a linker between ER and She2p and I 
created a sec3 deletion strain to test this assumption. 
I used all deletion strains mentioned above to prepare cell extracts and performed linear 
velocity sucrose gradients as described earlier to assess whether co-migration of She2p with 
ER markers was disrupted in one of those. Intriguingly however, She2p-ER co-segregation 
was not disturbed in any of the mutants tested (data not shown).  
 
 
RJY deleted protein genotype 
She2p-ER co-
fractionation 
2323 Myo4p myo4 + 
2475 She3p she3 + 
3307 Myo4p/She3p complex myo4 she3 + 
3279 hypothetical protein YBR027C::natNT2 + 
3280 hypothetical protein YOL073C::kanMX6 + 
3281 Ubx6p YJL048C::natNT2 + 
3282 Ufo1p YML088w::natNT2 + 
2812 Scp160 scp160::kanMX6 + 
2814 Asc1p asc1::kanMX6 + 
3031 Sec3p sec3::HIS3 + 
Table 2: Summary of the deletion strains analyzed for She2p-ER co-fractionation via linear 
velocity sucrose gradients  
In none of the knockout strains She2p co-migration with ER marker proteins was disrupted. 
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Table 2 depicts an overview of the different knockout mutants tested and the fractionation 
behaviour of She2p in velocity sucrose gradients of the respective deletion strains.  
 
In summary this means that none of the proteins mentioned above (Table 2) serves to tether 
She2p to ER membranes. In contrast, the RNA binding protein is most likely linked via 
another, still unidentified protein or it can bind to ER membranes by itself. 
 
2.11.She2 pellets with flotation purified ER membranes in an in vitro 
binding assay 
 
From the aforementioned data obtained in vivo by different subcellular fractionation methods 
(Section 2.4.) and in vitro by gradients with recombinant She2p and she2 whole cell 
extracts (Section 2.7.) we inferred that She2p interacted with ER membranes. In order to 
further substantiate this notion, I next set up an in vitro binding assay to test whether 
recombinant She2p could bind to purified ER membranes. She2p-ER co-segregation had 
already been observed with a crude membrane fraction (Section 2.4.2.). However, an in vitro 
assay with purified ER microsomes is even more specific and could provide even more 
compelling evidence for She2p’s association with ER. 
 
2.11.1. In vitro binding assay with flotation purified ER membranes 
 
An overview of the experimental setup for the in vitro binding assay applied is depicted in 
figure 25 A. For this experiment recombinant She2p was obtained as described earlier in 
section 2.7.1. (Figure 19). The second important step was to perform large scale purifications 
of ER microsomes from a yeast she2 strain (RJY2370) (Brodsky et al., 1993; Rothblatt et 
al., 1986). The latter will be entitled YRMs (yeast rough membranes) in the following text. 
Subsequent to the isolation of ER microsomes they were further purified via flotation through 
sucrose cushions (see coomassie gels and western blot depicted in figure 25 B). These 
successively purified membranes were then incubated with recombinant She2p to allow the 
binding reaction to occur. After pre-incubation, this mix was loaded on a 1.2 M sucrose 
cushion. Following ultracentrifugation, the resulting supernatant and the remaining pellet at 
the bottom of the cushion were analyzed by Western Blotting with regard to the distribution of 
ER marker and She2p. 
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Figure 25: Schematic overview and components of the in vitro binding assay:  
(A) Illustration of the experimental procedure constituting the in vitro binding assay of She2p with 
flotation purified ER microsomes. 
(B) Components of the binding assay: Coomassie Gel of purified She2p (left panel) and comparative 
coomassie gel (middle panel) of yeast whole cell extract (WCE), yeast rough membranes (YRMs) and 
flotation purified membranes (FPMs). WCE, YRMs and FPMs originate from a she2 strain (RJY2370) 
Right panel: Analytical Western Blot of YRMs compared to different fractions of the flotation procedure 
(FPM = flotation purified membranes). The Western Blot was probed with antibodies against an ER-
marker protein (Dpm1p) and cytosolic marker (Actin). 
 
Most notably, it was observed that recombinant She2p indeed pellets through the sucrose 
cushion along with ER membranes. Conversely, She2p was not detectable in the pellet 
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fraction when it was incubated with buffer only instead of flotation purified membranes 
indicating that the pelleting is not due to aggregation of the recombinant RNA-binding protein 
(Figure 26 A). 
 
 
Figure 26: In vitro binding assay of recombinant She2p and GST with flotation purified ER 
membranes 
(A) Recombinant She2p was either pre-incubated with flotation purified ER microsomes or buffer 
before loading on a 1.2 M sucrose cushion. After ultracentrifugation, She2p was detectable in the 
pellet only in presence of membranes but not with buffer. (B) The same assay was performed with 
GST instead of recombinant She2p but GST was neither pelleting with buffer nor with membranes. 
 
For the same reasons as mentioned in section 2.7.2. (similar molecular weight, dimer 
formation like She2p) I again used GST as a control for the specific behaviour of She2p. In 
strong contrast to She2p, GST does not only stay in the supernatant when pre-incubated 
with buffer but it also does not pellet through the sucrose cushion in presence of flotation 
purified membranes (Figure 26 B) indicating that pelleting of She2p with these ER 
microsomes is specific. 
The fact that She2p pellets with purified ER microsomes in an in vitro binding assay even 
stronger substantiates the idea that She2p can bind to ER membranes. 
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2.11.2. Protease treatment of ER membranes  
 
With the in vitro binding assay in our hands, I wanted to assess whether She2p-ER 
association is mediated by a peripheral or integral membrane protein. To discriminate 
between these two possibilities, carbonate treatment of microsomes can be used. 0.1 M 
Na2CO3, pH 11.0 is known to strip off peripheral membrane proteins from ER membranes in 
contrast to integral membrane proteins which are retained (Fujiki et al., 1982). Unfortunately I 
could not perform this binding assay with Na2CO3 treated, flotation purified membranes as 
the latter did not pellet properly through the sucrose cushion in the last step of the 
experiment. This was probably due to the fact that ER microsomes after Na2CO3 treatment 
are not only deprived of attached proteins but are also converted from their sealed vesicular 
shape to flat membrane sheets (Fujiki et al., 1982). 
 
 
Figure 27: Carbonate and protease treatment of 
YRMs. 
Isolated microsomes were either treated with 0.1 M 
Na2CO3 pH 11.5 to remove peripheral membrane proteins 
or with a protease mix consisting of Pronase E and 
Proteinase K to digest both peripheral and cytosolic 
domains of integral ER membrane proteins. Success of 
protease treatment was verified by probing for the integral 
ER marker protein Sec61p. 
 
In the following, protease treatment of isolated ER microsomes was performed. By these 
means I sought to investigate whether She2p-ER interaction would be abolished upon 
removal off any ER resident protein component. To achieve this, I isolated YRMs and either 
mock treated them or digested them with a combination of Pronase E and Proteinase K. The 
effect of protease treatment was verified by probing for the integral membrane protein 
Sec61p (Figure 27). The anti-Sec61p antibody was originally directed against a peptide at 
the extreme C-terminus of the protein (Matthias Seedorf, personal communication) and the 
C-terminus itself is protruding to the cytosolic side of the ER membrane (Osborne et al., 
2005). Following several washing steps and inactivation of the protease cocktail, the in vitro 
binding assay with recombinant She2p was performed as described above. The resulting 
fractions were again analyzed by Western Blotting.  
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Figure 28: In vitro binding assay with protease treated membranes and a membrane-free 
cytosolic fraction (S100). 
She2p was either incubated with mock treated membranes or membranes treated with a combination 
of Pronase E and Proteinase K. In addition She2p was mixed with a post 100,000 x g supernatant 
(S100) which is depleted of membranous components. After the binding reaction, all three samples 
were loaded on a 1.2 M sucrose cushion and the assay was performed as described above. 
 
Compared to the situation with mock treated membranes (Figure 28, first lane) I observed a 
reduction of the pelleting of She2p with protease treated microsomes (Figure 28, second 
lane). Nevertheless, the amount of pelleted She2p was decreased but not completely 
abolished. Due to the lack of antibodies, the efficiency of protease digest could not be 
checked for numerous ER membrane proteins. The digest could have been partially 
incomplete as different resident ER proteins might display varying resistance against 
protease treatment. Therefore I could not judge at this point whether the data indeed indicate 
a decreased binding of She2p to ER membranes due to partial digest of a putative ER linker 
protein or whether the pelleting behaviour of She2p is disturbed by some other cause. One 
such reason could be the loss of integrity of protease treated membranes. A rather harsh 
experimental condition which constitutes the only difference to mock treated membranes is 
the protease heat inactivation by a 15 – 20 min 80°C incubation step. Membrane integrity is 
hard to assess since protease treated membranes cannot be detected any more by western 
blotting. But if integrity is indeed disturbed, less efficient pelleting of the membranes 
themselves as seen after carbonate treatment could be the consequence. This would finally 
also result in a reduced precipitation of She2p.  
In summary, protease treatment of ER microsomes for the in vitro assay unfortunately did not 
lead to a clear-cut result.  
Nevertheless I used the in vitro binding assay to assess another issue. Seeing that She2p 
pellets through the sucrose cushion together with ER membranes, the question arose 
whether components of a membrane-free fraction of yeast extracts could provoke the same 
effect for She2p via unspecific aggregation. To investigate this, I prepared a post 100,000 x g 
supernatant (S100) of a yeast whole cell extract which is devoid of any membranous 
 Results  
 
 
  56   
 
structures. This was then incubated with recombinant She2p and the binding assay was 
performed as described above. The distribution of S100 was assessed by a cytosolic marker 
protein, Pgk1p (phosphor-glycerol-kinase 1). As shown in figure 28 (third lane), She2p does 
not pellet through the sucrose cushion in presence of the post 100,000 x g supernatant which 
is in strong contrast to its behaviour in company of ER membranes.  
This observation again strongly supports the notion that the pelleting of She2p with 
membranes is specific and that She2p indeed interacts with the ER compartment. 
 
2.12.She2p directly binds to synthetic liposomes 
 
We have seen earlier that the She2p-ER interaction is independent of ongoing translation or 
mRNA (Section 2.5. and 2.6.). The next rationale was that the association might be mediated 
via a protein linker. However, targeted deletion after “educated guesses” did not reveal such 
a factor (Section 2.10.). Since additionally the outcome of the protease treatment mentioned 
above was rather inconclusive, it remained elusive how the RNA binding protein might be 
linked to the membrane compartment. 
Therefore I sought to move one step further and tried to investigate whether She2p itself can 
directly interact with lipid membranes. 
 
2.12.1. She2p floats along with ER-like protein-free liposomes 
 
For this approach I prepared synthetic, protein-free liposomes with a composition similar to 
ER membranes (ergosterol 16%, phosphatidylcholine PC 40%, phosphatidylethanolamine 
PE 24%, phosphatidylserine PS 10%, phosphatidylinositol PI 10%) (Schneiter et al., 1999; 
Tuller et al., 1999; Zinser et al., 1991). 
Shortly, phospholipids and ergosterol – each in organic solvent – were mixed, organic 
solvent was evaporated, the lipid film resuspended in membrane buffer and synthetic 
liposomes were created by passage through the membrane of an extruder. 
The binding assay applied in the previous sections, however, did not work for such synthetic 
liposomes as they did not penetrate sucrose cushions of varying density. One possible 
explanation for this might be the complete absence of protein material in these synthetic lipid 
vesicles which reduces their density.  
Therefore I proceeded to an alternative method suited to test association of proteins to lipid 
membranes, a flotation assay. As depicted in figure 29 A, it is without any trouble possible to 
identify the fraction with floated liposomes after ultracentrifugation even if one cannot probe 
for the synthetic vesicles by detection of a protein marker.  
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Figure 29: She2p interacts with ER-like, synthetic liposomes. 
(A) Representative picture of a gradient with floated liposomes. Recombinant protein (She2p or GST) 
pre-incubated with liposomes or buffer was loaded into the bottom of a flotation gradient consisting of 
a 70% sucrose solution. This suspension was successively over-layered with three other cushions 
containing 50%, 40% and 0% sucrose. Liposomes visibly accumulate at the interphase between 40% 
and 0% sucrose. 
(B) She2p but not GST floats to the top of the gradient together with the ER-like liposomes. 
 
I incubated synthetic liposomes with either heterologously expressed She2p, GST or binding 
buffer alone before performing the flotation assay. Intriguingly, after harvesting the fractions 
with floated liposomes and analyzing them by western blotting, I found that She2p had 
floated along with the synthetic liposomes to the top of the gradient (Figure 29 B, left panel). 
This was in contrast to the GST control which was completely absent from the liposomal 
fraction (Figure 29 B right panel). 
This result indicates that the RNA binding protein She2p can directly interact with lipid 
membranes. 
 
2.12.2. She2p behaves like a bona fide peripheral membrane protein 
 
After the aforementioned observation that She2p can directly interact with liposomes, I 
wanted to investigate how this association occurs. In general, the basis of protein – 
membrane interactions can be roughly categorized into hydrophobic or electrostatic 
B 
A 
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interaction forces (W. Cho et al., 2005). Upon high salt treatment, electrostatic interactions 
should be disrupted whereas hydrophobic interactions should be even enhanced. Therefore I 
performed the pre-incubation of She2p and membranes under high salt conditions (1.0 M 
KCl) and also prepared flotation gradient solutions containing 1.0 M KCl. Under high salt 
conditions She2p was absent from the floated liposome fraction (Figure 30, flotation panel, 
lane 3) but it was also virtually gone in the input sample (Figure 30, input panel, lane 3). 
Thus, I unfortunately could not draw any conclusion regarding the mode of membrane 
interaction since She2p seems to be instable under this condition. 
 
Figure 30: She2p-liposome interaction can be disrupted by carbonate treatment. 
She2p is unstable under high salt conditions (lane 3, Input panel). However, She2p can be stripped off 
from liposomes by treatment with carbonate (lane 2, Flotation panel) 
 
Simultaneously I wanted to investigate whether She2p behaves like a peripheral membrane 
protein. As already mentioned in section 2.11.2., peripheral membrane proteins can be 
removed from the membranes they bind to by treatment with 0.1 M Na2CO3, pH 11.0 (Fujiki 
et al., 1982). When I performed the She2p-liposome flotation assay after pre-incubation in 
carbonate and with gradient solutions containing 0.1 M Na2CO3, pH 11.0, She2p was no 
longer detectable in the floated liposomal fraction though it was still present in the input 
samples (Figure 30, lane 2 flotation and input panels).  
Hence, She2p indeed behaves like a genuine peripheral membrane protein. 
 
2.12.3. Phosphatidylserine and phosphatidylinositol are not essential for 
She2p-liposome interaction 
 
In case of electrostatic interactions between proteins and membranes, phospholipids like 
phosphatidylserine and phosphoinositides with acidic head groups are known to be the major 
binding targets (Lemmon, 2008). Our synthetic ER-like liposomes indeed contained 
phosphatidylserine (PS) but only contained phosphatidylinositol (PI), the unphosphorylated 
precursor of phosphoinositides. This phospholipid however still exhibits an overall negative 
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charge in contrast to phospholipids like phosphatidylcholine or –ethanolamine. Therefore I 
synthesized a second batch of liposomes lacking not only PS but also PI.  
 
 
Figure 31: She2p interacts with liposomes deprived of phosphatidylserine and 
phosphatidylinositol. 
She2p was floated with either ER-like liposomes or with similar vesicles lacking the two phospholipids 
phosphatidylserine (PS) and phosphatidylinositol (PI). 
 
With the newly prepared synthetic membranes I performed flotation assays in presence of 
She2p as described above. However I could not detect any difference in flotation behaviour 
of She2p between liposomes lacking PS- and PI and vesicles with an ER-like composition 
(Figure 31). 
Thus, neither PS nor PI seems to be necessary for She2p’s membrane interaction activity. 
 
2.12.4. She2p interacts with liposomes in the presence of its RNA ligand 
 
As already described in section 1.3.2.1.3., She2p harbours a helical hairpin that contains a 
cluster of basic amino acid residues (Figure 32). This hairpin is essential for the RNA-binding 
activity of the protein.  
However, it seems possible that exactly the same positively charged basic residues could 
also be involved in the interaction with negatively charged head groups of membrane 
phospholipids. In light of this option I wanted to investigate whether She2p can still bind to 
phospholipid membranes in presence of its RNA ligand and whether the RNA is still bound to 
the She2p when the protein associates with synthetic membranes. 
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Figure 32: She2p contains a basic helical hairpin involved in ASH1 mRNA binding. 
Pictures taken from (Niessing et al., 2004). Left picture: GRASP surface representation of the 
chemical properties of the solvent-accessible surface of She2p. The surface electrostatic potential is 
colour coded red and blue, representing electrostatic potentials between < 14 to > +14 kBT, where 
kB is the Boltzmann constant and T is the temperature. Right picture: Schematic of the basic helical 
hairpin of She2p. In both pictures residues involved in mRNA binding are depicted in green. 
 
 
To test this I pre-incubated recombinant She2p with a 10 fold and 20 fold molar excess of the 
in vitro transcribed ASH1 E3 element or with binding buffer only (mock). In the following, 
synthetic liposomes were added and flotation was performed as described earlier. The 
floated liposomal fractions were analyzed by SDS-PAGE and Western Blotting. From the 
remaining samples, RNA was isolated by Phenol/Chloroform extraction and analyzed on 
TBE / Ethidium Bromide gels. Interestingly, the RNA binding protein in presence of the RNA 
substrate floated along with liposomes as much as in the mock treated reactions without the 
ASH1 E3 element (Figure 33 A, left panel).  
Part of the ASH1 E3 element had floated together with She2p and liposomes (Figure 33 B, 
left panel, fourth lane). The RNA fragment was a little bit smaller in size than the fragment in 
the input samples (Figure 33 B, right panel) which is most likely due to some degradation 
which occurred during the overnight flotation centrifugation.  
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Figure 33: She2p binds to lipid membranes in presence of its RNA ligand and he ASH1 E3 
element floats along with She2p and liposomes. 
(A) Western Blot of flotation assay of liposomes and She2p. Recombinant She2p was either pre-
incubated with a 10x or 20x molar excess of in vitro transcribed ASH1 E3 element or with buffer 
(mock). After pre-incubation, liposomes were added and flotation was performed as described earlier. 
(B) TBE-Ethidium bromide gel of RNA extracted from each floated liposomal fraction and from each 
input sample. 
 
In summary, this data strongly support the notion that She2p can indeed not only bind to 
membranes but also that it can simultaneously associate with both its RNA substrate and 
lipid membranes.  
 
She2p is already known to be an unconventional RNA binding protein not containing any so 
far characterized RNA interaction domain (Niessing et al., 2004). From the data presented 
above it seems highly likely that it is also an unconventional lipid binding protein, though the 
nature of its lipid binding activity still remains to be elucidated. 
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3. Discussion 
3.1. Functional linkage between mRNA localization and cortical ER 
inheritance 
 
mRNA localization and cortical ER inheritance are both cell trafficking routes that occur 
during the process of bud-formation and cell division in S. cerevisiae. After the discovery that 
both transport courses employ the same locomotion machinery, the Myo4/She3p complex 
(Estrada et al., 2003), I sought to explore whether the two pathways were functionally linked. 
Indeed, I found that mutants impaired in ER inheritance like myo4, aux1 and srp101-47ts 
simultaneously displayed defects in localization of ASH1 particles (Figure 10). The fact that 
both the defect in ER inheritance and in mRNA localization are not as prominent in the 
srp101-47ts strain as in the other two mutants is most likely due to the fact that this mutant, in 
contrast to myo4 and aux1 is not a deletion mutant, but a temperature sensitive allele of 
the wt SRP101 gene. A defect in the two transport routes was expected for the myo4 
mutant as Myo4p is the motor driving both processes. However, the aux1 and the srp101-
47ts mutant so far were only known to have a deficiency in ER segregation (Y. Du et al., 
2001; Prinz et al., 2000). Thus, the observation that in addition to ER inheritance defects 
those mutants are also impaired in mRNA localization provides the first evidence that mRNA 
localization and cortical ER inheritance are functionally linked and take place in a 
coordinated manner. 
In contrast to our results, a previous study states that mRNA trafficking and ER tubule 
movement are independent (Estrada et al., 2003). This conclusion was mainly reached by 
demonstrating that ER segregation is independent of She2p and that in aux1 mutant cells 
the localized IST2 mRNA can still be detected in the bud by in situ hybridization. At the 
moment I cannot thoroughly explain this discrepancy but one reason might be the use of 
different methodologies. Whereas Estrada et al. utilized in situ hybridization in fixed cells, I 
employed live cell imaging not only for ER structures but also for detection of ASH1 mRNPs 
by using the MS2-System (figure 10). 
The functional correlation between ER segregation and mRNA localization seen in ER 
inheritance mutants however is consistent with an earlier observation that by in vivo co-
imaging, ASH1 mRNPs co-localize and even stay associated with ER tubules (see section 
1.5. and A. Jaedicke in (Schmid et al., 2006)). These tubules move from the mother cell to 
the bud and are required for the segregation of cortical ER during early stages of the cell 
cycle (Y. Du et al., 2004). Interestingly, another study using microarrays to distinguish pools 
of membrane associated and cytoplasmic gene products identified ASH1 mRNA as an ER-
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associated mRNA (Diehn et al., 2000). This result is quite striking as ASH1 mRNA does not 
encode a membrane or secreted protein but a nuclear transcription repressor and therefore 
cannot be recruited to the ER via the SRP-pathway (Figure 6). Therefore, this observation 
supports the aforementioned live cell co-imaging data and the hypothesis of an mRNA-ER 
co-transport. 
In order to explain the discrepancy between Estrada et al. and my data, I employed a live cell 
imaging system using IST2 as tagged mRNA to be imaged. However, when expressed from 
its own promoter and even when expressed from a GAL1 promoter the bud localization 
efficiency for IST2 mRNPs was not the same than for ASH1 mRNPs. For ASH1 in wt cells, 
localization to the bud occurs in about 92% of the cells. With the IST2 mRNA only a value of 
54% was reached in wt cells. As mRNA targeting was already inefficient in wt cells, it was not 
feasible to use this mRNA for statistical analysis in ER inheritance mutants. However, there 
is one possible explanation for the low bud-localization rate of IST2 mRNA in live cell 
imaging. From recent publications it is known that even if targeting of its message is 
disrupted, there is still some Ist2 protein present in the daughter cell plasma membrane. To 
some extent Ist2p is transported to the bud independently of mRNA localization. A complex 
peptide-sorting signal is required for this transport pathway that also works independently of 
the classical secretory pathway (Franz et al., 2007; Juschke et al., 2004). The fact that for 
Ist2p, localization is not only mediated by its mRNA but that signals are also encoded on the 
protein level might be the reason why the transcript is targeted less efficiently to the bud than 
the ASH1 message, where localization signals are exclusively harboured within the mRNA. 
 Recently, the finding that mRNA localization and cortical ER inheritance to the yeast 
bud seem to be coordinated processes was strongly supported by observations of Aronov et 
al.. Consistent with my data they found that mutations that affect cortical ER segregation to 
the bud also affect mRNA localization (Aronov et al., 2007). In this study, Aronov and co-
workers identified an additional set of 9 bud localized mRNAs encoding polarity and 
secretion factors in yeast (POL mRNAs). These mRNAs localize asymmetrically to the tip of 
the emerging bud dependent on their 3’UTRs and the SHE genes and they are bound by the 
RNA binding protein She2p as demonstrated by IP and RT-PCR (Aronov et al., 2007). Thus, 
these newly identified mRNAs seem to utilize the same machinery like already described 
localized yeast messages. The conclusion that mRNA localization and cortical ER 
inheritance are connected was reached from the finding that POL mRNA localization to the 
tip of the emerging bud correlated directly with the presence of cortical ER. In analogy to my 
results Aronov et al. found defects in ER inheritance and mRNA localization not only in the 
myo4 strain but also in the srp101-47ts mutant. Additionally, they tested Sec3p, a non-
essential subunit of the exocyst complex which mediates targeting of post-Golgi vesicles to 
sites of active exocytosis (TerBush et al., 1996). Sec3p is thought to act as a spatial 
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landmark for secretion but was also shown to be involved in ER segregation (Wiederkehr et 
al., 2003). Similar to aux1, myo4 and srp101-47ts mutants, the SEC3 deletion strain was 
not only impaired in ER inheritance but also displayed a defect in mRNA trafficking. Finally, 
not only ASH1 but also the POL mRNAs were shown to associate with ER since they co-
fractionated with ER microsomes (Aronov et al., 2007). 
Our data in combination with the results from the aforementioned study strongly support the 
notion of an emerging interplay between the mechanism of mRNA transport and ER 
inheritance in the yeast bud. 
 
3.2. A connection between mRNAs and membranes: lessons from 
other organisms 
 
Our model of a coordination of mRNA and ER trafficking is not only supported by the findings 
of Aronov et al.. In addition there are also indications from multicellular eukaryotes for a 
connection between mRNAs and membranes suggesting that this is not only a yeast specific 
phenomenon.  
In Ascidians (sea squirts) for instance, a variety of maternal mRNAs like macho 1 and 
HrPEM associate with cortical ER in the developing embryo during the establishment of the 
animal-vegetal axis (Sardet et al., 2003). Cortical ER and bound mRNAs build a structure 
termed the “cortical ER-mRNA domain” and in concert they are localized the cortex of the 
ascidien zygote (Prodon et al., 2005; Sardet et al., 2005; Sardet et al., 2007).  
In the plant species Oryza, two mRNAs encoding distinct seed storage proteins – prolamines 
and globulin-like glutelins – are directed to different and separated ER sub-domains. 
Prolamine mRNAs localize to ER-derived prolamine-enriched bodies known as type-I protein 
bodies, whereas glutelin mRNAs are targeted to the cisternal (or cortical) ER. Both storage 
proteins are translated from their respective mRNA on the ER surface, translocated into the 
ER lumen and then further sorted. Early mRNA-ER association in this case helps to separate 
the two different storage proteins and to avoid aggregation and non-productive interactions.  
 In neurons, mRNPs including RNA binding proteins involved in mRNA localization 
such as Staufen and FMRP were found to be associated with ER and it was proposed that a 
structure consisting of ER bound mRNPs might mediate dendritic transport and local 
translation of mRNAs (Ohashi et al., 2002). Furthermore, it has been suggested that 
vesiculated rER/Staufen complexes originating from the perinuclear ER might have a role in 
mRNA localization in neurons (Kiebler et al., 2000). 
In Drosophila, there are several examples for an interconnection between mRNA- and 
membrane-transport. For instance, trailer hitch, a factor necessary for proper secretion of the 
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dorsal-ventral patterning factor Gurken, is part of a large mRNA-protein complex that also 
includes the translation/mRNA localization factors Me31B and Cup. This ribonucleoprotein 
complex associates with specific ER subdomains (Wilhelm et al., 2005) and thus creates a 
link between mRNA localization and membrane transport. Another study describes co-
localization of RNP complex components with a specific subtype of ER membranes that are 
enriched in the reticulon-like 1 protein (Rtnl1). Since these ER membranes are actively 
translocated into the oocyte as it has been described for localized mRNAs, co-localization 
indicates a putative role for ER membranes in mRNP localization and transport (Roper, 
2007). In the case of bicoid mRNA localization to the anterior pole of Drosophila eggs, it was 
recently found that the final steps of this pathway rely on the endosomal sorting complex 
required for transport (ESCRT-II) (Irion et al., 2007) thus creating an additional link between 
mRNA and membrane trafficking. gurken mRNA in Drosophila is localized to the 
dorsal/anterior corner of the oocyte (see 1.1.2.1). In a recent study it was demonstrated that 
gurken transcript is exclusively deposited on ER structures in this restricted area in order to 
mediate efficient exocytosis of the encoded protein only at the dorsal/anterior part of the 
oocyte (Herpers et al., 2004). ER association of a localized mRNA in this case facilitates 
asymmetric secretion of the respective protein. In contrast to gurken, oskar mRNA is 
targeted to the posterior pole of the Drosophila oocyte (see 1.1.2.1) and for this it depends in 
part on microtubule-base transport mechanisms. However, these cytoskeletal tracks do not 
reach beyond the middle of the oocyte (Cohen, 2005). Transport covering the remaining 
distance relies on Rab11, a protein involved in vesicle trafficking and organisation of 
posterior membrane compartments (Dollar et al., 2002). Finally, results from a different study 
demonstrate that the localization of oskar mRNA during Drosophila development is also 
disturbed in several mutants defective in the assembly of ER structures (Ruden et al., 2000) 
and the authors suggest an involvement of the ER in oskar mRNA localization. 
 In the amphibian Xenopus laevis, an interplay between ER transport and mRNA 
trafficking has been observed during embryonic development. As mentioned in section 
1.1.2.2., Vg1 mRNA is localized to the vegetal pole of the embryo via the late pathway by 
transport through the ER. Interestingly, the VgLE binding protein Vera (VgLE binding and 
endoplasmic reticulum association) associates with these ER membranes and is thought to 
mediate this mRNA-ER co-transport (Deshler et al., 1998; Deshler et al., 1997).  
Altogether there is a growing number of examples from higher eukaryotes for an 
interconnection between the transport of mRNAs and membranes supporting our 
observations made in yeast. 
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3.3. The RNA binding protein She2p associates with ER 
membranes 
 
In S. cerevisiae, it had been observed earlier by double live imaging that ASH1 mRNPs co-
localize with ER tubules (Section 1.5.). Here I sought to investigate whether She2p, a protein 
binding to all bud localized yeast mRNAs (Aronov et al., 2007; Bohl et al., 2000; Shepard et 
al., 2003), is also associated with ER. She2p is not required for ER segregation like She3p 
and Myo4p, two locasome components that also co-fractionate with ER markers (Estrada et 
al., 2003). Nevertheless it could tether localizing transcripts to the ER and thereby effect the 
observed connection between mRNA and ER transport (Section 2.1.).  
In order to test if She2p is associated with ER membranes, I tried to perform in vivo co-
imaging of ER tubules and She2p. As She2p could not be expressed as an RFP-tagged 
version but only as a GFP fusion protein, an RFP-labelled ER membrane marker had to 
replace the Hmg1p-GFP ER marker. Unfortunately, all RFP-ER markers that were tested 
exhibited extensive photo bleaching. Due to these bleaching problems, She2p-ER co-
imaging over time was not possible during this study. 
I also used a biochemical approach to investigate the issue of whether She2p associates 
with ER. Indeed, She2p was found to co-fractionate with ER marker proteins in a set of 
different subcellular fractionation assays such as sucrose velocity gradients, ER isolation 
procedures and membrane flotation assays (Section 2.4.). These data strongly indicate that 
the RNA binding protein She2p is associated with ER and might serve as the linker which 
tethers localizing mRNPs to this membrane compartment. 
This idea is consistent with the observation that, in contrast to wt cells where a dynamic co-
migration of cytoplasmic ER tubules and ASH1-MS2 RNPs can be detected (see 1.5.), 
mutants lacking She2p contain ASH1-MS2 particles that stay in close proximity to the 
nuclear envelope and do not associate with ER tubules emanating from the perinuclear ER 
(A. Jaedicke in (Schmid et al., 2006)). Similar to this, in situ hybridization of untagged ASH1 
mRNA expressed under similar conditions in she2 cells shows perinuclear staining (Figure 
S1 in (Schmid et al., 2006)). Moreover, another study demonstrated by subcellular co-
fractionation that ASH1 mRNA and POL mRNAs bind to the ER in a She2p dependent 
manner. In cells lacking She2p, bud-localizing mRNAs are released from ER membranes 
(Aronov et al., 2007). 
In light of these data it seems highly likely that She2p is the candidate that mediates ER 
membrane anchoring of localized mRNAs. 
Interestingly, She2p is not the only RNA localization factor that can associate with ER. For 
instance, such observations have also been made for Staufen 1, a conserved double-
stranded RNA binding protein involved in mRNA localization in various cell types (Allison et 
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al., 2004; Roegiers et al., 2000). In Xenopus oocytes (Allison et al., 2004) as well as in 
certain mammalian cell types, a population of Staufen 1 co-fractionates and co-localizes with 
rough ER (Duchaine et al., 2000; Gautrey et al., 2005; Kiebler et al., 1999; Marion et al., 
1999; Wickham et al., 1999). However, in case of Staufen 1 it is still unclear if this ER 
association is needed for mRNA localization. In Xenopus laevis oocytes, VgRBP (Vg1 RNA 
binding protein) binds to several localized mRNAs including Vg1 (King et al., 2005). As 
mentioned earlier, the protein has also been named Vera (VgLE-binding and endoplasmic 
reticulum association) since it co-fractionates and co-localizes with ER membranes (Deshler 
et al., 1998; Deshler et al., 1997) and in case of Vg1 mRNA it is thought that co-transport 
with ER is essential for its localization (Cohen, 2005).  
It is therefore interesting to reveal the molecular basis of the She2p-ER interaction in yeast. 
As mentioned before, the other two core locasome components, She3p and Myo4p, were 
shown to co-fractionate with ER (Estrada et al., 2003). Association of She2p with ER could 
therefore in principle occur via adaptor proteins like She3p (Bohl et al., 2000; Long et al., 
2000). Although previous results suggest a direct interaction between She2p and She3p 
(Bohl et al., 2000), She3p is not required for She2p co-fractionation with ER (Section 2.10., 
figure 24 A) in sucrose gradients and is therefore unlikely to be the linker between She2p 
and ER. The same is true for the motor protein Myo4p: She2p still co-fractionates with ER 
markers in a myo4 mutant. This result is consistent with data from live cell microscopy, as 
in cells lacking Myo4p, ASH1-MS2 particles are still associated with ER tubules even though 
these membrane structures do no longer migrate into the growing bud (A. Jaedicke in 
(Schmid et al., 2006)). In velocity sucrose gradients She2p – ER interaction was even not 
disturbed in a myo4she3 double knockout strain (Figure 24 B). This rules out a possible 
scenario in the respective single knockouts in which Myo4p could compensate for the loss of 
She3p and vice versa. She2p appears to attach to ER without the assistance of She3p or 
Myo4p. Consistent with these results an independent study observed that She3p does not 
co-fractionate with ER markers in the concurrent absence of She2p and Myo4p yet does so if 
only one of them is missing (Long, 2007). This indicates that either She2p or Myo4p are 
necessary for the She3p-ER interaction to occur. Simultaneously it implies that both Myo4p 
and, most relevant for this study, She2p are associated with ER independently from each 
other. 
She2p’s ER binding activity does also not depend on polysomes, i.e. ongoing translation, 
and SRP-mediated recruitment of mRNAs to the ER membranes (Section 2.5.). In theory, 
this would be one possible explanation as a large number of localized mRNAs and thus 
She2p substrates encode membrane or secreted proteins. From recent data it is known that 
membrane and non-membrane encoding messages are co-assembled into and co-
transported in common mRNPs (Lange et al., 2008). Such a particle harbouring She2p and 
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different localizing mRNA ligands could be tethered to the ER via mRNA/ribosome/nascent 
polypeptide chain complexes and the SRP pathway. By these means She2p would be 
anchored only indirectly to the ER. In neurons this is for instance the case for an ER bound 
mRNP comprising Staufen and FMRP: Upon EDTA treatment, which is known to disrupt 
polysomes, these RBPs detach from the ER (Ohashi et al., 2002). In strong contrast to this, 
She2p still co-fractionates with ER membranes in presence of EDTA. Even more notably it 
shifts along with ER membranes to slightly lighter fractions. This is presumably due to the 
removal of polysomes by EDTA (Figure 65) indicating that She2p stays associated with ER 
membranes independently of polysomes and translation. 
She2p is neither bound to ER via the mRNA translation machinery as mentioned before, nor 
via the mRNA itself. The latter was demonstrated by RNase treatment (Section 2.6.1.) and 
by use of She2p-N36S,R63K, a She2p mutant impaired in mRNA binding (Section 2.8.).  
 
To summarize, the association of an ASH1-MS2 mRNP with ER tubules and the co-
fractionation of She2p with ER occur independently of other She proteins like the motor 
protein Myo4p or the adaptor She3p. Since She2p itself is required for co-localization of 
ASH1-MS2 RNPs with ER tubules and co-fractionates with ER membranes independently of 
polysomes (thus ongoing translation) and of mRNA, it is suggestive that localizing mRNPs 
associate with ER tubules via She2p.  
 
If polysomes, mRNA and other She proteins do not mediate She2p’s interaction with ER, an 
unknown protein might act as bridging factor.  
Different potential candidates were tested that might tether She2p to ER (Section 2.10.) but 
none of them turned out to be essential for this association. Aronov et al. observed the 
detachment of ASH1 mRNA from ER upon deletion of Sec3p, an exocyst component also 
involved in ER segregation (Aronov et al., 2007), indicating a role for Sec3p in ASH1-ER 
anchoring. However, in contrast to this, velocity sucrose gradient experiments in this study 
demonstrated that She2p is still co-fractionating with ER markers in a sec3 mutant (see 
2.10.). Even if I cannot explain this discrepancy at the moment, in light of my data it appears 
that She2p is stably associated with ER even in absence of Sec3p. Hence it seems unlikely 
that Sec3p serves to tether She2p to ER membranes.  
In summary, every attempt to determine the She2p-ER bridging factor by such “educated 
guesses” failed (see 2.10.). However, the nature of linking factors can be too exotic to be 
identified via mere speculation. For example it was found recently that the G1 cyclin Cln3 is 
retained at the ER via an unusual chaperone-regulatory J domain which in turn is bound by 
the ER attached J-chaperone Ydj1 (Verges et al., 2007). 
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In order to identify the putative protein factor via a more general approach, I also carried out 
chemical cross-linking experiments using formaldehyde or bis-maleimide cross-linkers for 
conjugation between sulfhydryl-groups (data not shown). These were performed in whole cell 
extracts lacking She3p in order to avoid background signal due to cross-linking between core 
locasome components (She2p, She3p and Myo4p). In parallel, cross-linking was executed 
with a fraction containing recombinant She2p and purified ER membranes prepared via the 
She2p-ER pelleting assay (described in section 2.11.1.). In this purified ER membrane 
fraction, only integral and peripheral membrane proteins, no cytosolic components, should be 
present and therefore the range of possible candidates should be more restricted. However, 
none of these cross-linking approaches resulted in a specific band that would indicate a 
potential binding partner of She2p on ER membranes (data not shown). In addition, She2p-
ER pelleting assays with protease treated ER microsomes (Section 2.11.2.) did not show a 
sole protein dependency of the She2p-ER interaction.  
Taken together, these data infer that it is highly likely that She2p binds to ER membranes 
directly.  
 
3.4. She2p has the ability to directly interact with lipid membranes 
 
The notion of a direct interaction of She2p with membranes was further substantiated by 
binding assays with synthetic, protein free membranes: in membrane flotation assays She2p 
– in contrast to the control protein – floated along with artificial, ER-like liposomes (Section 
2.12.1.) suggesting that it can directly bind to membranes. 
From these observations the question arises how She2p might attach to membranes, i.e. 
which domain might serve as a lipid binding domain. 
 
In general, according to the nature of their association, membrane proteins can be divided 
into intrinsic (integral) or extrinsic (peripheral) membrane proteins (Goni, 2002).  
 She2p is not an integral membrane protein since it does neither contain an N-terminal 
signal peptide or any predicted transmembrane domains nor does it possess a carboxy-
terminal hydrophobic segment like tail-anchored ER membrane proteins do (Borgese et al., 
2003).  
 Within the class of peripheral membrane proteins, some contain covalently attached 
fatty acid- or prenyl-moieties such as myristate, palmitate, farnesyl and geranylgeranyl, which 
they embed in the lipid bilayer for membrane anchorage (Resh, 2006). However, since even 
recombinantly expressed She2p binds to liposomes, such a lipid binding mode can be 
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excluded for She2p. The same rationale applies to another posttranslational lipid 
modification, the glycosylphosphatidylinositol (GPI) anchor (Orlean et al., 2007). 
 Recently, a targeting signal responsible for directing a number of proteins to the 
cytosolic surface of the ER was identified (Loewen et al., 2003). This so called FFAT motif 
(with [FF] standing for diphenylalanine) has the consensus amino acid sequence EFFDAxE 
and mediates binding to a highly conserved class of ER transmembrane proteins, the VAP 
protein familiy (Kaiser et al., 2005). However, no such motif is present in the She2p primary 
sequence and therefore this anchoring mode does not apply for She2p. 
 
Nevertheless, it was observed in this study that She2p behaves like a genuine peripheral 
membrane proteins since it could be removed from liposomes by Na2CO3 treatment (Section 
2.12.2.). Na2CO3, pH 11 is known to shear off extrinsic membrane proteins (Fujiki et al., 
1982).  
 Another class of peripheral membrane proteins contains globular domains specialized 
for lipid binding, which are also termed membrane-targeting domains (W. Cho et al., 2005). 
This group includes various members and amongst them are protein kinase C conserved 1 
(C1), conserved 2 (C2), and annexin domains. C1 binds to phorbolesters and diacylglyerol 
(DAG) whereas C2 and annexin domains are known to bind phosphatidylserine (PS) in a 
Ca2+-ion dependent manner (Lemmon, 2008). Other membrane-targeting domains like PH 
(pleckstrin homology), FYVE (Fab1, YOTB, Vac1, and EEA1), PX (Phox-homology), ANTH 
(AP180 N-terminal homology), BAR (Bin amphiphysin Rvs), FERM (band 4.1, ezrin, radixin, 
moesin), PDZ (postsynaptic density, disk large, zonula occludens), and tubby domains all 
have a specificity for different phosphoinositides (PIPs), derivatives of phosphatidylinositol 
(PI) with one ore more phosphates attached by specific kinases to the 3, 4 or 5 positions of 
the inositol ring (Balla, 2005). However, attempts to detect similarities between She2p and 
those domains failed, suggesting that She2p does not contain homology to any known 
globular lipid binding domains (analysis performed by Johannes Söding, Genecenter, LMU 
Munich). Yet it is interesting to note at this point that, concerning its mRNA association 
activity, She2p turned out to be an unconventional RNA-binding protein not belonging to any 
previously identified classes of RNA binding proteins (Niessing et al., 2004). In analogy to 
this it is tempting to speculate that She2p might also constitute a so far uncharacterized type 
of lipid binding protein. 
 Finally there are also peripheral membrane proteins that do not have special globular 
lipid-binding domains but rather interact with the membrane via their molecular surface or an 
amphiphatic secondary structure (W. Cho et al., 2005). In this case, membrane anchoring 
can occur either via hydrophobic forces with non-polar parts of the membrane matrix or via 
electrostatic or polar forces with charged head groups of the phospholipids (Goni, 2002). 
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Concerning membrane polarity, zwitterionic phospholipids like PC (phosphatidylcholine) or 
PE (phosphatidylethanolamine) have a zero net charge and in total behave electrically 
neutral like the yeast steroid ergosterol. In contrast, PS (phosphatidylserine) and PI 
(phosphatidylinositol) are phospholipids with a single net negative charge whereas 
phosphoinositides (PIPs) can be highly negatively charged. Often, clusters of basic amino 
acids in extrinsic membrane proteins interact with negatively charged lipids like PI, PS or 
PIPs and such interaction can be even stronger than the interaction between lipids and the 
aforementioned specific membrane targeting domains (McLaughlin et al., 2005). In case of 
the yeast exosome component Sec3p such a polybasic region lies within its N-terminal 
domain and mediates interaction with PS and a specific type of PIP, thereby facilitating 
membrane recruitment (Zhang et al., 2008).  
Analysis with the web-based tool ConSurf (http://consurf.tau.ac.il) (Glaser et al., 2003; 
Landau et al., 2005) to identify highly conserved and basic residues in She2p yielded one 
larger region that simultaneously displays amino acids matching both criteria (Figure 34). 
 However, this surface exposed region, also called the “basic helical hairpin”, has 
been identified as a She2p domain involved in mRNA binding (Niessing et al., 2004). After 
this analysis, one major flaw of the in vitro lipid binding assay using liposomes and 
recombinant She2p had to be addressed: In absence of its mRNA ligand, She2p might non-
specifically associate with negatively charged phospholipids in synthetic vesicles via its basic 
helical hairpin. To investigate this, the She2p-lipid binding assay was performed in presence 
of in vitro transcribed ASH1 E3 localization element, one of the three RNA elements bound 
by She2p. The RNA ligand floats together with the She2p/vesicle fraction (see 2.12.4.) 
suggesting that She2p can simultaneously bind RNA and liposomes and does not merely 
attach randomly to lipid membranes if the RNA ligand is absent. This notion is further 
supported by the observation that She2p-N36S,R63K, a protein which carries mutations in 
the basic helical hairpin and is incapable of binding mRNA, can still bind as efficient to 
liposomes as wild type She2p (data not shown). Moreover, in vivo, She2p is known to 
associate with ER membranes even upon over-expression of its mRNA ligand from a 2μ 
plasmid (Section 2.4.1., figure 13) and it has been shown that both mRNA and She2p co-
fractionate simultaneously with ER membranes (Aronov et al., 2007). Together, these results 
strongly suggest that the mRNA and lipid binding activities in She2p are not mutually 
exclusive and that the basic helical hairpin is not necessarily involved or at least is not a 
major player in the process of membrane attachment. Consistent with these results She2p’s 
ability to interact with synthetic membranes remains even if liposomes are lacking PS and PI 
and thus do not contain any phospholipids with a negative net charge (Section 2.12.3.). In 
summary these observations indicate that She2p does not interact unspecifically with lipid 
membranes via its polybasic stretch.  
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Figure 34: The surface exposed basic helical hairpin of She2p is highly conserved and 
harbours a stretch of basic amino acids: Surface residue conservation and distribution of 
negatively charged amino acids of She2p was analysed using CONSURF (http://consurf.tau.ac.il). 
Left panel: the degree of conservation is depicted in a colour range where green indicates high 
variability and deep purple represents a high degree of conservation. Right panel: structures are 
duplicates from the ones in the left panel with the additional information that basic amino acid 
residues are depicted in red. Please note that only the fully elaborated A chain of the She2p PDB 
structure is illustrated with its atoms in colour whereas the incomplete B chain is only shown in ribbon 
form.  
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Another option for She2p would be membrane attachment via hydrophobic interaction forces. 
One possible candidate for such a binding mode could be Leu130 which is positioned on the 
top of the She2p dimer (Figure 35). However, the mutant She2p-L130S is not impaired in its 
association with ER in fractionation assays (see 2.9.). Moreover this hydrophobic region is 
implied in the oligomerization of She2p (Marisa Müller, personal communication). Another 
possible hydrophobic surface patch is the region above the aliphatic amino acid Val202 
(Figure 35). This amino acid was identified in the same screen for mutants defective in 
mRNA localization as residue Leu130 (Gonsalvez et al., 2003). Yet, due to limitations in time, 
V202 was not analyzed within this study. Currently one can only speculate but this amino 
acid and the adjacent hydrophobic region should be investigated for involvement in She2p-
membrane interaction in future. 
 
 
Figure 35: Hydrophobic residues on the She2p surface: Hydrophobic patches were displayed 
using CONSURF (http://consurf.tau.ac.il); polar (charged & uncharged) amino acids are depicted in 
purple, hydrophobic residues in grey.  
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In order to analyze She2p for possible candidate regions involved in membrane binding, I 
used MAPAS, a web-based tool to predict membrane-contacting protein surfaces 
(http://cancer-tools.sdsc.edu/MAPAS/pro2.html) (Sharikov et al., 2008). The results of this 
analysis for She2p are depicted in figure 36. 
 
Figure 36: Prediction of possible She2p-membrane interactions by MAPAS analysis 
(http://cancer-tools.sdsc.edu/MAPAS/pro2.html): The two She2p monomers of the PDB structure are 
depicted in different colours, chain A in blue, chain B in light green. Note that due to the PDB data 
chain B is incomplete and lacks e.g. the unstructured loops at the bottom of the dimer. 
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Figure 36 A shows one possible interaction mode in which parts of the protruding helix of the 
She2p dimer and hydrophobic residues including Leu130 in the head domain interact with 
the membrane. However, as mentioned above, mutation of Leu130 did not affect membrane 
association. Concerning the -helix which protrudes at right angles from both sides at the 
middle of the She2 dimer, its effect was tested via She2p-Helix (She2p-amino acids 174-
183), a protein bearing a deletion in this secondary structure. When analyzed by velocity 
sucrose centrifugation, She2p-Helix was not impaired in its association with ER membranes 
indicating that it is not involved in lipid binding (see 2.9.). 
In figure 36 B, a second potential lipid contact is illustrated which consists of the interaction 
between membranes and the unstructured loops at the bottom end of the She2p dimer 
(ranging approximately from Asn79 to Ser91). It is important to note at this point that chain B 
of the She2p dimer (depicted in light green in figure 36) is incomplete in the PDB structure 
and lacks the region of the unstructured loop which was therefore also not considered in the 
MAPAS analysis. So far, no mutational analyses have been performed with residues in this 
unstructured loop which might contact membranes according to MAPAS. Even if the 
probability of being a lipid interacting domain according to MAPAS is not too high, it will be 
interesting in the future to investigate its role in She2p membrane anchoring.  
Unfortunately amino acid Val202 did not come up in the MAPAS analysis, although the 
residues Asn203, Ser204, Glu205, Glu206 in its near surrounding were amongst the amino 
acid group which was involved in the potential lipid interactions depicted in figure 36 B. 
 
Besides the question about the molecular basis of the She2p-membrane interaction another 
key issue that emerges is specificity: how does She2p recognize ER structures and discern 
them from any other intracellular membranes? 
In general it was believed for a long time that specific subcellular localization of peripheral 
membrane proteins can be only based on protein-protein interactions with integral membrane 
proteins, because lipid-protein interactions could not confer such precise specificity. Today it 
is known that the majority of extrinsic membrane proteins binds two families of compounds: 
The first class consists of numerous activated GTPases that are displayed on the surface of 
the respective organelles. The second class of molecules that contributes to the unique 
identity of membrane compartments are specific lipids (Behnia et al., 2005). Recent studies 
have indicated that high specificity and affinity can be also attained through lipid-protein 
interactions (W. Cho et al., 2005). Cellular membrane compartments have different lipid 
compositions and recognition of these specific lipid species is another mode for extrinsic 
membrane proteins to distinguish one intracellular organelle from another (Lemmon, 2008). 
 Within the class of lipids, polyvalent phosphoinositides (PIPs) are major players in 
defining organelle identity and in recruiting proteins to specific membranes even though they 
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are only low abundant (Behnia et al., 2005; Lemmon, 2008; McLaughlin et al., 2005; van 
Meer et al., 2008). For instance PI(3)P is exclusively found on early endosomes, PI(3,5)P2 on 
late endosomes and lysosomes, PI(4)P on trans-Golgi stacks, and PI(4)P, PI(4,5)P2, 
PI(3,4)P2 and PI(3,4,5)P3 on plasma membranes (Behnia et al., 2005; van Meer et al., 2008). 
However, from recent studies it is known that not only PIPs but also the more abundant, 
anionic lipid phosphatidylserine (PS) is involved in specific recruitment events (Behnia et al., 
2005). By use of a biosensor it was shown to be accumulated in the cytosolic leaflets of 
plasma membrane, endosomes and lysosomes and to redirect cationic proteins to the 
endocytic pathway (Yeung et al., 2008). 
But in contrast to other intracellular compartments, the ER itself is exceptional since there 
are no specific lipids found on this organelle (Behnia et al., 2005). PS is only present at low 
levels and PIPs are completely absent. The ER-like liposomes for my binding assay were 
prepared according the yeast ER lipid composition (see methods section 5.7.1.) (Schneiter et 
al., 1999; Tuller et al., 1999; Zinser et al., 1991). In order to assess whether the two anionic 
phospholipids PS and PI act as landmarks for She2p-ER recruitment, I prepared synthetic 
vesicles lacking both PS and PI and tested them for She2p-lipid interaction. She2p was 
floating with these PS-/PI-minus liposomes just as well as with the ER-like vesicles (Section 
2.12.3.) indicating that neither PS nor PI are the components which mediate specificity in the 
She2p-ER interaction. This result was anticipated due to absolutely “basic” phospholipid 
equipment of the ER compartment from which one can conclude that in case of the ER, 
proteins should still act as organelle markers. Consistent with this idea I had observed a 
slight but not complete reduction in the pelleting of She2p with protease treated ER 
microsomes (Section 2.11.2.). One could speculate that this is due to the loss of a factor 
which – although not acting as the ER-linker for She2p – might in contrast act as a landmark 
for efficient ER-recognition and the adjacent recruitment of She2p. 
In summary, the data of this study strongly suggest that She2p has indeed the ability to 
directly interact with lipid membranes even though the nature or molecular basis of this 
association still has to be elucidated. However, extensive mutational analysis based on the 
surface analyses as discussed above should finally help to elucidate the domains involved in 
lipid binding. Thus, it seems likely that the specificity for She2p-membrane interaction is not 
only mediated by lipids but might also be mediated by accessory protein factors. In order to 
further analyse lipid specificity in the She2p-ER interaction, additional studies could be 
performed. Phospholipid strips could be used to quickly identify a potential preference of 
She2p for a certain species of phospholipids (Membrane Lipid ArrayTM; Echelon 
Biosciences). In addition, surface plasmon resonance (SPR) technology could be used to 
investigate in detail affinities between She2p and different membranes. The lipid specificity of 
protein-membrane interactions can be easily studied with this method by manipulating the 
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lipid composition of immobilised synthetic membranes. But such BiocoreTM sensor chips do 
not only allow the capture of liposomes but even of subcellular membrane preparations 
(Besenicar et al., 2006). This would permit investigating the strength of She2p interaction 
with natural ER membranes in contrast to other intracellular membrane compartments and in 
comparison to e.g. protease treated ER microsomes or microsomes from various yeast 
mutants in search of the aforementioned hypothetical accessory factor. Finally, different 
She2p mutants could be analyzed for their binding affinities to lipid membranes. 
 
3.5. Benefits of coordinated mRNA and ER transport and 
implications for a possible model 
 
In summary, I observed a functional correlation between mRNA localization and ER transport 
in yeast. The RNA binding protein She2p associates with ER membranes and thus most 
likely serves as the linker that attaches localizing mRNPs to this subcellular compartment. 
The She2p-ER interaction occurs independently of polysomes (thus ongoing translation), of 
mRNA and other She proteins like Myo4p or She3p. In the contrary, She2p was shown to 
directly interact with lipid bilayers even though the molecular details of this membrane 
binding activity still have to be unravelled. 
Taken together, these results support the notion that She2p and the She3p/Myo4p motor 
complex attach to ER independently and that the trimeric She2p-She3p-Myo4p locasome 
that has been considered as the device for mRNA localization in yeast (Bohl et al., 2000; 
Gonsalvez et al., 2005; Long et al., 2000; Takizawa & Vale, 2000) is only a component of a 
still more complex transport machinery that includes ER tubules. 
 
For both mRNAs encoding cytosolic (mRNAcyt) or mRNAs encoding membrane or secreted 
proteins (mRNAsmemb/sec), a co-transport together with ER membranes would have several 
benefits compared to separate transfer processes. 
In case of mRNAsmemb/sec, common transport with ER would allow the pre-assembly with 
structures responsible for synthesis and processing of the encoded proteins. The localized 
mRNAs would be already present firstly near ER-resident ribosomes on which the proteins 
are synthesized in the following; secondly they would be already close to the translocon, the 
machinery that mediates transfer of membrane proteins or secreted proteins to the ER 
lumen. Finally, mRNAs for secreted proteins would be in close proximity of ER structures like 
tER from which their encoded proteins are packed into transport vesicles and then released 
into the secretory pathway. This would therefore enable a much more efficient performance 
of processes like ER-located synthesis, membrane insertion and ER import and secretion of 
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the respective proteins. Another example of mRNA-organelle targeting and a resultant more 
efficient transfer process of the encoded protein, is the localization of transcripts like 
metallothionein-1 (MT-1) and transcription factors c-FOS and c-MYC to the nuclear periphery 
(Chabanon et al., 2005; ChabanonNury et al., 2004; Dalgleish et al., 2001). Upon disruption 
of perinuclear localization of its message, MT-1 protein is not efficiently imported into the 
nucleus any more indicating that mRNA targeting to the nuclear periphery enhances nuclear 
transport (Levadoux et al., 1999).  
As mentioned earlier (see 1.3.3.), the majority of localized mRNAs in yeast encodes 
membrane or secreted proteins and therefore this possible advantage is of special 
importance. In view of the following facts, the co-transport model seems even more 
plausible: Firstly, it is known that localized mRNAs are transported in a translationally 
silenced state (Deng et al., 2008; Paquin et al., 2007). Therefore, it is questionable whether 
targeted mRNAsmemb/sec can in fact be recruited to the ER via the SRP pathway, a process 
completely dependent on translation (Halic et al., 2005; Keenan et al., 2001). Even though 
this will have to be investigated, the probability is high that SRP recruitment might not work 
for localizing mRNAs and that recruitment via She2p might help to circumvent this problem. 
Secondly this idea is consistent with the recent finding that the mRNAs for membrane and 
secreted proteins can be also directed to ER membranes in a signal peptide and translation 
independent manner, putatively via specific RNA binding proteins (Pyhtila et al., 2008), like 
She2p.  
 In the case of localized mRNAs for cytoplasmic proteins, it has been found recently 
that different mRNA species, encoding either soluble factors or membrane proteins, are co-
assembled and simultaneously transported in the same mRNP (Lange et al., 2008). A 
common recruitment of mRNAcyt and mRNAsmemb/sec to ER membranes is therefore highly 
likely to occur. This notion is supported by the striking observation of a cDNA-microarray 
based screen for novel secretory and integral membrane proteins: in addition to identifying 
novel genes for this group, a large number of mRNAs encoding soluble proteins, amongst 
them also ASH1 mRNA, was found to be ER associated (Diehn et al., 2000). Independently, 
other results show that mRNAscyt are present and sometimes even enriched on the ER and 
are also translated by ER bound polysomes (Lerner et al., 2003; Nicchitta et al., 2005). 
In summary, the model of a co-trafficking of both mRNAsmemb/sec and mRNAcyt with ER 
membranes is substantiated by these observations. 
Concerning local protein synthesis at peripheral cell regions, the two types of localizing 
mRNAs, the ones for soluble and the ones for membrane or secreted proteins would both 
equally benefit from a co-transport with ER. In yeast the final destination of mRNA and ER 
trafficking is the newly forming bud and in higher eukaryotes like in neurons this would be 
distant cellular areas in axonal and dendritic processes. The co-assembly and co-transport of 
 Discussion  
 
 
  79   
 
localizing mRNAs and ER would ensure that the transcripts and their necessary translational 
infrastructure such as cortical ER associated polysomes (Baba, 1987), ER resident 
translocon and tER areas reach the peripheral regions together. This in turn could greatly 
enhance the efficiency of local translation and, in case of mRNAsmemb/sec, accelerate 
membrane insertion and secretion of the respective proteins. 
The concept of coordination between mRNA and ER transport is also supported by the fact 
that several recent reviews also describe the emerging interplay between the two processes 
(Cohen, 2005; Gerst, 2008; Paquin et al., 2008).  
However, there is one point which seems to be controversial in the concept of a common 
transport of mRNAs and ER. In live cell microscopy studies using MS2 tagged full-length 
ASH1 mRNA, the ASH1-MS2 particles reach a mean transport velocity of 546 nm/sec 
(Lange et al., 2008). Values in the same range (200-440 nm/sec) were reported in another 
study though in that case fusion constructs of bacterial lacZ mRNA with one ASH1 
localization element was used (Bertrand et al., 1998). This speed of mRNP transport is also 
compatible with that expected for a myosin V motor (Cheney et al., 1993). In contrast to this, 
the rate of ER tubule movement was estimated to an average of 13 nm/sec (Estrada et al., 
2003) and thus much slower than the observed speed of ASH1 mRNA trafficking. I cannot 
explain this discrepancy at the moment. However, recent in vivo imaging experiments using 
the ASH1-MS2 detection system and a GFP-tagged ER tubule marker clearly demonstrated 
co-localization and co-migration of the ER tubule and an attached ASH1-MS2 mRNP particle 
(A. Jaedicke in (Schmid et al., 2006), see also section 1.5.). 
Another issue arises from the observation that ER tubules migrate only into the newly 
forming bud during S-phase, when the yeast bud is small to medium sized (Y. Du et al., 
2001; Estrada et al., 2003; Preuss et al., 1991). Is this compatible with the observed co-
transport of ER tubules and ASH1-MS2 mRNPs, an mRNA which is expressed during late 
anaphase at the end of mitosis? At this point one has to consider that in our experiments, 
ASH1 mRNA was expressed from a constitutive promoter (Section 1.5.) and therefore was 
present throughout the whole cell cycle. 
As mentioned earlier, amongst the group of cell cycle regulated localized mRNAs, ASH1 is 
expressed very late in cell cycle. However, others like WSC2 or SRL1 are expressed early in 
S and G1 respectively. Therefore it is tempting to speculate that in S. cerevisiae there might 
be chronologically different mechanisms for mRNA localization, in analogy to the transport 
routes that exist in Xenopus laevis. As mentioned earlier, dependent on the time-scale there 
are two different mechanisms for mRNA targeting in Xenopus: the early and the late 
pathway. The early one uses a structure called METRO and the late one involves the ER in 
order to achieve translocation of the respective messages (see 1.1.2.2.). Analogously one 
could imagine for S. cerevisiae that there is on the one hand an early pathway which 
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depends on ER and occurs by co-trafficking of early expressed mRNAs and ER tubules; 
localized mRNAs like the POL mRNAs would also be likely candidates for such a transport 
mechanism because they start to localize very early when buds are just about to grow 
(Aronov et al., 2007). On the other hand, the late pathway would proceed without ER 
membrane involvement since ER tubules no longer move to the bud and peripheral ER 
already extends through the complete cortex of the bud at this stage of cell cycle (Figure 37). 
 
Figure 37: Hypothetical model for early and late mRNA localization mechanisms in 
S. cerevisiae. (A) Early mechanism involves co-transport of ER tubules and mRNAs to the small to 
medium sized buds. (B) Late mechanism: No ER tubules move to the bud since cortical ER in the bud 
is already established. mRNA targeting proceeds independently of ER tubule movement. 
 
However, to date this model is only based on speculation and additional experiments have to 
be performed to test this hypothesis. For instance, localized mRNAs expressed early in cell 
cycle such as WSC2 could be used to investigate the impact of ER inheritance on the 
trafficking of such early localizing transcripts. 
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4. Materials 
4.1. Consumables and Chemicals 
 
Consumables and chemicals were purchased from the following companies: 
Acros Organics (Geel, Belgium), Applichem (Darmstadt), Applied Biosciences (Darmstadt), 
Apollo Scientific Limited (Bredbury, UK), Axon (Kaiserslautern), Becton Dickinson, 
(Heidelberg), Beckman Coulter (Krefeld), Biaffin (Kassel), Biomol (Hamburg), Biorad 
(Munich), Biozym (Hess. Oldendorf), Chemicon (Temecula, Canada), Fermentas (St. Leon-
Rot), Formedium (Norwich, UK), GE Healthcare (München), Gilson (Bad Camberg), 
Invitrogen (Karlsruhe), Macherey & Nagel (Düren), Medac (Hamburg), Medigenomix 
(München), Membra Pure (Bodenheim), Merck Biosciences (Darmstadt), Millipore 
(Molsheim, France), Mobitec (Göttingen), MP Biomedical (Illkirch, France), NEB (Frankfurt), 
Neolab (Heidelberg), Nunc (Wiesbaden), Peske (Aindling-Arnhofen), Promega (Mannheim), 
Qiagen (Hilden), Roche (Mannheim), Roth (Karlsruhe), Santa Cruz (Santa Cruz, USA), 
Sarstedt (Nümbrecht), Semadeni (Düsseldorf), Serva (Heidelberg), Sigma (Taufkirchen), 
Stratagene (Amsterdam, The Netherlands), VWR (Ismaning). 
 
4.2. Equipment 
 
Abimed Pipetman Gilson P10, P20, P200, P1000 
Avestin Extruder LiposoFast-Basic 
Beckman Coulter Ultracentrifuge L-80; rotors SW40, SW55 and SW60 
Ultracentrifuge Optima MAX; rotor TLA120.2  
Biorad E. coli Pulser 
Biometra T1 Thermal Cycler 
Branson Sonifier 200 
Eppendorf Thermomixer Compact, Cooling centrifuge 5415R, 
BioPhotometer 
Fuji Europe Fuji LAS-3000 mini imaging system 
Haereus Tabletop centrifuge Biofuge pico, Multifuge 3 L-R 
Ika Vibrax VXR basic 
Julabo Waterbath Shaker SW 2 
Liebherr Freezer -20°C, Fridge 
Mitsubishi Gel documentations system 
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MJ Research PCR cycler PTC-200 
Neolab Akku-Jet 
New Brunswick Freezer -80°C, Shaking incubator 
Olympus Fluorescence Microscope BX60 
Peqlab Semi-dry blotting device 
Sartorius Universal Analytical balance 
Scientific Industries  Vortex Genie 2 
Thermo Fisher Scientific Sorvall Evolution RC; rotors SLC6000, SS-34, GS-3, 
GSA; 
RC M120 Ex Micro-Ultracentrifuge; rotor RP120-AT  
Zeiss Light microscope ICS/KF 2 
ZMBH (Heidelberg) Gel electrophoresis chamber 
 
4.3. Commercially available kits 
 
Ambion MEGAshortscript T7 Kit 
Invitrogen Topo TA Cloning® 
Machery&Nagel Nucleospin Miniprep Kit 
New England Biolabs (NEB) Quick Ligation Kit 
Qiagen QIAquick Gel Extraction Kit, QIAquick PCR Purification 
Kit 
Stratagene QuickChange® Site-directed Mutagenesis 
 
4.4. Enzymes 
 
Axon Taq Polymerase 
Biomol Lysozyme 
Fermentas CIP (Calf Intestine Alkaline Phosphatase); Restriction 
endonucleases 
New England Biolabs (NEB) Quick-T4-DNA-Ligase, Vent® DNA Polymerase  
Roche Micrococcal Nuclease, RNase A 
Seikagaku America, ICN Zymolyase 20T,100T 
Stratagene Herculase® II Fusion DNA Polymerase 
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4.5. Oligonucleotides 
 
RJO name sequence purpose 
73 ASH1-RTPCR2A TACATGGATAACTGAATCTC RT-PCR 
74 ASH1-RTPCR2B CAGGATGACCAATCTATTGC RT-PCR 
214 ASH1_1383_r GGGGGAGAGTCGAGAGC sequencing 
282 ASH1_639_f CGCGAAGAAGTGGCTCATTTC sequencing 
166 Yxplac-5’ cccgactggaaagcgggcag gap repair cloning 
167 Yxplac-3’ ggagaaaataccgcatcaggc gap repair cloning 
184 Myo4-ko-forw. 
CCAGTTTGGCGAGACAATTTATTTT
CAATACGATACCCCAGCTGAAGCTT
CGTACGC 
knockout 
185 Myo4-ko-rev 
CAGCTTCGCCCTTGTTAGCAGGCTT
GTATTTCAACGCATAGGCCACTAGT
GGATCTG 
knockout/tagging 
434 s MYO4ko GTTACCAGTTTGGCGAGACA yeast colony PCR 
541 She3-Tag-forw. GGGAAATAGTATGGTTGTTCACGGGGCCCAATCCcgtacgctgcaggtcgac tagging 
542 She3-tag-rev TCCTATATATATACTCCCTTGTGTCGGCATATTatcgatgaattcgagctcg knockout/tagging 
850 IST2-BamH1-F(2544) ttttggatcCTGAACAAACAAAAAAG sequencing 
1110 URA3_+365_R CAATACCTGGGCCCACCACACCG yeast colony PCR 
1082 WSC2-1F ATGCACCTAGATCTCATAC RT for in situ 
1083 WSC2-1R-T7 TAATACGACTCACTATAGGGACTGTAACTGAGCTACGG RT for in situ 
1084 WSC2-2F GTGGTGGTTCTTCTGCCATG RT for in situ 
1085 WSC2-2R-T7 TAATACGACTCACTATAGGGGAGGAAGTAGTTGTCTC RT for in situ 
1086 WSC2-3F GCCTCTTCCAGTTCAGAAACG RT for in situ 
1087 WSC2-3R-T7 TAATACGACTCACTATAGGGCTAGTAGAGGAGGACGTAGACG RT for in situ 
1088 WSC2-4F GAGTGGTGGCGCCATCGCAGG RT for in situ 
1089 WSC2-4R-T7 TAATACGACTCACTATAGGATCTCTGCCGCCCGGCG RT for in situ 
1992 MYO4_epi_S3_f 
CAGCAATACAGAGGGCTTAGCTAC
TGTCAGTAAAATTATAAAATTAGACA
GAAAAcgtacgctgcaggtcgac 
tagging 
1993 MYO4_epi_S2_r 
GTAGGATATATGTATATATACATATA
TACATATATGGGCGTATATTTACTTT
GTTCatcgatgaattcgagctcg 
knockout/tagging 
1999 She2_N36S_for CTCATCTTATATTCACGTGCTGAgCAAGTTCATCAGTCATTTGCG 
site directed 
mutagenesis 
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2000 She2_N36S_rev 
CGCAAATGACTGATGAACTTGCTCA
GcACGTGAATATAAGATGAGAGATA
CC 
site directed 
mutagenesis 
2001 She2_R63K_for GATTAAATTTGTTAAGAAATTGAaATTTTACAACGATTGTGTGTTAAGC 
site directed 
mutagenesis 
2002 She2_R63K_rev GCTTAACACACAATCGTTGTAAAATtTCAATTTCTTAACAAATTTAATC 
site directed 
mutagenesis 
2020 TRP1_sequ_f GAGGTTCCAGTTCCCACAGG yeast colony PCR 
2021 TRP1_sequ_r CCTGTGGGAACTGGAACCTC yeast colony PCR 
2027 kann_C_primer_f tgattttgatgacgagcgtaat yeast colony PCR 
2028 SHE3_ko_S3_f 
CGTTAGCTCGTCTATCAAGCACGC
CAAGGTTCAACGACACTACTTTTGT
GTAAGcgtacgctgcaggtcgac 
knockout 
2029 SHE3_ko_S2_r 
CTTTTGTTCTATTATCTAAATGAATC
CTATATATATACTCCCTTGTGTCGG
CATATTatcgatgaattcgagctcg 
knockout/tagging 
2033 She2_L130S_f CAAAAGGAAATTTTATCTAAAACTTcGAACGAGGACCTAACGCTAAC 
site directed 
mutagenesis 
2034 She2_L130S_r GTTAGCGTTAGGTCCTCGTTCgAAGTTTTAGATAAAATTTCCTTTTG 
site directed 
mutagenesis 
2035 She2_L130Y_f CAAAAGGAAATTTTATCTAAAACTTacAACGAGGACCTAACGCTAAC 
site directed 
mutagenesis 
2036 She2_L130Y_r GTTAGCGTTAGGTCCTCGTTgtAAGTTTTAGATAAAATTTCCTTTTG 
site directed 
mutagenesis 
2039 She3_ko_check_f CGTTGGTAGATCTTGATGG yeast colony PCR 
2068 SHE2_ORF486_r CAAAGACTCAATCATCCATTGAG sequencing 
2069 SHE2_ORF262_f GAGGCGGATTCGTTTGACAAG sequencing 
2070 SHE2_epiK_f 
GAATTTGATGTTGTCGCTACTAAAT
GGCATGACAAATTTGGTAAATTGAA
AAACcgtacgctgcaggtcgac 
tagging 
2071 SHE2_epiK_r 
CTATTAACTAGTGGTACTTATTTGCT
CTTTTTGAGCTAAAAACTGAAGGCC
atcgatgaattcgagctcg 
tagging 
2090 PDA1_RT_f CCATCTTGTTTGAAGACGTCTAC RT-PCR 
2091 PDA1_RT_r gggaagaatatcatgcgatcac RT-PCR 
2092 SEC61_RT_f GTACTTTAGGTTCTGGGGCATC RT-PCR 
2093 SEC61_RT_r ggaggggtgtggctaaatgcg RT-PCR 
2150 SHE2_ORF558_r CGTTCCGTCCTCATCTGCG sequencing 
2147 AUX1_ko_f 
AACCTATTCCTGTGCTTCTGGAAAG
GACGCAGCCTGCAAGAAACAGTCA
ACATCAcgtacgctgcaggtcgac 
knockout 
2149 AUX1_ko_r 
ATTTGTATAAAGTACATATCAAAAAC
AACTGAGCGAAGCAGGCACACAAG
GGAAAatcgatgaattcgagctcg 
knockout 
2165 Aux1_5UTR_check_f ggctcaatgagagcgtggc yeast colony PCR 
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2166 Aux1_3UTR_check_r GATACGCCTTCCTTGACC yeast colony PCR 
2235 GFPamp_pYM12_f cgcGGATCCggagcaggtgctggtgctgg GFP Amplification 
2236 GFPamp_pYM12_r GAagatctTTTGTACAATTCATCCATACC GFP Amplification 
2330 clonNAT_for  AATCGGACGACGAATCGGACG yeast colony PCR 
2347 f_BamHI_IST2UTR GAAGCTTTAAAAAAAAGCTAGGAtccTAACAAATTTTATTTTTATAATATGG 
site directed 
mutagenesis 
2348 r_BamHI_IST2UTR CCATATTATAAAAATAAAATTTGTTAggaTCCTAGCTTTTTTTTAAAGCTTC 
site directed 
mutagenesis 
2356 scp160_check GAACGTCTAAGTACACAACAGC yeast colony PCR 
2357 asc1_check CATTGGGCTATTCCTTTAATTG yeast colony PCR 
2360 clonNAT_rev (maria) CCGTGTCGTCAAGAGTGGTAC yeast colony PCR 
2395 MYO4_del_f 
CTAATTCTAAAACACAAAAAAACAA
AAAAAATCCTATAACCAGTTCTCCC
GCcgtacgctgcaggtcgac 
knockout 
2420 SHE2_ko_f 
GTAAACCCTCCTTAATTTTCCTTTTG
CATAATACCAGACACTTAAAAcgtacg
ctgcaggtcgac 
knockout 
2425 MYO4_5’UTR_f cattgttaccagtttggcgagac yeast colony PCR 
2426 HMG1_bp64_r TATGAATTGGTCGTTTCGCCG sequencing 
2427 HMG1_bp2037_f GACTACGACCGCGTATTTGGCG sequencing 
2428 IST2_RT_f CTACAGATGCTACTCAGCC RT-PCR 
2429 IST2_RT_r GCTTCTTTTTCAGCTTATGC RT-PCR 
2495 kanMX_outfor GCAGTTTCATTTGATGCTCGATGAG yeast colony PCR 
2496 natNT2_outfor CGCTCTACATGAGCATGCCCTGCCC yeast colony PCR 
2497 IST2_ORF2718-39_f GCTGGAGTGAAGAATGTCACG sequencing 
2550 pGEX_Tev_sequ_f GCATGGCCTTTGCAGGGCTG sequencing 
2551 pGEX_Tev_sequ_r CATGTGTCAGAGGTTTTCACCGTC sequencing 
2568 YBR027C_ko_f 
GAGAGAAGGCTCGGATCTGCACTG
ACTTACTTTTTTTTGTTTTTTTGcgtac
gctgcaggtcgac 
knockout 
2569 YBR027C_epi_r 
CTGATGAGCTGAGGACGACATGTA
ACGTTTGAATGTGGGAAGCATCTTG
atcgatgaattcgagctcg 
knockout 
2570 YOL073C_ko_f 
GGAGAGAAAGTCAACGACATAAAA
AGCAAACACAATAGTCTACAAATAcg
tacgctgcaggtcgac 
knockout 
2571 YOL073C_epi_r 
CTAAACCGTTGCTATGTTTATTTGTT
TATGTAGGTATATGCTGATATAAAat
cgatgaattcgagctcg 
knockout 
2572 YJL048C_ko_f 
GACATTTTTGACCCTCAAAGGAAGT
GAATTACAGGTATTGAATAACAGAA
cgtacgctgcaggtcgac 
knockout 
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2573 YJL048C_epi_r 
GAAAGAAAATATGTGTGAATAACCA
AATAGGAAATAAACAAAAGCACATat
cgatgaattcgagctcg 
knockout 
2574 YML088w_ko_f 
GAGTTAAAAACCTTTATCAGGTGGC
CGACACTAGGGAATAAGACAGCcgt
acgctgcaggtcgac 
knockout 
2575 YML088w_epi_r 
CTATAAATAAAATATTTAACATATGC
TCTTCCAAATGTACATACTTatcgatga
attcgagctcg 
knockout 
2611 YJL048C_5UTR_f GATTCGTTAGTAGTTGTATAGGGAC yeast colony PCR 
2612 YJL048C_3UTR_r CACGTTGACGAACTGAGTGAC yeast colony PCR 
2613 YML088w_5UTR_f CATTTTCTCGCATGTGGCGG yeast colony PCR 
2614 YML088w_3UTR_r GAGGAATAAAGTCCGACATTTTTTTC yeast colony PCR 
2615 YBR027C_5UTR_f GCAAGTCCCCGGATATGTTC yeast colony PCR 
2616 YBR027C_3UTR_r CTGACAAAACCTTGGTACAATCC yeast colony PCR 
2617 YOL073C_5UTR_f GAATGCCATTGATGTGAAGATGG yeast colony PCR 
2618 YOL073C_3UTR_r CAACCCAACAATACTAAAGCCAG yeast colony PCR 
2598 SEC3_ko_f 
GCCAGATATCTCCAGCTAGGTAACA
AGGCTACGCAATTTATTCTATATTcgt
acgctgcaggtcgac 
knockout 
2599 SEC3_epi_r 
CTTAATTAGTCTAAATATGTAATATG
AAGCGACAATGCAGAGGTTACatcga
tgaattcgagctcg 
knockout/tagging 
2585 IST2_ORF_1113_r CCATGCTAAATTGAATCAGTTGG sequencing 
2586 IST2_ORF_619_r CAACATGATAACCGAACTAGC sequencing 
2587 IST2_ORF_2408_r GTTATTTTCGCCACCAGTAACAG sequencing 
2588 IST2_ORF_1923_r CCGAGTTCTTGGTGCAACTTC sequencing 
2589 IST2_ORF_313_r GATAGGTTGTACAACTCATACTG sequencing 
2619 SEC3_kocheck_f GGCAAATACTAACTTGGTGAACAC yeast colony PCR 
2620 SEC3_kocheck_r CAATGAAGCTAACTAATATTCTGTTCC yeast colony PCR 
2621 SHE3_kocheck_r ccgttgtgagtgaccgaaagtg yeast colony PCR 
2631 SEC3_kocheck_f CTGAGTCGGTGCCAGATATC yeast colony PCR 
2632 HIS3 MX6 rev  CGACTCTTCAGGTAAGGGAGC yeast colony PCR 
2633 HIS3 MX6 out for  GTAATGACCATCATCGTGCTG yeast colony PCR 
2650 Ash1_-110bpStart_f cctatcgctcctgtcctatcc sequencing 
2656 Ash1_XhoI_3’UTR230bp_r 
CCGCTCGAGgagaagttattagaatgatttca
c sequencing 
2734 ASH1_ORF586_f CTGATCTTACCCATTGGTGTAAGG sequencing 
2735 ASH1_ORF486_f CTACCATCACTAAGGCATCTGC sequencing 
2736 ASH1_ORF1272_r CGTCGGTGTGGAGGGAGATGG sequencing 
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2737 ASH1_ORF1029_r GGCATGGGAAATGAATTTCCACG sequencing 
2774 SHE3tag_f 
CCACTCATAAGAAAAAGGGAAATAG
TATGGTTGTTCACGGGGCCCAATC
Ccgtacgctgcaggtcgac 
tagging 
3024 Kann_ORF_rev GAAACGTGAGTCTTTTCCTTACCC yeast colony PCR 
3141 ASH1_E3_r GTGTCGAATGAAAATGAAAGAAAATG RT 
3140 ASH1_E3_f_T7 ttaatacgactcactatagggCCGTTGCTTATTTTGTAATTACATAAC RT 
3158 5’RDN18-1_RT2 GGGATCGGGTGGTGTTTTTT RT-PCR 
3159 3’RDN18-1_RT2 CCAGAACCCAAAGACTTTGATTTC RT-PCR 
 
4.6. Plasmids 
 
pRJ name origin 
88 YEplac181-ASH1 pC3319 in Long et al., 1997 
132 YEplac195-ASH1 Jansen lab plasmid collection 
135 pFA6a-HIS3MX6 Wach et al., Yeast , 1994 
138/144 YCplac22 Gietz and Sugino, Gene, 1988 
139 YCplac33  Gietz and Sugino, Gene, 1988 
140 YIplac128 Gietz and Sugino, Gene, 1988 
141 YIplac204 Gietz and Sugino, Gene, 1988 
142 YIplac211 Gietz and Sugino, Gene, 1988 
143 YEplac181  Gietz and Sugino, Gene, 1988 
138/144 YCplac22 Gietz and Sugino, Gene, 1988 
145 YCplac111 Gietz and Sugino, Gene, 1988 
146 pRS303  Sikorski & Hieter, Genetics, 1989 
276 pYM2 Knop et al., Yeast, 1999 
286 pYM12 Knop et al., Yeast, 1999 
308 pRS426 Christianson et al. , Gene, 1992 
413 YEplac195 Gietz and Sugino, Gene, 1988 
577 pRS426-IST2-full length Matthias Seedorf, ZMBH Heidelberg  
630 pGEX-GST-Tev-She2p Jansen lab plasmid collection 
673 pRS426-WSC2-full length incl. UTRs Matthias Seedorf, ZMBH Heidelberg  
700 pRS424 Christianson et al. , Gene, 1992 
 Materials  
 
 
  88   
 
721 pRS313 Sikorski & Hieter, Genetics, 1989 
741 pG14-pGPD-NLS-HA-MS2-DSRed A. Jaedicke in Schmid et al., 2006 
915 YIp211-pGAPDH-HMG1-GFP Wihovsky et al., MBC, 2000 
916 YCplac111-SHE2-ATG-KpnI Thesis, T.G. Du 
920 YCplac111-GFP::She2 Thesis, T.G. Du 
921/2 YCplac111-GFP::She2 Thesis, T.G. Du 
1062 pRS423 Christianson et al. , Gene, 1992 
1063 pRS313-pGAL1-ASH1-MS2(6) A. Jaedicke in Schmid et al., 2006 
1101 YCplac22-She2 A1/2-16 Thesis, T.G. Du 
1146 YCplac111-She2p N36S this study 
1147 YCplac111-She2p R63K this study 
1148 YCplac111-She2p N36S R63K this study 
1149 YCplac111-She2p N36S,R63K this study 
1150 pRS313-She2p N36S,R63K this study 
1213 pFA6a-natNT2 Janke et al., Yeast, 2004 
1313 2xGFP-tag-cassette this study 
1314 pRS426-IST2-minusXho/BamHI sites this study 
1337 pRS426-IST2-BamHI3’UTR this study 
1338 pRS426-IST2-6xMS2 this study 
1341 YCp22-pGAPDH-HMG1-GFP this study 
1342 YCp33-pGAPDH-HMG1-GFP this study 
1343 YCplac111-pGAPDH-HMG1-GFP this study 
1347 pFA6a-kanMX6 Wach et al., Yeast, 1994 
1605 YCplac111-She2p L130S this study 
1606 pRS313-She2p L130S this study 
1384 pGEX-GST-Tev-She2p N36S this study 
1385 pGEX-GST-Tev-She2p R63K this study 
1386 pGEX-GST-Tev-She2p S120Y this study 
1387 pGEX-GST-Tev-She2p L130S this study 
1398 Sec63p-RFP (2 μ, URA3) S. Michaelis, John Hopkins, Baltimore, USA (pSM1960) 
1399 p431-GAL1-IST2-6xMS2 this study 
1403 pGEX-GST-Tev-TIS11 this study 
1404 pGEX-GST-Tev-SEC53 this study 
1412 pGEX-GST-Tev-She2p N36S,R63K this study 
1482 YCplac111-She2p-Helix Marisa Mueller; Gene Center, Munich 
1517 YCplac22-She2p-Helix Marisa Mueller; Gene Center, Munich 
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4.7. E. coli strains 
 
Strain essential genotype 
TOP10 cells 
(molecular biology) 
F- mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1 
araD139 (ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG 
(Invitrogen) 
XL1-Blue 
(molecular biology) 
hsd R17 rec A1 end A1 gyrA46 thi-1 sup E44 relA1 lac [F’ pro AB 
lacIqZM15 Tn10 (Tetr)] (Stratagene) 
BL21 (DE3)/RIL 
(protein expression) 
B F- ompT hsdS(rB-mB-) dcm+ Tetr gal
 (DE3) EndA Hte [argU ileY 
leuW Camr] (Stratagene) 
 
RJB transformed bacterial strain + pRJ  Plasmid name 
441 BL21(DE3)pRIL 630 pGEX-GST-Tev-She2p 
442 BL21(DE3)pRIL 1384 pGEX-GST-Tev-She2p N36S 
443 BL21(DE3)pRIL 1385 pGEX-GST-Tev-She2p R63K 
444 BL21(DE3)pRIL 1386 pGEX-GST-Tev-She2p S120Y 
445 BL21(DE3)pRIL 1387 pGEX-GST-Tev-She2p L130S 
448 BL21(DE3)pRIL 1412 pGEX-GST-Tev-She2p N36S,R63K 
 
4.8. S. cerevisiae strains 
 
RJY essential genotype 
358 MATa, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+  
359 MATalpha, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+ 
361 MAT a, his1 
362 MAT alpha, his1 
2049 MATa ; his31 ; leu20 ; met150 ; ura30 
2050 MAT alpha; his31; leu20; ura30 
2053 MAT alpha; his31; leu20; lys20; ura30; she2::kanMX4 
2292 MAT a his3 leu2 HMG1-GFP::URA3, ash1::TRP1, pRJ88 (YEplac181-ASH1) 
2299 MAT a his31 leu20 met150 ura30 myo4::kanMX6 
2321 MAT a URA3::HMG1-GFP 
2323 MAT a URA3::HMG1-GFP ash1::TRP1 myo4::kanMX6, pRJ88 (YEplac181-ASH1) 
2339 MAT a URA3::HMG1-GFP, pRJ1063 (pRS313-prGAL1-ASH1-MS2(6)) pRJ741 (pG14-prGPD1-MS2CP-RedStar) 
2369 MAT alpha his3 leu2 TRP1 HMG1-GFP::URA3, myo4::kanMX6, 
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2370 MAT a his3 leu2 TRP1 she2::kanMX6 HMG1-GFP::URA3, pRJ88 (YEplac181-ASH1) 
2372 MATalpha URA3::HMG1-GFP myo4::kanMX6, pRJ1063 (pRS313-prGAL1-ASH1-MS2(6)) pRJ741 (pG14-prGPD1-MS2CP-RedStar) 
2474 MAT a his3, leu2,TRP1, HMG1-GFP::URA she3::kanMX6 
2475 MAT a his3 leu2 TRP1  HMG1-GFP::URA she3::kanMX6, pRJ88 (YEplac181-ASH1) 
2479 MAT a URA3::HMG1-GFP ash1::TRP1 MYO4-HA3::HIS3MX6, pRJ88 (YEplac181-ASH1) 
2656 MAT a his3, TRP1, she2::kanMX4, HMG1-GFP::URA3, pRJ88 (YEplac181-ASH1), pRJ1150 (pRS313-She2pN36SR63K) 
2657 MAT a his3, TRP1, she2::kanMX4, HMG1-GFP::URA3, pRJ88 (YEplac181-ASH1), pRJ721 (pRS313) 
2731 MAT a URA3 ::HMG1-GFP aux1 ::kanMX6 
2794 MAT a URA3::HMG1-GFP aux1::kanMX6, pRJ1063 (pRS313-prGAL1-ASH1-MS2(6)) pRJ741 (pG14-prGPD1-MS2CP-RedStar) 
2807 MAT alpha ura3-52 his3200 leu21 srp101-47-ts 
2812 MAT a his3 leu2 met15 ura3 scp160 ::kanMX4 
2813 MAT alpha his3 leu2 lys2 met15 ura3 scp160::kanMX4 
2814 MAT a, his3, leu2, met15, ura3, asc1::kanMX4 
2815 MAT alpha, his3, leu2, lys2, met15, ura3, asc1::kanMX4 
2830 MAT alpha ura3-52 his3200 leu21 (FY68 WT; for 2807, 2858, 2859, 2866, 2867) 
2847 MAT a; his31; leu20; met150; ura30; trp1 
2848 MAT alpha; his31; leu20; ura30; trp1 
2858 MAT alpha ura3-52 his3200 leu21 srp101-47-ts, pRJ1063 (pRS313-prGAL1-ASH1-MS2(6)) pRJ741 (pG14-prGPD1-MS2CP-RedStar) 
2859 MAT alpha ura3-52 his3200 leu21 srp101-47-ts, pRJ1343 (YCplac111-HMG1-GFP) 
2862 MAT a; his31; leu20; met150; ura30, aux1::kanMx6 
2866 MAT alpha ura3-52 his3200 leu21, pG14-MS2-DSRed (p741), pRS313-pGAL1-ASH1-MS2(6) (p1063) 
2867 MAT alpha ura3-52 his3200 leu21, YCplac111-pGAPDH-HMG1-GFP (p1343) 
3279 MAT a, his3, leu2, TRP1, HMG1-GFP::URA3, YBR027C::natNT2 
3280 MAT a, his3, leu2, TRP1, HMG1-GFP::URA3, YOL073C::kanMX6 
3281 MAT a, his3, leu2, TRP1, HMG1-GFP::URA3, YJL048C::natNT2 
3282 MAT a, his3, leu2, TRP1, HMG1-GFP::URA3, YML088w::natNT2 
3031 MAT a sec3::HIS3MX6 (ts, grows at 25°C on –His, does not grow on YPD!) 
3283 MAT a; his3D1; leu2D0; met15D0; ura3D0; trp1D, p1179 (MS2CP), p1398 (SEC63-RFP), p1063 (ASH1-6MS2), p922 (GFP-She2p)  
3307 MAT a his3 leu2 TRP1 HMG1-GFP::URA she3::kanMX6 myo4::natNT2 
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4.9. Antibodies 
 
Name Source Dilution Company 
Primary Antibodies 
anti-Dpm1 (5C5) mouse 1:5 000 (Western) Molecular Probes  
anti-GFP (B-34) mouse 1:25 000 (Western) Covance 
anti-GST (B-14) mouse 1:10 000 (Western) Santa Cruz 
anti-HA (3F10) rat 1:1 000 (Western) Roche Applied Sciences 
anti-HA (16B12) mouse 1:1 000 (Western) HISS Diagnostics GmbH 
anti-myc (9E10) mouse 1:1 000 (IF,Western) Evan et al., 1985 
anti-Pgk1 (22C5) mouse 1:10 000 (Western) Molecular Probes  
anti-Rpa49p rabbit 1:50 000 (Western) Gift from H. Tschochner, Ratisbon 
anti-Rpl13p rabbit 1:10 000 (Western) Gift from M. Seedorf, Heidelberg 
anti-Sec61 rabbit 1:10 000 (Western) Gift from M. Seedorf, Heidelberg 
anti-She2p (323/4) rabbit 1:2000 (IF) Thesis T.-G. Du, 2007 
anti-She2p (134/3) rabbit 1:2 000 (Western) Thesis T.-G. Du, 2007 
Secondary Antibodies 
Alexa®488 anti-mouse-IgG goat 1:250 (IF) MoBiTec 
Alexa®488 anti-mouse-IgG rabbit 1:250 (IF) MoBiTec 
Alexa®488 anti-rabbit-IgG goat 1:250 (IF) MoBiTec 
Alexa®488 anti-rat-IgG donkey 1:100 (IF) MoBiTec 
Alexa®594 anti-mouse-IgG goat 1:250 (IF) MoBiTec 
Alexa®594 anti-mouse-IgG rabbit 1:250 (IF) MoBiTec 
Alexa®594 anti-rabbit-IgG goat 1:250 (IF) MoBiTec 
anti-mouse-IgG-HRPO goat 1:5 000 (Western) Dianova 
anti-rabbit-IgG-HRPO goat 1:5 000 (Western) Dianova 
anti-rat-IgG-HRPO goat 1:5 000 (Western) Dianova 
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5. Methods 
 
Many of the following microbiological, biochemical methods and in particular molecular 
biological methods such as restriction digest, dephosphorylation of fragments, ligations and 
separation of DNA in agarose gels are based on standard techniques (Ausubel, 2000; 
Sambrook et al., 2001). Commercially available kits were used according to the 
manufacturer’s instructions. Point mutations were inserted by quick change site directed 
mutagenesis using the QuickChange® Site-directed Mutagenesis Kit (Stratagene). Plasmids 
were sequenced by the in-house sequencing service (AG Blum, Gene Center Munich). For 
all methods described, deionised sterile water, sterile solutions and sterile flasks were used. 
 
5.1. E. coli-specific techniques 
 
5.1.1. Preparation of competent E. coli cells 
E. coli cells were grown at 37°C in 1l of LB medium (16 g bacto tryptone, 10 g yeast extract, 
5 g NaCl pH 7.4). At an OD600 ~0.7–0.8 cells were chilled on ice for 30 min and then 
harvested by centrifugation (15 min, 5000 rpm, 4°C). In the following, all steps were 
performed at 4°C, with prechilled sterile materials and solutions. For the preparation of 
electrocompetent bacteria, sedimented cells were washed once with 1l water centrifuged and 
washed a second time with 0,5 l water containing 10% (v/v) glycerol. After another 
centrifugation step, cells were resuspended in 3 ml 10% (v/v) glycerol and after shock 
freezing stored as aliquots at -80°C in 100 l. For the preparation of chemically competent 
cells, sedimented cells were carefully resuspended in half of the culture volume of 0.1 M 
CaCl2 and cooled on ice for 30 min. Finally competent cells were pelleted and resuspended 
in 1/40 volume of 0.1 M CaCl2/10% glycerol, divided into aliquots of 100 l, shock frozen in 
LN2 and stored at -80°C. 
 
5.1.2. Transformation of competent E. coli cells 
Both types of competent E. coli cells were thawed on ice shortly before transformation. For 
electroporation, 25 l competent cells were mixed with 10 ng plasmid DNA or 10 μl plasmid 
isolate from yeast which before had been micro-dialyzed on a nitrocellulose filter (Millipore, 
13 mm, 0.025 μm pores) against water. This mix was then electroporated in a pre-chilled 
cuvette (0.1cm electrode gap) with a pulse of 1.8 kV and 25 F at a resistance of 200 . For 
transformation of chemically competent cells, 1-10 ng of plasmid DNA or 10 l of a ligation 
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mix was pre-cooled and incubated with 50 l thawed cells for 15 min on ice. Cells were then 
heat shocked for 1min at 42°C and incubated on ice for 2 min. Subsequent to both 
transformation methods, cells were recovered in 1ml pre-warmed LB medium at 37°C for 1h 
and plated on antibiotic containing LB agar plates overnight at 37°C. Candidate colonies 
were picked to inoculate a 3ml LB Medium containing the appropriate antibiotics (e.g. 100 
g/ml ampicillin) for plasmid preparation (Miniprep), and incubated in a 37°C-shaker over 
night. 
 
5.1.3. Preparation of Plasmid-DNA 
Isolation of pure plasmid DNA for restriction analysis and sequencing was performed with the 
Nucleospin Miniprep Kit (Machery&Nagel). 
 
5.2. S. cerevisiae-specific techniques 
 
5.2.1. Cell density of yeast cultures 
The cell density of a yeast culture was determined in a spectrophotometer at a wavelength of 
600 nm. One OD at 600 nm (1 OD600) corresponds to 2.5 x 107 cells. 
 
5.2.2. Culture of S. cerevisiae 
Yeast strains were cultured in either full-medium or synthetic complete (SC) medium at 30°C 
or at 24°C in case of temperature sensitive strains. Full-medium contained 1% yeast extract 
(Becton Dickinson, Heidelberg), 2% Bacto-Peptone (Becton Dickinson, Heidelberg) and 
either 2% glucose (YPD) or 2% galactose (YPG). Synthetic complete media contained 0.67% 
yeast nitrogen base (Formedium, Norwich, UK), 0.06% CSM dropout mix (including all 
essential amino acids except the amino acids used as auxotrophy markers, i.e. leucine, 
tryptophane, histidine, uracil and adenine) and either 2% glucose (SDC) or 2% galactose 
(SGC). 5-FOA, G418 and clonNAT were added to a final concentration of 1g/l, 300 mg/l or 
100 mg/l respectively. 
 
5.2.3. Transformation of yeast cells 
‘One-step’ transformation with plasmid DNA was performed according to Chen et al. (Chen 
et al., 1992). The protocol for high-efficiency yeast transformations with linear DNA 
fragments and PCR products was adapted from Gietz and Schiestl (Gietz et al., 1992; 
Schiestl et al., 1989). Cells from a mid-log phase growing culture were harvested by 
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centrifugation (500g, 5 min, room temperature), washed first with 1/5 volume sterile water, 
then with 1/10 volume SORB solution (0.1 M LiOAc, 10 mM Tris-HCl pH 7.5, 1mM EDTA, 1.0 
M Sorbitol) and resuspended in 200l SORB solution. 50 μl of this cell suspension were 
gently mixed with 10μl of carrier DNA (salmon sperm DNA, 2 mg/ml), up to 4 μg of linear 
PCR fragment, 6 volumes of PEG (40 % PEG 4000 in 0.1 M LiOAc, 10 mM Tris-HCl, pH 7.5, 
1mM EDTA, 1.0 M Sorbitol) and incubated at 30°C for 30 min. To enhance the 
transformation rate DMSO in 10% final concentration was added (Hill et al., 1991) before 
heat shocking the cells for 15 min at 42°C. Cells were then centrifuged at 400g for 3min at 
room temperature, resuspended in 100l sterile water and plated on the selective SC 
medium plates. For transformation of temperature sensitive strains the 30°C step was 
performed at 25°C for 40 min and the duration of the 42°C heat shock was reduced to 5 min. 
If G418 or clonNAT was used for selection, transformed cells were first shaken for 3h or over 
night respectively in liquid YPD medium before plating. Selection of transformants was 
carried out for 2-3 days at 30°C (or 24°C for temperature sensitive strains). If necessary, 
transformants were replica-plated on selection plates to remove the background. 
 
5.2.4. Preparation of yeast genomic DNA 
Genomic DNA from yeast was extracted in order to use it as a template for PCR amplification 
of a desired gene. Cells from a (24 h) stationary yeast culture (15ml) were pelleted by 
centrifugation (3000 xg, 5 min, 4°C), washed once with 0.5 ml water and resuspended in 200 
l breaking buffer (2% (v/v) Triton X-100, 1% (v/v) SDS, 100 mM NaCl, 10 mM Tris-HCl pH 
8.0, 1 mM EDTA pH 8.0). Subsequently, 200l phenol/chloroform/isoamyl alcohol (24:24:1 
v/v/v; Roth) and 300 mg acid washed glass beads ( 425-600m; Sigma) were added, and 
the mixture was vibraxed for 5 min (highest speed, 4°C). The lysate was mixed with 200l TE 
buffer, centrifuged for 5 min at 16000 xg, 23 °C and the upper, aqueous layer transferred to a 
new tube. The genomic DNA was precipitated by addition of 1ml 100 % ethanol followed by a 
3 min centrifugation at 16000 xg, 23°C. The pellet was resuspended in 0.4 ml TE buffer and 
RNA contaminants were digested by treatment with 30 l of DNase-free RNase A (1 mg/ml) 
for 5min at 37°C. Next, the genomic DNA was re-precipitated by addition of 10l ammonium 
acetate (4M) and 1ml ethanol (100%). After a brief centrifugation, the pellet was shortly dried 
at 37°C to remove residual traces of ethanol and finally resuspended in 50 l TE buffer. The 
quality of isolated genomic DNA was assessed by agarose gel electrophoresis. 
 
5.2.5. Isolation of plasmid-DNA from yeast 
After cloning in yeast via gap repair for example, the plasmid DNA was re-isolated for its 
direct propagation in E. coli. 15 ml overnight yeast culture were harvested (5 min, 3000 xg, 
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4°C), resuspended in 300 l lysis buffer (1% (v/v) SDS, 10 mM Tris-HCl pH 8.0, 1 mM EDTA 
pH 8.0), and after addition of an equal volume of phenol/chloroform/isoamyl alcohol (24:24:1 
v/v/v; Roth), the liquid volume was filled with acid-washed glass-beads ( 425-600m; 
Sigma). Cells were then lysed by shaking on a vibrax (5 min, highest speed). The DNA was 
recovered by a 5 min centrifugation at 16000 xg, 4°C. The aqueous upper phase containing 
DNA was transferred to a new tube. For ethanol precipitation, 0.1 volume sodium acetate (3 
M, pH 4.8) and 2.5 volumes pre-chilled ethanol were added to the DNA solution and 
incubated at –20°C for 30 min. The mixture was then centrifuged for 20min at 16000 xg, 4°C. 
The DNA pellet was washed once with 0.5 ml 70% ethanol. After centrifugation, the DNA 
was air-dried and resuspended in an appropriated volume of TE buffer. The recovered 
plasmid DNA was subsequently transformed into E. coli by electroporation. 
 
5.2.6. Gap repair cloning via homologous recombination 
In S. cerevisiae one molecular feature namely its capability for homologous recombination 
can be used for plasmid construction via gap repair. A PCR fragment (including a gene of 
choice accompanied by a promoter and terminator) can be amplified with two primers each 
containing short stretches homologous to the backbone of the target vector. The 
amplification product is then co-transformed with the linearized target vector in yeast. 
Recombination of the two linear DNA fragments subsequently results in an intact plasmid 
which must be recovered from yeast for further propagation in E. coli. 
 
5.2.7. Genomic integration via homologous recombination 
Chromosomal gene deletions or insertions of epitope tags were performed by a PCR 
strategy (Janke et al., 2004; Knop et al., 1999; Longtine et al., 1998). Basis of this genomic 
manipulation are special cassette modules consisting of a selection marker and in case of C-
terminal tagging an additional sequence encoding for a tag. The PCR products generated 
from these template cassettes contain flanking homologous sequences which allow their 
targeted integration into the correct genomic loci. This is achieved by using PCR primers that 
have a 5’ end (45-55 bp) corresponding to the respective target genes and 3’ ends (22 bp) 
that anneal on and permit amplification of the chosen cassette. For gene deletions, the 
forward oligonucleotide contains 55bp immediately upstream of the start ATG whereas the 
reverse primer constist of a stretch of up to 55 bp downstream of the STOP codon. For 
integration of C-terminal epitope tags the forward primer must instead include 55 bp of the 
ORF just 5’ of the STOP codon (excluding the STOP). After amplification of the cassette, the 
PCR fragment was concentrated by ethanol precipitation and transformed into the desired 
yeast strains. In case of gene disruption, homologous recombination leads to replacement of 
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the complete ORF by the marker gene contained within the PCR cassette. Upon tag 
integration however the STOP codon of the target gene is substituted by the tag’s sequence 
followed by a marker gene. To assess whether the correct integration event had occurred, 
candidate yeast clones were subjected to yeast colony PCR (for gene deletion) or WCEs 
were prepared and used for Western Blot analysis (in case of epitope tagging). 
 
5.2.8. Yeast colony PCR 
After transformation single yeast colonies growing on selective plates were subjected to 
colony PCR in order to test whether they have integrated the gene disruption cassette at the 
correct locus. Simultaneously each colony was streaked out on new selective plates. For the 
colony PCR, one inoculation loop of cells from each colony was resuspended in 100 l 
0.02 M NaOH. For cell lysis an equal volume of glass beads was added and the suspension 
was incubated on a thermo-mixer for 5 min at 99°C, 1400 rpm. Finally the lysate was shortly 
incubated on ice, pelleted for 30 s at 16000xg and 5 μl of the supernatant was used as a 
template in 50 μl PCR reactions. 
 
5.2.9. Analytical whole cell extracts (WCEs) 
Analytical WCEs were used to check yeast clones for correct integration of the tagging 
cassettes. Preparation was performed as described previously (Knop et al., 1999). About 
2 OD600 of a logarithmically grown yeast culture or one inoculation loop of cells from a freshly 
grown yeast plate were resuspended in 1 ml of water. This cell suspension was vigorously 
mixed with 150 μl of a freshly prepared alkaline solution (1.85 M NaOH, 7.5% ß-MeEtOH) 
and cells were lysed by incubation on ice for 15 min. After addition of 150 μl of 55% TCA, 
precipitation of the cell lysate was performed for 15 min on ice. Following a 30 min 
centrifugation at 16 000xg and 4°C the supernatant was discarded and the tubes were 
centrifuged shortly for a second time to remove residual traces of TCA. The pellet was then 
resuspended in 100 μl of HU-buffer (8 M urea, 5% SDS, 200 mM Tris pH 6.8, 1 mM EDTA, 
with a trace of bromophenol blue as colouring and pH indicator, 1.5% DTT; the buffer is 
stored without DTT at -20°C). In case the samples turned yellow they were neutralized with 
1-3 μl 2 M Tris base. Proteins were then denatured at 65°C for 10 min in a thermomixer and 
insoluble aggregates were pelleted by centrifugation for 2 min at 16 000xg. Aliquots of the 
samples were analyzed by SDS Page and Immunoblotting. 
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5.3. SDS-PAGE and Western Blotting 
 
SDS-PAGE was performed according to Laemmli (Laemmli, 1970) on a Hoefer SE 260 
Mighty Small II system (Amersham Pharmacia). Proteins were transferred onto nitrocellulose 
membrane using a semi-dry blotting machine (Peqlab) for 1 h at 7 V. After transfer, the 
membrane was blocked with blocking buffer (2% milk-powder in PBS) and incubated 
overnight at 4°C with the first antibody dissolved in blocking buffer. Excess of first antibody 
was removed by washing the membrane 6 times for 5 min with blocking buffer at RT. The 
membrane was incubated with secondary antibodies diluted in blocking buffer for 1h at RT. 
Visualization of immuno-decorated proteins was performed using an ECL-Kit (Applichem), 
either followed by exposure of the membrane to light-sensitive films (GE Healthcare) and 
subsequent developing using a Kodak Xomat M35 developing machine or by direct analysis 
with the Fuji LAS-3000 mini chemiluminescence imaging system. 
 
5.4. Purification of recombinant She2p and She2p mutants from 
E. coli 
 
5.4.1. Recombinant expression in E. coli 
GST-She2p and GST-She2p-Mutants were recombinantly expressed in the E. coli strain 
BL21(DE3)/RIL (RJB343) using pGEX-GST-TEV-SHE2/she2 plasmids. 800 ml of LB medium 
containing ampicillin and chloramphenicol were inoculated with a stationary overnight culture 
to a starting OD600 of 0.2 and grown at 37°C until an OD600 of 0.8. 200 ml cold LB (4°C) 
medium was added, and expression was induced by the addition of 1 mM IPTG and 
incubation for 5-6 hours at 25°C. Cells were harvested in a SLC6000 rotor at 7800x g for 10 
min. After washing with 200 ml water, cells were pelleted in a GSA rotor for 10 min at 7800x 
g, and pellet was frozen in LN2 and stored at -20°C. 
5.4.2. Lysis of cells 
For the lysis, cells were resuspended in 30 ml lysis-buffer (25 mM Hepes-KOH pH 7.5, 0.1 
mM EDTA pH 8, 1 M NaCl, 2 mM DTT, 1x protease inhibitors) containing 100 mg/l Lysozyme 
and rotated in a 50 ml Falcon tube for 30 min at 30°C. After 3 rounds of freezing (LN2) and 
thawing (37°C water bath), cells were subjected to sonification with a flat tip in a 50 ml steal 
beaker. Cells were broken 4 times for 5 min with a pause of 5 min on ice in the Sonifier® 
(70% output, 40% duty cycle). NP40 was added to the lysate in a final concentration of 0.1% 
and rotated for 30 min. Cell debris was pelleted in a SS34 rotor at 4°C at 15.000 rpm for 30 
min. Samples of 100l of pellet and supernatant were taken and analyzed via SDS-PAGE. 
 Methods  
 
 
  98   
 
5.4.3. Affinity purification 
The GST-She2 fusion protein was purified using 500 l slurry of Glutathione Fast Flow 
Sepharose (Amersham Pharmacia). Beads were pre-washed with 10 ml lysis buffer and 
added to the lysate for binding in a 50 ml Falcon tube while rotating at 4°C for one hour. After 
binding, beads were washed with 10 ml wash buffer I (25 mM Hepes-KOH pH 7.5, 0.1 mM 
EDTA pH 8.0, 12.5 mM MgCl2, 1 M NaCl, 0.1% NP40, 2 mM DTT, 1x protease inhibitors) 
and  washbuffer II (25 mM Hepes-KOH pH 7.5, 0.1 mM EDTA pH 8.0, 12.5 mM MgCl2, 0.7 M 
NaCl, 0.1% NP40, 1 mM DTT), and finally equilibrated in 10 ml TEV-buffer (50 mM HEPES-
KOH pH 7.5, 100 mM NaCl, 1.5 mM MgCl2, 0.5 mM DTT, 0.15% NP40, 1 mM PMSF – add 
DTT and PMSF freshly before use) using a Poly-Prep Chromatography Column (BioRad). 
The remaining slurry was then transferred to a Mobicol column (MobiTec). After addition of 
500 l TEV-buffer and 10 l of TEV-protease, the column was rotated for 1 ½ hour at 16°C 
for TEV-cleavage. She2p was eluted by centrifugation of the Mobicol at 2000 rpm for 2 min. 
An aliquot (10 l) of the eluate (~500 l) was removed for analysis in SDS-PAGE. The His6-
tagged TEV-protease was removed using NiNTA sepharose (Quiagen). NiNTA-beads were 
washed 3 times with 10 ml TEV–buffer in a Mobicol. The TEV-eluate was added to the beads 
and rotated for 2 hours at 4°C. Recombinant She2p was eluted into a fresh eppendorf tube 
by a short spin for 1 min at 2000 rpm in a cooling centrifuge. If necessary, concentration of 
the recombinant eluate was further increased using vivaspin® concentrators. The protein 
concentration was determined using the Bradford assay (Biorad) according to the 
manufacturer’s manual. As standard a BSA solution (NEB) with a concentration of 10 mg/ml 
was employed. The She2p eluate was adjusted to a glycerol content of 20%, divided into 
small aliquots, shock frozen in liquid N2 and stored at -80°C. 
 
5.5. Subcellular Fractionation Experiments 
 
5.5.1. Spheroplasting of yeast and cell lysis 
Cell disruption by shearing the cell wall with glass beads is very fast and effective method. 
Nevertheless it is not applicable for most subcellular fractionation experiments as the strong 
mechanical forces arising damage intracellular organells and might possibly disrupt protein-
membrane interactions. In order preserve subcellular integrity, it is therefore more 
recommendable to enzymatically convert yeast cells to spheroplasts and to disrupt them by 
application of gentle mechanical forces. For the subcellular fractionation experiments 
described here, yeast cells were treated as follows: In short, the appropriate amount of cells 
(up to 530 OD600) was harvested and spheroplasted by Zymolyase treatment for 1h at 30°C 
under gentle shaking in 5 ml isotonic buffer SB (1.4 M sorbitol, 50 mM KPi pH 7.5, 10 mM 
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NaN3, 0.4% ß-MeEtOH, 2 mg/ml Zymolyase 20T). After this treatment intact spheroplasts 
were harvested through 8 ml of a sorbitol cushion (1.7 M Sorbitol, 50 mM KPi pH 7.5) by 
centrifugation for 10 min, 600 xg, 4°C. The spheropellet was then resuspended in 6 ml 
Hepes lysis buffer (20 mM Hepes/KOH, 140 mM KOAc, 1 mM MgOAc2, 1 mM EDTA, 
100U/ml Superasin RNAse inhibitor (Ambion, Huntingdon, UK) and a protease inhibitor 
cocktail) and lysis was performed by either 12 passages through a 25 gauge needle or by 
dounce homogenisation using a loose pestle. After pelleting cell debris (5x 5 min at 400xg) 
the homogenate was further processed as described in each fractionation assay. 
 
5.5.2. Velocity gradient centrifugation on discontinuous sucrose gradients 
Velocity gradient centrifugation on 18-60% sucrose gradients was essentially performed 
according to Barrowman et al., 2000 and Estrada et al., 2003 (Barrowman et al., 2000; 
Estrada et al., 2003). In short, cells corresponding to 400 OD600 units were harvested, 
spheroplasted, lysed with a needle and cleared from cell debris as described above. 1 ml of 
the homogenate (corresponding to 66 OD600 units) was then loaded onto a linear 18%-60% 
gradient of sucrose in 20 mM Hepes/KOH, 140 mM KOAc, 1 mM MgOAc2. Gradients were 
spun in a SW40 rotor for 2.3 h at 38000xg. 12x 1 ml fractions were collected starting close to 
the bottom of the gradient and the remaining pellet was resuspended in 1 ml lysis buffer. 
Fractions were TCA precipitated and resuspended in 100 μl SDS sample buffer. 20 μl of 
these were used for western blot analysis except for the top three fractions where only 7 μl 
were used in order to avoid overloading of the gel. 
 
5.5.2.1. RNase Treatment 
To entirely deplete extracts from mRNA, RNAse inhibitors were omitted from the lysis buffer 
and the lysate was treated with 0.2 mg/ml RNaseA (Roth) and 25 U/ml Microccocal Nuclease 
(SIGMA) in presence of 1 mM CaCl2
 
for 15 min at RT. The reaction was stopped by addition 
of 2 mM EDTA and by on cooling on ice. The RNAse/Micrococcal Nuclease treated as well 
as the mock treated lysate were carefully loaded on discontinuous gradients and further 
processed as above. After collecting the centrifuged gradient in 1 ml fractions, 800 μl of each 
sample were TCA precipitated for SDS-PAGE and immunoblotting. The remaining 200 μl 
were processed for RT-PCR analysis. Shortly, RNA was isolated by Phenol/Chloroform 
extraction, treated with RNase-free DNase (Promega) and reverse transcription was 
performed using oligo d(T)18 primers (NEB) and the BD PowerSript Reverse Transcriptase 
(Clontech). Different primer pairs was used on the cDNA for RT-PCR to asses the complete 
digest of RNA (ASH1: RJO 73+74; IST2: RJO 2428+2429; ribosomal rRNA RDN18: RJO 
3158+3159). 
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5.5.2.2. EDTA Treatment 
By addition of EDTA, ribosomes and polysomes can be disrupted into 40S and 60S subunits. 
To achieve this, lysis and gradients were performed in lysis buffer and sucrose solutions 
containing 10 mM EDTA. After SDS-PAGE and immunoblotting, polysome disruption was 
verified by using an antibody directed against a ribosomal protein (anti-Rpl13p). For 
quantification, ECL western blots were exposed for the shortest time possible that still gave a 
detectable signal on film, films were scanned at 600 dpi resolution and pixel values of the 
corresponding bands were determined using ImageJ 1.36b (http://rsb.info.nih.gov/ij/). After 
background subtraction, pixel values (= ‘amount of antigenic material’ in supplementary 
figure 3) were calculated using the integrated ‘Analyze Gels’ function of ImageJ. In order to 
compensate for unequal loading of the top 3 fractions (see above), these values were 
multiplied by three. 
 
5.5.3. In vitro binding assay: Velocity gradient with WCE and recombinant 
protein 
For in vitro binding experiments, a crude yeast lysate was prepared by spheroblasting and 
preclearing as described above except that instead of a SHE2 wt strain, a she2 strain 
(RJY2370) was used. 1 ml of the lysate (corresponding to 66 OD600) was pre-incubated with 
recombinant She2p and She2p-mutants (about 1.5 μg protein per reaction) for 30 min on ice. 
The suspension was then carefully loaded on an 18%-60% gradient. Centrifugation with a 
SW40 rotor, collection of the fractions and processing of the fractions was done exactly as 
described earlier. 
 
5.5.4. Purification of ER membranes on a 2-step sucrose gradient 
For the two-step microsome purification we used a scaled-down variant of a published 
protocol (Rieder et al., 2000; Wuestehube et al., 1992) originally designed to separate ER 
membranes from vacuolar and Golgi membranes. Logarithmically growing cells 
corresponding to 40 OD600 units were spheroplasted, lysed by dounce homogenisation and 
the cell homogenate pre-cleared as described above. Subsequently the lysate was spun for 
10 min at 16000xg, the supernatant was removed and the membrane pellet spun again for 1 
min at 13000xg to get rid of remaining supernatant. The resulting pellet was resuspended in 
200 μl HEPES lysis buffer and loaded on top of a two-step sucrose gradient (1.5 ml cushions 
of 1.2 M and 1.5 M sucrose in HEPES lysis buffer). After centrifugation in a SW60Ti rotor 
(1.6 h at 80000xg), two bands at the interphases of the sucrose cushions were visible. The 
upper band was collected as fraction 2 and the lower band, representing microsomes, as 
fraction 4. Five additional fractions were harvested (F1 = layer on top of upper band, F3 = 
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layer between upper and lower bands, F5 and F6 = layer below lower band, F7 = pellet). 
Protein from these fractions was precipitated with TCA and processed as above. 
 
5.5.5. Flotation Assay 
For membrane flotation of ER membranes via equilibrium density centrifugation we adapted 
a protocol from Kanai et al. (Kanai et al., 2004). 530 OD600 units of logarithmically growing 
cells were harvested, spheroplasted and lysed by dounce homogenisation and cleared from 
cell debris as described above. The crude lysate was mixed with gradient buffer (50 mM 
Hepes/KOH, 150 mM KOAc, 5 mM MgOAc2) containing 85 % sucrose to give a final sucrose 
percentage of 50%. 3 ml of this suspension was layered on top of 3 ml 70% sucrose in 
gradient buffer. Two additional 3 ml cushions (40% sucrose and 0% sucrose) were layered 
on top. The 4-step gradient was spun in a SW40 rotor for 8.6 h at 38000xg. After 
centrifugation, fractions were collected from each cushion and the interphases (in total 7 
fractions). Protein was precipitated with TCA and processed as above. 
 
5.6. In vitro binding assay with flotation purified ER membranes 
 
5.6.1. Preparation of yeast microsomal membranes 
Preparation of yeast microsomes was in principle performed as described previously 
(Brodsky et al., 1993; Rothblatt et al., 1986). 4.5 l of yeast cell culture from a she2 strain 
(RJY2370) were harvested at an OD600 of 1.0-2.0 (SLC 6000 rotor, 5min, 5000 rpm, RT) and 
washed once with water. After weighing the cell pellet it was resuspended in 100 mM Tris-
SO4 pH 9.4, 10 mM DTT to a final concentration of 50 OD600/ml and incubated for 15 min at 
RT. Following this preincubation, cells were washed once with 1.2 M sorbitol and then 
resuspended in 80 ml of YPD medium containing 0.7 M sorbitol, 20mM KPi pH 7.4 and 
Zymolyase 20T (in a concentration of 2.5 mg Zymolyase/g cells). Spheroplast formation was 
allowed to proceed for 90 min at 30°C with very gentle swirling. The spheroplast suspension 
was then layered on “cushion 1” (0.8 M sucrose, 1.5% ficoll 400, 20 mM Hepes/KOH pH 7.4) 
in 50 ml conical tubes and was centrifuged at 3000 rpm for 15 min at 4°C. The supernatant 
was carefully removed, and the spheropellet was resuspended in 0.7 M sorbitol, 20mM KPi 
pH 7.4 at 1000 OD600/ml and frozen in LN2 for storage at -80°C. Alternatively, spheroplasts 
were directly further processed. In the latter case, the spheropellet was resuspended to 100-
200 OD600/ml in ice cold lysis buffer (100 mM sorbitol, 50 mM KOAc pH 7.4, 2 mM EDTA, pH 
8.0, 20 mM Hepes/KOH, pH 7.4,1 mM DTT, 1 mM PMSF) and homogenized extensively on 
ice in a glass potter with tight fitting pestle. To collect microsomes, 15 ml “cushion 2” (1 M 
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sucrose, 50 mM KOAc pH 7.4, 20 mM Hepes/KOH pH 7.4, 1 mM DTT) were over layered 
with 15 ml lysate in several 50 ml conical tubes and centrifuged (10 min, 4000 rpm, 4°C). 
Material remaining in the upper 15 ml layer was recovered avoiding the interface and 
centrifuged (21000 xg, 10 min, 4°C). The membrane pellet was washed once with buffer 88 
(20 mM Hepes/KOH pH 6.8, 150 mM KOAc pH 7.4, 250 mM sorbitol, 5 mM MgOAc2) and 
pelleted again at 21000 xg for 10 min at 4°C. The microsome pellet was then resolved in 
about 2 ml of buffer 88 to a final concentration of OD260= 40 in 2% SDS corresponding to a 
protein concentration of 10-12 mg/ml. Finally these yeast rough membranes (YRMs) were 
aliquoted, shock frozen in LN2 and stored at -80°C. 
For protease treatment of YRMs, purified microsomes before aliquoting and storage were 
adjusted to 10 mM CaCl2 and either mock treated or treated with a combination of 2mg/ml 
Pronase E (20mg/ml stock; SIGMA) and 2mg/ml Proteinase K (20mg/ml stock; Roche) for 30 
min at 37°C. Subsequent to digest, both mock and protease containing samples were treated 
with excess EDTA and EGTA and 1 mM PMSF to inhibit proteases. Only the protease-
containing membranes were additionally incubated for 15 min at 80°C to inactivate protease 
activity by heat denaturation. This step was not performed for mock treated membranes to 
maintain the integrity of ER marker proteins. Both membrane preparations were then washed 
2 times with buffer 88, resuspended in the original volume of buffer 88 and treated for 
storage at -80°C as described above. 
 
5.6.2. Flotation purification of ER membranes 
For flotation purification of YRMs, 5 μl of the above prepared microsomes were mixed with 
200 μl cushion III (2.3 M sucrose in 50 mM Hepes/KOH pH 7.5, 5 mM MgOAc2, 150 mM 
KOAc, 1.5 mM DTT). This cushion was layered at the bottom of an ultra clear SW55 tube 
(5x41 mm) and carefully covered with 360 μl of cushion II (1.9 M sucrose in 50 mM 
Hepes/KOH pH 7.5, 5 mM MgOAc2, 150 mM KOAc, 1.5 mM DTT) followed by 120 μl of 
cushion I (50 mM Hepes/KOH pH 7.5, 5 mM MgOAc2, 150 mM KOAc, 1.5 mM DTT). After 
centrifugation with adaptors in a SW55 Ti rotor for 90 min at 45 000 rpm and 4°C the 
membrane fraction was collected at the interface between cushion I and II. Harvested 
membranes were either TCA precipitated to check for composition via SDS-PAGE and 
Western blotting or they were used directly for the in vitro binding assay (see below). 
 
5.6.3. In vitro pelleting assay 
For the binding-assay, four fractions of flotation-purified membranes were combined and 
diluted with 2 volumes of binding-assay buffer (50 mM HEPES/KOH pH 7.5, 5 mM MgOAc2, 
150 mM KOAc, 1,5 mM DTT) to reduce the sucrose concentration. After re-solubilisation of 
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the membranes they were mixed and incubated with recombinant protein (850 ng She2p or 
GST) for 10 min at RT and 15 min on ice. This in vitro binding mix was then layered over a 
500 μl sucrose cushion (1.2 M sucrose, 50 mM HEPES pH 7.5, 5 mM MgOAc2, 150 mM 
KOAc, 1.5 mM DTT) and centrifuged in a TLA 120.2 rotor for 1h at 100 000 rpm, 4°C. 
Subsequent to centrifugation, the supernatant was collected, the lowest level of the cushion 
(225 μl) including the pellet was resuspended in 1 ml of binding-assay buffer and both were 
TCA precipitated. Samples were then analyzed by SDS-PAGE and immunoblotting. 
 
5.7. Flotation assay with ER-like protein-free liposomes 
 
5.7.1. Preparation of ER-like, protein free Liposomes: 
Liposomes with ER-like lipid content (ergosterol 16%, phosphatidylcholine PC 40%, 
phosphatidylethanolamine PE 24%, phosphatidylserine PS 10%, phosphatidylinositol PI 
10%) (Schneiter et al., 1999; Tuller et al., 1999; Zinser et al., 1991) were prepared as follows 
(Qbadou, JCS 2003). All lipids used were solved in chloroform/methanol (Avanti Polar Lipids, 
Roth, Sigma). They were mixed to a total amount of 100 mg lipid in a round bottom flask 
darkened with aluminium foil and filled with N2 gas. The lipid mixture was then dried with a 
rotary evaporator at 95 mbar under N2 atmosphere and slow rotational speed for 2-3 h until 
all residual organic solvent was completely removed. The created lipid film was completely 
dissolved to a final total lipid concentration of 10mg/ml in degassed liposome buffer (20 mM 
HEPES pH 7.4, 100 mM NaCl) by gentle swirling at RT for about 1 h. The lipid emulsion was 
then passed 21 times through a 400 nm pore polycarbonate filter membrane mounted in an 
extruder (“LiposoFast-Basic”, Avestin) in order to create unilamellar liposomes. The 
liposomes were then aliquoted, shock frozen in LN2 and stored at – 80°C.  
For preparation of liposomes lacking PS and PI, the lipid composition was changed to 18% 
ergosterol, 41% PC and 41% PE. Apart from this change liposomes were prepared as 
described above. 
 
5.7.2. In vitro binding and flotation of liposomes 
In order to assess protein-liposome interaction, 1.36 μg (48 pmol) She2p or 1.45 μg GST 
were combined with 100 μl liposomes and 140 μl binding buffer (50 mM Hepes/KOH, 150 
mM KOAc, 1 mM MgOAc2, 1mM EDTA, 1mM DTT) and incubated for 15 min at RT followed 
by 10 min on ice to allow binding. 40 μl of sample were kept as “input” for SDS-PAGE and 
Western blotting. 200 μl were mixed with 3 ml binding buffer containing 70% sucrose to form 
the bottom of the gradient in a SW40 ultraclear polycarbonate tube. The sample containing 
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cushion was then over layered with 3 ml binding buffer containing 50%, 40% and 0% sucrose 
respectively. After centrifugation to equilibrium (22000 rpm, 16.5 h, 4°C, SW40 rotor) the lipid 
containing fraction of about 1ml was collected at the 40%-0% sucrose interface, TCA 
precipitated and resolved in 45 μl HU buffer. Flotation samples together with “input” samples 
were analysed by SDS-PAGE and immunoblotting. 
 
For carbonate treatment, which is known to shear off peripheral membrane proteins (Fujiki et 
al., 1982), 1 M Na2CO3, pH 11.5 solution was added to the She2p/liposome resuspension to 
a final concentration of 0.1 M Na2CO3, pH 11.5. Flotation was performed as described above 
with the exception that all sucrose cushions contained 0.1 M Na2CO3, pH 11.5. 
For high salt treatment to test for ionic interaction forces, 2.5 M KCl was added to the 
She2p/liposome mixture to a final concentration of 1 M KCl. The flotation assay was carried 
out in a gradient consisting of sucrose cushions in binding buffer containing 1M KCl. 
 
For the RNA competition assay, 48 pmol She2p was pre-incubated with either mock (binding 
buffer) or 480 pmol (10x) or 960 pmol (20x) of in vitro transcribed ASH1 E3 element for 15 
min at RT and 10 on ice in 140 μl RNAse free binding buffer containing RNasin	 (Promega). 
Liposomes were added only afterwards and were incubated with the protein – mRNA mix 
under the same conditions. Centrifugation and sample processing was performed as 
mentioned above. The ASH1 E3 element mRNA was synthesized with the Ambion 
MEGAshortscript T7 Kit according to the manufacturer’s instructions. As template for reverse 
transcription, a PCR fragment amplified from pRJ88 with the oligonucleotide pair RJO 3140, 
3141 was used.  
 
5.8. Indirect immunofluorescence 
 
Cellular distribution of a protein was detected in the microscope by indirect 
immunofluorescence (IF) using specific antibodies. 
5.8.1. Preparation of cells 
Cells of a logarithmically growing culture (10 ml) were fixed with formaldehyde in a final 
concentration of 3.7%. Fixation was performed in a shaking incubator for one hour either at 
30°C or at 37°C in order to maintain non-permissive conditions. Cells were centrifuged and 
washed three times with spheroplasting buffer (1.2 M Sorbitol, 0.1 M Potassium phosphate 
(pH 7.4), and 0.5 M MgCl2). They were subsequently spheroplasted in 500l spheroplasting 
buffer containing 100 g/ml of Zymolyase 100T and 0.2% 2-Mercaptoethanol for 45 minutes 
at 30°C. Spheroplasts were pelleted at low speed (3000 rpm/1000x g) in a tabletop 
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centrifuge for one minute. They were washed and finally resuspended in 200 l 
spheroplasting buffer. The cell suspension was stored in aliquots at -80°C or directly used for 
immunofluorescence. 
5.8.2. Immunofluorescence 
Multi-well slides (Neolab) used for immunofluorescence microscopy were coated with drops 
of 0.02% Poly-L-Lysine for 5 min and washed with distilled water. A drop of the cell 
suspension (~10 μl) was applied onto each well for 5 min. Cells were blocked for 5 min with 
blocking solution (1x PBS, 1% BSA). A dilute solution of the primary antibody was put onto 
each well and incubated for 2 hours in a wet chamber. After three rounds of washing (1x 
PBS, 1% BSA, 0.1% Triton X-100), cells were incubated with diluted Alexa®-coupled 
secondary antibodies (Molecular Probes) in a darkened wet chamber for one hour. After 
another three rounds of washing, nuclei were stained with Hoechst Stain Solution (SIGMA) 
and cells were mounted in mounting solution (1x PBS, 80% glycerol). Cells were inspected 
with an Olympus BX60 fluorescence microscope (Olympus) and a 100x NA 1.3 DIC oil 
objective. Images were acquired using an ORCA ER CCD camera (Hamamatsu Photonics) 
controlled by Openlab 4.01 software (Improvision). 
 
5.9. Fluorescent in situ hybridisation using oligonucleotides (FISH) 
Cellular localization of mRNAs was determined in the microscope using fluorescently labelled 
antisense oligonucleotides for ASH1 and DIG labelled anti-sense probes for WSC2 mRNA. 
 
5.9.1. Preparation of FISH probes 
5.9.1.1. Fluorescently labelled (Cy3-conjugated) antisense DNA 
oligonucleotides (ASH1) 
A stock solution containing 100 ng/l of each oligonucleotide was diluted with DEPC treated 
water to yield aliquots sufficient for 6 wells. Aliquots of 10l were dried in a speed-vac and 
stored at -80°C. (1 ng/l oligonucleotides, 1 mg/ml E. coli tRNA and 1 mg/ml salmon sperm 
DNA in DEPC water) 
 
5.9.1.2. DIG-labelled antisense probes (WSC2) 
The anti WSC2 probe was prepared by generating four different digoxigenin (DIG)-labelled, 
antisense WSC2 RNA fragments with the MEGAshortscript T7 Kit (Ambion) according to the 
manufacturer’s protocol. Shortly, four DNA fragments (250-310 bp long) were amplified from 
a WSC2 template (pRJ675) with a set of primer pairs (RJO 1082 – 1089) with each reverse 
primer harbouring the T7 promoter for in vitro transcription. After Phenol-Chloroform 
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extraction of the fragments, reverse transcription with simultaneous DIG-labelling was 
performed with the MEGAshortscript T7 Kit to create antisense RNA probes. The four 
different anti-WSC2 RNA-fragments were then mixed in equal amounts to yield an anti-
WSC2 probe which allows annealing over a long stretch of the WSC2 ORF. The mix of the 4 
probes (3.3 μg/μl) was diluted to 660 ng/μl, split into 10 μl aliquots and frozen at -80°C. 
 
5.9.2. Preparation of cells 
Cells of a logarithmically growing culture (10 ml) were fixed with formaldehyde (3.7 % final 
concentration). Fixation of cells was performed in a shaking incubator for one hour either at 
30°C. Cells were pelleted and washed three times with Buffer B (1.2 M sorbitol, 100 mM 
potassium phosphate pH 7.4). Cells were spheroplasted for 10 min at 30°C in 200l 
spheroplasting buffer (1ml contains: 100 g Oxalyticase (Enzogenetics); 720 l 1.4 x Buffer B 
(1.7 M sorbitol, 140 mM KPi pH 7.4); 3.5 l AEBSF (4-(2-Aminoethyl)-benzensulfofluorid; 
Applichem); 100 l RVC (Ribonucleoside-Vanadyl-Complex, Sigma); 3 l RNasin	 
(Promega); 2 l ß-MeEtOH; 171.5 l DEPC-water). After spheroplasting, cells were pelleted 
carefully for one minute at low speed (3000 rpm/1000x g) and washed with buffer B. 
Spheroplasts were finally resuspended in 100 l buffer B. Multi-well slides were coated with 
0.02% Poly-L-Lysine for 5 min and washed with DEPC water. 5l of the cell suspension was 
applied onto each well for 30 min at 4°C. After washing with Buffer B, the slide was fixed and 
stored in 70% ethanol at -20°C. 
 
5.9.3. Hybridisation procedure 
5.9.3.1. Hybridisation of fluorescently-labelled oligonucleotides (ASH1)  
Multi-well slides were re-hydrated in a jar with 2x SSC (20x SSC: 3 M NaCl; 0.3 M Na3-
citrate) and 2x SSC, 40% formamide for 5 min. In the meantime a frozen aliquot of the ASH1 
probe was resuspended in 15 l of solution 1 (49.3 l formamide, 0.63 l 1M Na-phosphate 
pH 7.0, 11.7 ul DEPC-water) and incubated at 80°C for 3 min. Probes were then mixed with 
15 l of ice-cold solution 2 (12.3 l BSA (20 mg/ml); Roche), 12.3 l 20 x SSC, 0.75 l 
RNasin	 (Promega), 36.2 l DEPC-water) and centrifuged at full speed for 5 min. Each well 
was wetted with 5l of the probe solution, covered with a large cover slip and hybridised over 
night at 37°C in a darkened wet chamber.  
After hybridisation, the slide was washed in a jar with pre-warmed (37°C) solution of 2x SSC, 
40% formamide at 37°C for 15 min, two times with 2x SSC, 0.1% Triton for 15 min at RT and 
finally with 1x SSC for 15 min at RT. Nuclei were stained with Hoechst Stain Solution 
(SIGMA) for 15 min and cells were mounted in mounting solution (1x PBS, 80% glycerol).  
 Methods  
 
 
  107   
 
 
5.9.3.2. Hybridisation of DIG-labelled probes (WSC2) 
Slides with adherent cells were re-hydrated in a 50 ml jar for 5 min at RT with 5xSCC buffer. 
After this, they were pre-hybridised with 40 ml of hybridisation mix (for 40 ml: 20 ml 100% 
formamide; 10 ml 20xSSC; 400 μl 500 mM EDTA pH 8.0; 400 μl 10% Tween; 800 μl 50x 
Denhardt’s; 400μl 10% CHAPS; 400μl 10mg/ml tRNA; 400μl 10mg/ml herring sperm DNA; 
400μl 10mg/ml Heparin; 6,8ml DEPC-water) for 1h at RT. In the meantime, 10 μl of WSC2-
probe solution was mixed with 90 μl of hybridisation mix, applied to the multi-well slides after 
pre-hybridisation and incubated over night at 37°C in a darkened wet chamber.  
Subsequent to hybridisation, slides were washed in a jar with pre-warmed (37°C) solution of 
2x SSC, 40% formamide at 37°C for 15 min and two times with antibody solution (1x PBS, 
10% FCS, 0.1% TritonX-100) for 15 min at RT. After this, the primary mouse-anti-DIG 
antibody was applied to the wells (diluted 1:250 in antibody solution) and incubated at RT for 
2 hrs. After three washing steps with 1x PBS, 0.1% BSA, the secondary rabbit-anti-mouse- 
Alexa	488 antibody (1:1000 in antibody solution) was applied at RT for 1 h. Again after 3 
washing steps with 1x PBS, 0.1% BSA, the tertiary goat-anti-rabbit-Alexa	488 antibody was 
used in a 1:1000 dilution for 1 hr at RT. Slides were washed again twice and nuclei were 
stained with Hoechst Stain Solution (SIGMA) for 15 min at RT before the stain was washed 
away and cells were mounted with 1x PBS, 80% glycerol. 
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6. Summary 
 
mRNA localization is a widespread mechanism in most eukaryotic cells to spatially restrict 
protein synthesis. During cell propagation of the budding yeast S. cerevisiae, mRNA 
localization is the basis for an asymmetric, stem-cell like division process. At least 24 
transcripts are known to be localized to the yeast bud tip and the common core machinery 
mediating this mRNA translocation pathway consists of three components: the type V motor 
protein Myo4p, its adaptor She3p and the mRNA binding protein She2p. Recently, Myo4p 
and She3p were identified as essential factors of another bud-directed transport process, the 
inheritance of cortical endoplasmic reticulum (ER). In addition, live cell imaging revealed a 
co-localization and co-migration of localizing mRNPs with ER tubules that move to the yeast 
bud, implying for the first time that there might be a common transport of mRNAs and ER 
membranes. 
Within the scope of this study it was demonstrated that mutants defective in ER segregation 
are simultaneously impaired in mRNA localization indicating that there is indeed a connection 
between the two processes. Additionally, the RNA binding protein She2p associates with ER 
membranes in different sucellular fractionation assays and it does so independently of 
polysomes (thus, ongoing translation), mRNA and the Myo4p/She3p complex. During in vitro 
binding assays, recombinant She2p binds to flotation purified ER microsomes and protease 
treated membranes suggesting that She2p is not tethered to ER via a protein factor. Finally, 
She2p was found to have an inherent membrane binding activity since it directly associated 
with synthetic lipid vesicles in flotation assays. She2p attaches to liposomes also in presence 
of its RNA ligand excluding the possibility of an unspecific binding via its basic mRNA binding 
moiety. 
In summary, these data indicate that mRNA trafficking and ER inheritance are coordinated 
processes in S. cerevisiae and that She2p is the factor that tethers localizing mRNPs to the 
ER membranes. Consistent with this observation there is a growing number of examples 
from higher eukaryotes for a connection between membrane and mRNA transport. This in 
turn suggests that it is not a yeast specific phenomenon but rather might be a common 
theme throughout all kinds of eukaryotic species. 
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8. Abbreviations 
 
aa amino acid 
ab antibody 
Amp ampicillin 
ATP adenosine triphosphate 
ß-MeEtOH beta-mercaptoethanol 
BSA bovine serum albumin 
bp basepair 
°C degree centigrade 
C. elegans Caenorhabditis elegans 
CIP calf intestine phospatase 
clonNAT nourseothricin 
CSM complete supplement mix 
C-terminal carboxy terminal 
Da dalton 
DEPC diethylpyrocarbonate 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
dNTP deoxyribonucleosid triphosphate 
DTT dithiothreitol 
ECL enhanced chemoluminiscence 
E. coli Escherichia coli 
EDTA ethylenediaminotetraacetic acid 
ER endoplasmic reticulum 
et al.  et alii (from Latin, “and others”) 
5-FOA 5-Fluoroorotic acid  
g gram 
x g relative centrifugal force (rcf) 
G418 Geniticin 
GFP green fluorescent protein 
GST glutathione S-transferase 
h hour 
HA hemagglutinin 
Hepes 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HO endonuclease homothallic switching endonuclease 
 Abbreviations  
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IPTG isopropyl-beta-D-thiogalactoside 
k kilo 
kb kilo basepairs 
KH-domain heterogeneous nuclear (hn)RNP K-homology 
domain 
l litre 
LB Luria Bertani 
LE localization element 
LN2 liquid nitrogen 
μ micro 
m milli 
M molar 
mA milliampere  
MC mitochondrial cloud 
min minutes 
METRO  messenger transport organizer 
mRNA messenger ribonucleic acid 
n nano 
NE nuclear envelope 
NP-40 Nonidet P-40 (Igepal-CA-630) 
NTP nucleoside triphosphate 
nt nucleotide 
OD optical density 
ORF open reading frame 
p picot 
PAGE polyacrylamide gelelectrophoresis 
PBS phosphate-buffered saline 
PC phosphatidylcholine 
PCR polymerase chain reaction 
PE phosphatidylethanolamine 
PEG polyethylene glycol 
pH potential of hydrogen 
PI phosphatidylinositol 
PIP phosphoinositol 
PS phosphatidylserine 
RNA ribonucleic acid 
RBP RNA binding protein 
 Abbreviations  
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RNP ribonucleoprotein 
rpm revolutions per minute 
RT room temperature 
S. cerevisiae Saccharomyces cerevisiae 
SDS sodium dodecyl sulfate 
s second 
S sedimentation coefficient (Svedberg) 
SHE Swi5p-dependent HO expression 
TCA trichloroacetic acid 
TMD transmembrane domain 
Tris trishydroxymethylaminomethane 
tRNA transfer ribonucleic acid 
UTR untranslated region 
V volt 
WCE whole cell extract 
wt wild type 
YEP yeast extract peptone 
YNB yeast nitrogen base 
YRMs yeast rough membranes 
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